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(57) ABSTRACT 
This disclosure concerns nucleic acid molecules and methods 
of use thereof for control of hemipteran pests through RNA 
interference-mediated inhibition of target coding and tran 
scribed non-coding sequences in hemipteran pests. The dis 
closure also concerns methods for making transgenic plants 
that express nucleic acid molecules useful for the control of 
hemipteran pests, and the plant cells and plants obtained 
thereby. 
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PARENTAL RNA SUPPRESSION OF 
HUNCHBACKGENE TO CONTROL 
HEMPTERAN PESTS 
PRIORITY CLAIM 
0001. This application claims the benefit of the filing date 
of U.S. Provisional Patent Application Ser. No. 62/092,776, 
filed Dec. 16, 2014, for “PARENTAL RNAISUPPRESSION 
OF HUNCHBACK GENE TO CONTROL HEMIPTERAN 
PESTS” which is incorporated herein in its entirety. 
FIELD OF THE DISCLOSURE 
0002 The present invention relates generally to genetic 
control of plant damage caused by hemipteran pests. In par 
ticular embodiments, the present disclosure relates to identi 
fication of target coding and non-coding polynucleotides, and 
the use of recombinant DNA technologies for post-transcrip 
tionally repressing or inhibiting expression of target coding 
and non-coding polynucleotides in the cells of a hemipteran 
pest to provide a plant protective effect. 
BACKGROUND 
0003 Stink bugs and other hemipteran insects (het 
eroptera) are an important agricultural pest complex. World 
wide, over 50 closely related species of stink bugs are known 
to cause crop damage. McPherson & McPherson (2000) Stink 
bugs of economic importance in America north of Mexico, 
CRC Press. Hemipteran insects are present in a large number 
of important crops including maize, soybean, fruit, veg 
etables, and cereals. 
0004 Stink bugs go through multiple nymph stages before 
reaching the adult stage. These insects develop from eggs to 
adults in about 30-40 days. Both nymphs and adults feed on 
sap from Soft tissues into which they also inject digestive 
enzymes causing extra-oral tissue digestion and necrosis. 
Digested plant material and nutrients are then ingested. 
Depletion of water and nutrients from the plant vascular sys 
tem results in plant tissue damage. Damage to developing 
grain and seeds is the most significant as yield and germina 
tion are significantly reduced. Multiple generations occur in 
warm climates resulting in significant insect pressure. Cur 
rent management of Stink bugs relies on insecticide treatment 
on an individual field basis. Therefore, alternative manage 
ment strategies are urgently needed to minimize ongoing crop 
losses. 
0005 RNA interference (RNAi) is a process utilizing 
endogenous cellular pathways, whereby an interfering RNA 
(iRNA) molecule (e.g., a double stranded RNA (dsRNA) 
molecule) that is specific for all, or any portion of adequate 
size, of a target gene results in the degradation of the mRNA 
encoded thereby. In recent years, RNAi has been used to 
perform gene "knockdown” in a number of species and 
experimental systems; for example, Caenorhabditis elegans, 
plants, insect embryos, and cells in tissue culture. See, e.g., 
Fire et al. (1998) Nature 391:806-11; Martinez et al. (2002) 
Cell 110:563-74; McManus and Sharp (2002) Nature Rev. 
Genetics 3: 737-47. 
0006 RNAi accomplishes degradation of mRNA through 
an endogenous pathway including the DICER protein com 
plex. DICER cleaves long dsRNA molecules into short frag 
ments of approximately 20 nucleotides, termed Small inter 
fering RNA (siRNA). The siRNA is unwound into two single 
Stranded RNAS: the passenger strand and the guide strand. 
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The passenger Strand is degraded, and the guide Strand is 
incorporated into the RNA-induced silencing complex 
(RISC). Micro inhibitory ribonucleic acids (miRNAs) are 
structurally very similar molecules that are cleaved from pre 
cursor molecules containing a polynucleotide "loop' con 
necting the hybridized passenger and guide Strands, and they 
may be similarly incorporated into RISC. Post-transcrip 
tional gene silencing occurs when the guide Strand binds 
specifically to a complementary mRNA molecule and 
induces cleavage by Argonaute, the catalytic component of 
the RISC complex. This process is known to spread systemi 
cally throughout some eukaryotic organisms despite initially 
limited concentrations of siRNA and/or miRNA such as 
plants, nematodes, and some insects. 
0007 Only transcripts complementary to the siRNA and/ 
or miRNA are cleaved and degraded, and thus the knock 
down of mRNA expression is sequence-specific. In plants, 
several functional groups of DICER genes exist. The gene 
silencing effect of RNAi persists for days and, under experi 
mental conditions, can lead to a decline in abundance of the 
targeted transcript of 90% or more, with consequent reduc 
tion in levels of the corresponding protein. In insects, there 
are at least two DICER genes, where DICER1 facilitates 
miRNA-directed degradation by Argonaute 1. Lee et al. 
(2004) Cell 117(1):69-81. DICER2 facilitates siRNA-di 
rected degradation by Argonaute2. 
0008. The overwhelming majority of sequences comple 
mentary to insect DNAs (such as, for example, the 9,000+ 
sequences identified in U.S. Pat. No. 7,612,194 and U.S. 
Patent Publication Nos. 2007/0050860, 2010/0192265, and 
2011/0154545) do not provide a plant protective effect when 
used as dsRNA or siRNA. For example, Baum et al. (2007) 
Nature Biotechnology 25:1322-1326, describe the effects of 
inhibiting several WCR gene targets by RNAi. These authors 
reported that 8 of the 26 target genes they tested were notable 
to provide experimentally significant coleopteran pest mor 
tality at a very high iERNA (e.g., dsRNA) concentration of 
more than 520 ng/cm. 
0009. The authors of U.S. Pat. No. 7,612,194 and U.S. 
Patent Publication No. 2007/0050860 made the first report of 
in planta RNAi in corn plants targeting the western corn 
rootworm. Baum et al. (2007) Nat. Biotechnol. 25(11): 1322 
6. These authors describe a high-throughput in vivo dietary 
RNAi system to screen potential target genes for developing 
transgenic RNAi maize. Of an initial gene pool of 290 targets, 
only 14 exhibited larval control potential. One of the most 
effective double-stranded RNAs (dsRNA) targeted a gene 
encoding vacuolar ATPase subunit A (V-ATPase), resulting in 
a rapid Suppression of corresponding endogenous mRNA and 
triggering a specific RNAi response with low concentrations 
of dsRNA. Thus, these authors documented for the first time 
the potential for in planta RNAi as a possible pest manage 
ment tool, while simultaneously demonstrating that effective 
targets could not be accurately identified a priori, even from a 
relatively small set of candidate genes. 
0010. Another potential application of RNAi for insect 
control involves parental RNAi (pRNAi). First described in 
Caenorhabditis elegans, pRNAi was identified by injection 
of dsRNA into the body cavity (or application of dsRNA via 
ingestion), causing gene inactivity in offspring embryos. Fire 
et al. (1998), supra; Timmons and Fire (1998) Nature 395 
(6705):854. A similar process was described in the model 
coleopteran, Tribolium castaneum, whereby female pupae 
injected with dsRNA corresponding to three unique genes 
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that control segmentation during embryonic development 
resulted in knock down of Zygotic genes in offspring 
embryos. Bucher et al. (2002) Curr. Biol. 12(3):R85-6. 
Nearly all of the offspring larvae in this study displayed 
gene-specific phenotypes one week after injection. Although 
injection of dsRNA for functional genomics studies has been 
successful in a variety of insects, uptake of dsRNA from the 
gut environment through oral exposure to dsRNA and Subse 
quent down-regulation of essential genes is required in order 
for RNAi to be effective as a pest management tool. Auer and 
Frederick (2009) Trends Biotechnol. 27(11):644-51. 
0.011 Parental RNAi has been used to describe the func 
tion of embryonic genes in a number of insect species, includ 
ing the springtail, Orchesella cincta (Konopova and Akam 
(2014) Evodevo 5(1):2); the brown planthopper, Nilaparvata 
higens; the sawfly, Athalia rosae (Yoshiyama et al. (2013) J. 
Insect Physiol. 59(4):400-7); the German cockroach, Mat 
tel/a germanica (Piulachs et al. (2010) Insect Biochem. Mol. 
Biol. 40:468-75); and the pea aphid, Acyrthosiphon pisum 
(Mao et al. (2013) Arch Insect Biochem Physiol 84(4): 209 
21). The pRNAi response in all these instances was achieved 
by injection of dsRNA into the hemocoel of the parental 
female. 
SUMMARY OF THE DISCLOSURE 
0012 Disclosed herein are nucleic acid molecules (e.g., 
target genes, DNAs, dsRNAs, siRNAs, shRNAs, miRNAs, 
and hpRNAs), and methods of use thereof, for the control of 
hemipteran pests, including, for example, Euschistus heros 
(Fabr) (Neotropical Brown Stink Bug, “BSB'); E. servus 
(Say) (Brown Stink Bug); Nezara viridula (L.) (Southern 
Green Stink Bug); Piezodorus guildinii (Westwood) (Red 
banded Stink Bug); Halyomorpha halys (Stal) (Brown Mar 
morated Stink Bug); Chinavia hilare (Say) (Green Stink 
Bug); C marginiatum (Palisot de Beauvois); Dichelops mela 
canthus (Dallas); D. furcatus (F.); Edessa meditabunda (F.); 
Thyanta perditor (F) (Neotropical Red Shouldered Stink 
Bug); Horcias nobilellus (Berg) (Cotton Bug); Taedia Stig 
mosa (Berg); Dysdercus peruvianus (Guérin-Méneville): 
NeOmegalotomus parvus (Westwood); Leptoglossus Zonatus 
(Dallas); Niesthrea Sidae (F.); Lygus hesperus (Knight) 
(Western Tarnished Plant Bug); and L. lineolaris (Palisot de 
Beauvois). In particular examples, exemplary nucleic acid 
molecules are disclosed that may be homologous to at least a 
portion of one or more native nucleic acids in a hemipteran 
pest. In some embodiments, hemipteran pests are controlled 
by reducing the capacity of an existing generation of the pest 
to produce a Subsequent generation of the pest. In certain 
examples, delivery of the nucleic acid molecules to hemi 
pteran pests does not result in significant mortality to the 
pests, but reduces the number of viable progeny produced 
therefrom. 
0013. In these and further examples, the native nucleic 
acid may be a target gene, the product of which may be, for 
example and without limitation: involved in a metabolic pro 
cess; involved in a reproductive process; and/or involved in 
embryonic and/or nymph development. In some examples, 
post-transcriptional inhibition of the expression of a target 
gene by a nucleic acid molecule comprising a polynucleotide 
homologous thereto may result in reduced growth and/or 
reproduction of the hemipteran pest. In specific examples, a 
hunchback gene is selected as a target gene for post-transcrip 
tional silencing. In particular examples, a target gene useful 
for post-transcriptional inhibition is the novel gene referred to 
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hereinas BSB hunchback (SEQID NO:1), referred to herein 
in some places as BSB hb. An isolated nucleic acid molecule 
comprising the polynucleotide of SEQID NO:1; the comple 
ment of SEQ ID NO:1; and/or fragments of either of the 
foregoing (e.g., SEQ ID NO:2) is therefore also disclosed 
herein. 
0014. Also disclosed are nucleic acid molecules compris 
ing a polynucleotide that encodes a polypeptide that is at least 
about 85% identical to an amino acid sequence within a target 
gene product (for example, the product of a hunchback gene). 
For example, a nucleic acid molecule may comprise a poly 
nucleotide encoding a polypeptide that is at least 85% iden 
tical to SEQ ID NO:3 (BSB HUNCHBACK); and/or an 
amino acid sequence within a product of BSB hb. Further 
disclosed are nucleic acid molecules comprising a polynucle 
otide that is the reverse complement of a polynucleotide that 
encodes a polypeptide at least 85% identical to an amino acid 
sequence within a target gene product. 
0015. Further disclosed are cDNA polynucleotides that 
may be used for the production of iRNA (e.g., dsRNA, 
siRNA, shRNA, miRNA, and hpRNA) molecules that are 
complementary to all or part of a hemipteran pest target gene, 
for example, a hunchback gene. In particular embodiments, 
dsRNAs, siRNAs, shRNAs, miRNAs, and/or hpRNAs may 
be produced in vitro, or in vivo by a genetically-modified 
organism, such as a plant or bacterium. In particular 
examples, cDNA molecules are disclosed that may be used to 
produce iRNA molecules that are complementary to all or 
part of mRNA transcribed from BSB hb (SEQID NO:1). 
0016. Additionally disclosed are means for inhibiting 
expression of an essential gene in a hemipteran pest, and 
means for protecting a plant from a hemipteran pest. A means 
for inhibiting expression of an essential gene in a hemipteran 
pest is a single- or double-stranded RNA molecule consisting 
of a polynucleotide selected from the group consisting of 
SEQ ID NO:12 and SEQ ID NO:13; and the complements 
thereof. Functional equivalents of means for inhibiting 
expression of an essential gene in a hemipteran pest include 
single- or double-stranded RNA molecules that are substan 
tially homologous to all or part of mRNA transcribed from a 
BSB gene comprising SEQID NO:1. A means for protecting 
a plant from a hemipteran pest is a DNA molecule comprising 
a polynucleotide encoding a means for inhibiting expression 
of an essential gene in a hemipteran pest operably linked to a 
promoter, wherein the DNA molecule is capable of being 
integrated into the genome of a maize plant. 
0017 Disclosed are methods for controlling a population 
of a hemipteran pest, comprising providing to a hemipteran 
pest an iRNA (e.g., dsRNA, siRNA, shRNA, miRNA, and 
hpRNA) molecule that functions upon being taken up by the 
pest to inhibit a biological function within the pest, wherein 
the iRNA molecule comprises all or part of (e.g., at least 15 
contiguous nucleotides of) a polynucleotide selected from the 
group consisting of: SEQID NO:1; the complement of SEQ 
ID NO:1; SEQID NO:2; the complement of SEQID NO:2; a 
native coding polynucleotide of a hemipteran organism (e.g., 
BSB) comprising all or part of SEQID NO:1 and/or SEQID 
NO:2; the complement of a native coding polynucleotide of a 
hemipteran organism comprising all or part of SEQID NO:1 
and/or SEQID NO:2; a native non-coding polynucleotide of 
a hemipteran organism that is transcribed into a native RNA 
molecule comprising all or part of SEQID NO:1 and/or SEQ 
ID NO:2; and the complement of a native non-coding poly 
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nucleotide of a hemipteran organism that is transcribed into a 
native RNA molecule comprising all or part of SEQID NO:1 
and/or SEQID NO:2. 
0018. In particular examples, methods are disclosed for 
controlling a population of a hemipteran pest, comprising 
providing to a hemipteran pest an iRNA (e.g., dsRNA, 
siRNA, shRNA, miRNA, and hpRNA) molecule that func 
tions upon being taken up by the pest to inhibit a biological 
function within the pest, wherein the iRNA molecule com 
prises a polynucleotide selected from the group consisting of 
all or part of: SEQ ID NO:12; the complement of SEQ ID 
NO:12: SEQID NO:13; the complement of SEQID NO:13; 
a polynucleotide that hybridizes to a native coding polynucle 
otide of a hemipteran (e.g., BSB) organism comprising all or 
part of SEQID NO:1 or SEQID NO:2; and the complement 
of a polynucleotide that hybridizes to a native coding poly 
nucleotide of a hemipteran (e.g., BSB) organism comprising 
all or part of SEQID NO:1 or SEQID NO:2. 
0019. Also disclosed herein are methods wherein dsR 
NAs, siRNAs, shRNAs, miRNAs, and/or hpRNAs may be 
provided to a hemipteran pest in a diet-based assay, or in 
genetically-modified plant cells expressing the dsRNAS, siR 
NAs, shRNAs, miRNAs, and/or hpRNAs. In these and further 
examples, the dsRNAs, siRNAs, shRNAs, miRNAs, and/or 
hpRNAS may be ingested by a hemipteran pest. Ingestion of 
dsRNAs, siRNA, shRNAs, miRNAs, and/or hpRNAs of the 
invention may then result in RNAi in the pest, which in turn 
may result in silencing of a gene essential for a metabolic 
process; a reproductive process; and/or nymph development. 
Thus, methods are disclosed wherein nucleic acid molecules 
comprising exemplary polynucleotide(s) useful for parental 
control of hemipteran pests are provided to a hemipteran pest. 
In particular examples, the hemipteran pest controlled by use 
of nucleic acid molecules of the invention may be BSB. In 
Some examples, delivery of the nucleic acid molecules to 
hemipteran pests does not result in significant mortality to the 
pests, but reduces the number of viable progeny produced 
therefrom. In some examples, delivery of the nucleic acid 
molecules to hemipteran pests results in significant mortality 
to the pests, and also reduces the number of viable progeny 
produced therefrom. 
0020. The foregoing and other features will become more 
apparent from the following Detailed Description of several 
embodiments, which proceeds with reference to the accom 
panying Figures. 
BRIEF DESCRIPTION OF THE FIGURES 
0021 FIG. 1A includes a depiction of the strategy used to 
generate dsRNA from a single transcription template with a 
single pair of primers, and FIG.1B includes a depiction of the 
strategy used to generate dsRNA from two transcription tem 
plates. 
0022 FIG. 2 includes a summary of modeling data show 
ing the effect of relative magnitude of a pRNAi effect on 
female BSB adults emerging from a “refuge patch” (i.e., that 
did not express insecticidal iRNAs or recombinant proteins in 
a transgenic crop) on the rate of increase in allele frequencies 
for resistance to an insecticidal protein (R) and RNAi (Y) 
when non-refuge plants express the insecticidal protein and 
parental active iRNA. 
0023 FIG. 3 includes a summary of modeling data show 
ing the effect of relative magnitude of a pRNAi effect on 
female BSB adults emerging from a “refuge patch” (i.e., that 
did not express insecticidal iRNAs or recombinant proteins in 
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a transgenic crop of plants comprising BSB nymph-active 
interfering dsRNA in combination with the BSB-active insec 
ticidal protein in the transgenic crop) on the rate of increase in 
allele frequencies for resistance to an insecticidal protein (R) 
and RNAi (Y) when non-refuge plants express the insecti 
cidal protein and both larval active and parental active iRNA 
molecules. 
0024 FIG. 4 shows relative transcript level for genes of 
hunchback (hb) in the ovaries of E. heros females. Insects not 
injected with dsRNA were used as a reference;YFP dsRNA 
injected insects were used as a negative control. Means com 
parisons were performed with Dunnett's test using non-in jected insects as controls. ** indicates significance at p<0. 
OO1. 
(0025 FIGS. 5A-5C show oviposition, development and 
hatch rates of eggs from hunchback dsRNA-injected E. heros 
females. Females were injected with dsRNA at 0 to 2 days 
post adult molt. The counts are based on 1342 eggs oviposited 
by un-injected females, 1202 eggs byYFPv2 dsRNA-injected 
females, and 922 eggs by hb dsRNA-injected females in a 
two-week period. Eggs were collected on daily bases starting 
at 7 days post injection; the development and hatch rates are 
weekly intervals. FIG. 5A shows thenumber of eggs ovipos 
ited per day perfemale and averaged in weekly intervals. FIG. 
5B shows the percent of eggs that developed past the stage of 
visible head pigmentation. FIG. 5C shows the percentiles of 
eggs hatched of the eggs oviposited during weeks one and two 
of egg collection. Means comparisons were performed with 
Dunnett's test using non-injected insects as controls, * indi 
cates significance at p-0.001. 
(0026 FIGS. 6A-6C show parental hunchback dsRNA 
phenotypes in E. heros. E. heros females were injected with 
dsRNA at 0 to 2 days post adult molt. FIG. 6A showsa four 
day-old embryo dissected from an egg of an hb dsRNA 
injected female. The embryo exhibits a phenotype that 
includes shortened limbs and head structures. FIG. 6B shows 
a four-day-old embryo from a non-injected female shows the 
normal arrangement of developing head structures and limbs. 
FIG. 6C shows a two-day-old embryo from a non-injected 
female shows an earlier stage of development with elongated 
appendages. 
SEQUENCE LISTING 
0027. The nucleic acid sequences listed in the accompa 
nying sequence listing are shown using standard letter abbre 
viations for nucleotide bases, as defined in 37 C.F.R.S 1.822. 
The nucleic acid and amino acid sequences listed define mol 
ecules (i.e., polynucleotides and polypeptides, respectively) 
having the nucleotide and amino acid monomers arranged in 
the manner described. The nucleic acid and amino acid 
sequences listed also each define a genus of polynucleotides 
or polypeptides that comprise the nucleotide and amino acid 
monomers arranged in the manner described. In view of the 
redundancy of the genetic code, it will be understood that a 
nucleotide sequence including a coding sequence also 
describes the genus of polynucleotides encoding the same 
polypeptide as a polynucleotide consisting of the reference 
sequence. It will further be understood that an amino acid 
sequence describes the genus of polynucleotide ORFs encod 
ing that polypeptide. 
0028. Only one strand of each nucleic acid sequence is 
shown, but the complementary strand is understood as 
included by any reference to the displayed strand. As the 
complement and reverse complement of a primary nucleic 
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acid sequence are necessarily disclosed by the primary 
sequence, the complementary sequence and reverse comple 
mentary sequence of a nucleic acid sequence are included by 
any reference to the nucleic acid sequence, unless it is explic 
itly stated to be otherwise (or it is clear to be otherwise from 
the context in which the sequence appears). Furthermore, as it 
is understood in the art that the nucleotide sequence of an 
RNA strand is determined by the sequence of the DNA from 
which it was transcribed (but for the substitution ofuracil (U) 
nucleobases for thymine (T)), an RNA sequence is included 
by any reference to the DNA sequence encoding it. In the 
accompanying sequence listing: 
0029 SEQID NO:1 shows an exemplary BSB hb DNA: 
GCCCTTTGGGTTTAGTTCTCTACGAGCTGCTCTACCATCCACTAGGACTA 
GCTCTATCTTCTCTCTTATATTAGTTCTGGATATATATCTCTCTCTCTCT 
ATCTATATCTACAGCTGGGAACACCGTAGTCGTCTTTTGTTTTATATATA 
TTGCCTGCATGTTGGAATGAGATGATTATAACTCCTGATATATACTTTAA 
CAATCCGAGGATGAACATCGGTGTGCAATACGACCCAAGGCATTCCGTCT 
TCCCGAATTTGGAGCACCATCCATGGATGGCTTCCCCGACTCCGGCACAA 
GTCGTTAAAGAGGAGCCGCGAGATGACGCGGAGTACGGTCAGAACAGCCA 
GGAGAGCCAGCTGCCGCTGACGCCGCCCCCCTTCCAGGGCTACCCCCCGG 
GGAACACCTACCGCGAGGCCACGCCCCCTAAGGATACGCCCCCCGCCTCC 
ACCCCCTCGCCTCAGGAGAAGCAGGAAGGCAGCTCCAACTCCGAGGGAGA 
GTACTACGAGAGCGGAGAGTCCCTAAAGAGGCTGCAGATGGCCCTCCATA 
GGACCGGGATGATAACGGAGGAGAAGCTGCAATGTCCTGTATGCGAGTTC 
TCTTGCAGTGTCAGGTCACAGTTCAATGAACACCTATTGTCACACGAGAC 
TAAATGTTCCATGTGCGACTTCAGTGGAGAAACCAGTGAAAAATTGAGAG 
AGCACATGAGGAATGTCCACGACTGCGATGATGACAGCAGCTGGGGAGAA 
GAAGAGCTCAACACTCCCAAAGTCAATTCTCAGGGAAAGGTCAAAACGTT 
TCGCTGCAAGCAGTGTGAGTTTTCAGCTGTGACGAAACTAGAATTTTGGG 
ATCACTCTCGCACCCACATCAAACAGGAGCGATTGCTCACTTGCCCAAAG 
TGCCCATTCGTCACTGAATACAAACACCATCTCGAATACCATTTGAGGAA 
TCATTTTGGATCGAAACCGTTCAAGTGTGACAAGTGTTCCTACTCTTGCG 
TGAACAAATCCATGCTCAATTCTCACTTGAAAAGTCACAGCAACATTTAC 
CAGTTCAGATGTGCTGATTGCACCTACGCTACTAAGTATTGTCACAGCTT 
GAAGCTGCATCTGAGAAAATATGCTCACAACCCAGCCATGGTTCTTAACC 
CTGACGGTTCTCCTAATCCTCTACCAATCG TAGATGTATATGGAACTAGG 
CGTGGTCCAAAGCAGAAGCCCAAGAATGAACAGCAACCACAACAACCGCC 
GCAGGTCCCGACTATTTTCAACCCATATTCCTTACTTCCAACACAGATGC 
CATATTACAACATCCTTAATGGATTTGGAGGATTTCCTTTCCCACAAGAT 
GTTAACATGGAAGAGAAAAACAACAATGTTGAAAAAGAAGAGATCAGAGA 
AGATAAAGCTCCTCTTGACTTGAGCTGCCCTGAACCGATGGTAGAAGACA 
GCAATCAAGAAGCCCCAGTGAAAAACCGTAGAAAAGGGAAAGCCTTCAAA. 
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- Continued 
CTTGACAGAATCGCCCTTCGCCTACAGCAGCAAGTCGAAGTGGAAGAGCA 
GCCAGAACCGCCAAAACCGATCCCACCACCTGTGGTTTCCGAGCCGGCAA 
AATCACCTGAAATTAAGTCCTGCGAAGCTGACAGCGAGCAGCAGAAGGTG 
GAGAAAACAGAACAGGAGAATGTGTATAGTTGCACTTTTTGTGATATTTT 
ATTTAAGGACATTGTTATGTATACAATGCATATGGGTTACCATGGCTACG 
AAGACCCCTTCAAGTGCAACATGTGCGGGCAGCAAACAACCGACAAGGTT 
TCTTTCTTCCTCCACATTGCAAGAACATCACACTCATAAGGATTACAATT 
CTATTATTAATCAAATAGATTTTTTTCTGGTTTTAAAAGAGAATCCAACT 
TGTTACCCAGTTCACGTCATTAACTGTCTCTCGTGGCAGTTTATGTAAATA 
TTTATTATATCATCATTTAGATTATTAATATATTATTTTCCAGATATATT 
TAGCGTTGGTGTCTAGTCATGTGTATAACAACATAATGTGTAAAAAAAAA 
ATGTGGAATTAGGAAATAGTGTCCTAACATATGAAATATGTAAACAAGAG 
AAAGGAATAACAAAAATGTTAAAAGTAATTAACATTATTAAGAATATTTG 
AAAAACAATATTATGTTCCCTTCTAATGTTAATGAGCGAGTAAAAAAAGT 
TAAAACGATTGCATAGTTTTAAGGTATTTTATAGCCG 
0030 SEQID NO:2 shows an exemplary E. heros hunch 
back DNA, of which the complementary strand is transcribed 
to become the sense strand of an exemplary BSB hunchback 
dsRNA (BSB hb-1): 
GTCCACGACTGCGATGATGACAGCAGCTGGGGAGAAGAAGAGCTCAACAC 
TCCCAAAGTCAATTCTCAGGGAAAGGTCAAAACGTTTCGCTGCAAGCAGT 
GTGAGTTTTCAGCTGTGACGAAACTAGAATTTTGGGATCACTCTCGCACC 
CACATCAAACAGGAGCGATTGCTCACTTGCCCAAAGTGCCCATTCGTCAC 
TGAATACAAACACCATCTCGAATACCATTTGAGGAATCATTTTGGATCGA 
AACCGTTCAAGTGTGACAAGTGTTCCTACTCTTGCGTGAACAAATCCATG 
CT CAATTCTCACTTGAAAAGTCACAGCAACATTTACCAGTTCAGATGTGC 
TGATTGCACCTACGCTACTAAGTATTGTCACAGCTTGAAGCTGCATCTGA 
GAAAATATGCTCACAACCCAGCCATGGTTCTTAACCCTGACGGTTCTCCT 
AATCCTCTACCAATCGTAG 
0031 SEQID NO:3 shows the amino acid sequence of a 
BSB HUNCHBACK polypeptide encoded by an exemplary 
BSB hb DNA: 
MIITPDIYFNNPRMNIGVOYDPRHSVFPNLEHHPWMASPTPAOVVKEEPR 
DDAEYGONSOESOLPLTPPPFOGYPPGNTYREATPPKDTPPASTPSPOEK 
QEGSSNSEGEYYESGESLKRLOMALHRTGMITEEKLOCPVCEFSCSVRSO 
FNEHILLSHETKCSMCDFSGETSEKLREHMRNWHDCDDDSSWGEEELNTPK 
WNSOGKVKTFRCKOCEFSAVTKLEFWDHSRTHIKOERLLTCPKCPFWTEY 
KHHLEYHLRNHFGSKPFKCDKCSYSCVNKSMLNSHLKSHSNIYOFRCADC 
TYATKYCHSLKLHLRKYAHNPAMVLNPDGSPNPLPIVDWYGTRRGPKOKP 
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KNEOOPOOPPOVPTIFNPYSLLPTOMPYYNILNGFGGFPFPODVNMEEKN 
NNWEKEEIREDKAPLDLSCPEPMVEDSNOEAPVKNRRKGKAFKLDRIALR 
LOOOVEVEEOPEPPKPIPPPVVSEPAKSPEIKSCEADSEOOKVEKTEOEN 
WYSCTFCDILFKDIWMYTMHMGYHGYEDPFKCNMCGOOTTDKVSFFLHIA 
RTSHS 
0032 SEQ ID NO:4 shows the nucleotide sequence of a 
T7 phage promoter. 
0033 SEQID NO:5 shows an exemplary DNA encoding a 
YFPv2 gene targeting hairpin-RNA-forming RNA; contain 
ing a YFPv2 sense polynucleotide, a loop polynucleotide 
including an ST-LS1 intron (underlined), and YFPv2 anti 
sense polynucleotide (bold font): 
ATGTCATCTGGAGCACTTCTCTTTCATGGGAAGATTCCTTACGTTGTGGA 
GATGGAAGGGAATGTTGATGGCCACACCTTTAGCATACGTGGGAAAGGCT 
ACGGAGATGCCTCAGTGGGAAAGGACTAGTACCGGTTGGGAAAGGTATGT 
TTCTGCTTCTACCTTTGATATATATATAATAATTATCACTAATTAGTAGT 
AATATAGTATTTCAAGTATTTTTTTCAAAATAAAAGAATGTAGTATATAG 
CTATTGCTTTTCTGTAGTTTATAAGTGTGTATATTTTAATTTATAACTTT 
TCTAATATATGACCAAAACATGGTGATGTGCAGGTTGATCCGCGGTTACT 
TTCCCACTGAGGCATCTCCGTAGCCTTTCCCACGTAIGCTAAAGGTGTGG 
CCATCAACATTCCCTCCATCTCCACAACGTAAGGAACTTCCCAGAAA 
GAGAAGGCTCCAGATGACAT 
0034 SEQID NO:6 shows an exemplary DNA compris 
ing an ST-LS1 intron. 
0035) SEQ ID NOs:7 and 8 show primers used for PCR 
amplification of a BSB hb polynucleotide. 
0036 SEQ ID NO:9 shows the DNA template for the 
sense strand of an exemplary YFPv2 dsRNA. 
0037 SEQID NOS:10 and 11 show primers used for PCR 
amplification of a YFP gene. 
0038 SEQ ID NOS:12 and 13 show exemplary RNAs 
transcribed from nucleic acids comprising exemplary hunch 
back polynucleotides and fragments thereof. 
0039 SEQID NO:14 shows an actin-ORF. 
TACAAAATGTGTGACGAAGAAGTTGCTGCTTTAGTTGTAGACAATGGATC 
TGGTATGTGCAAAGCCGGTTTCGCTGGAGATGATGCACCCCGAGCTGTAT 
TCCCATCAATTGTTGGCAGGCCTAGACACCAGGGTGTCATGGTTGGAATG 
GGACAAAAGGACAGTTATGTTGGAGACGAAGCCCAAAGCAAGAGAGGTAT 
CCT CACCCTGAAATACCCCATTGAACACGGTATCATCACCAACTGGGACG 
ACATGGAAAAGATCTGGCATCACACCTTCTACAACGAGCTGCGAGTCGCT 
CCAGAGGAACACCCCATCCTCCTGACTGAGGCTCCCCTCAACCCCAAAGC 
CAACAGGGAGAAGATGACCCAGATCATGTTTGAGACCTTCAACACCCCAG 
CCATGTATGTCGCCATCCAGGCTGTACTCTCCCTCTATGCCTCCGGTCGT 
ACTACCGGTATTGTACTTGACTCAGGAGATGGTGTCTCCCACACCGTACC 
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CATCTATGAAGGTTATGCCCTTCCCCACGCCATCCTCCGTCTGGATCTTG 
CTGGACGTGACTTGACTGACTATCTTATGAAGATCCT CACCGAGCGTGGT 
TACAGCTTCACCACCACCGCTGAAAGGGAAATCGTCAGGGACATCAAGGA 
AAAACTGTGCTATGTCGCCCTGGACTTTGAGCAGGAAATGGCCACCGCCG 
CTGCCTCCACCTCCCTGGAGAAGTCCTATGAACTTCCCGACGGTCAGGTC 
ATCACCATCGGTAACGAGAGGTTCCGTTGCCCAGAGGCTCTCTTCCAGCC 
TTCCTTCTTGGGTATGGAATCTTGCGGTATCCATGAGACTGTCTACAACT 
CCATCATGAAGTGCGACGTTGACATCAGGAAGGACTTGTACGCCAACACC 
GTCCTCTCCGGAGGTACCACCATGTACCCAGGTATTGCTGACAGGATGCA 
GAAGGAAATCACCGCCCTCGCTCCTTCAACCATCAAGATCAAGATCATTG 
CTCCCCCAGAAAGGAAGTACTCCGTATGGATCGGTGGTTCCATCTTGGCT 
TCCCTGTCCACCTTCCAGCAGATGTGGATCTCCAAGCAGGAATACGACGA 
ATCCGGCCCAGGCATCGTCCACCGCAAATGCTTC 
DETAILED DESCRIPTION 
I. Overview of Several Embodiments 
0040 We developed RNA interference (RNAi) as a tool 
for insect pest management, using a target pest species for 
transgenic plants that express dsRNA; the Neotropical brown 
Stink bug. Thus far, most genes proposed as targets for RNAi 
in particular insects do not achieve their purpose, and those 
useful targets that have been identified involve typically those 
that cause lethality in the nymph stage. Herein, we describe 
RNAi-mediated knockdown of hunchback (hb) in the Neo 
tropical brown stink bug, which is shown to disrupt embry 
onic development when, for example, iRNA are molecules 
are delivered via hunchback dsRNA provided to adult 
females. Exposure of adult female insects to hunchback 
dsRNA did not affect adult longevity when administered 
orally. However, there was almost complete absence of hatch 
ing in the eggs collected from females exposed to hunchback 
dsRNA. In embodiments herein, the ability to deliver hunch 
back dsRNA by feeding to adult insects confers a pRNAi 
effect that is very useful for insect (e.g., hemipteran) pest 
management. Furthermore, the potential to affect multiple 
target sequences in both nymph and adult hemipteran pests 
may increase opportunities to develop Sustainable 
approaches to insect pest management involving RNAi tech 
nologies. 
0041 Disclosed herein are methods and compositions for 
genetic control of hemipteran pest infestations. Methods for 
identifying one or more gene(s) essential to the lifecycle of a 
hemipteran pest (e.g., gene(s) essential for normal reproduc 
tive capacity and/or embryonic and/or nymph development) 
for use as a target gene for RNAi-mediated control of a 
hemipteran pest population are also provided. DNA plasmid 
vectors encoding an RNA molecule may be designed to Sup 
press one or more target gene(s) essential for growth, Sur 
vival, development, and/or reproduction. In some embodi 
ments, the RNA molecule may be capable of forming dsRNA 
molecules. In some embodiments, methods are provided for 
post-transcriptional repression of expression or inhibition of 
a target gene via nucleic acid molecules that are complemen 
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tary to a coding or non-coding sequence of the target gene in 
a hemipteran pest. In these and further embodiments, a hemi 
pteran pest may ingest one or more dsRNA, siRNA, shRNA, 
miRNA, and/or hpRNA molecules transcribed from all or a 
portion of a nucleic acid molecule that is complementary to a 
coding or non-coding sequence of a target gene, thereby 
providing a plant-protective effect. 
0042 Some embodiments involve sequence-specific inhi 
bition of expression of target gene products, using dsRNA, 
siRNA, shRNA, miRNA and/or hpRNA that is complemen 
tary to coding and/or non-coding sequences of the target 
gene(s) to achieve at least partial control of a hemipteran pest. 
Disclosed is a set of isolated and purified nucleic acid mol 
ecules comprising a polynucleotide, for example, as set forth 
in SEQ ID NO:1, and fragments thereof. In some embodi 
ments, a stabilized dsRNA molecule may be expressed from 
these polynucleotides, fragments thereof, or a gene compris 
ing one of these polynucleotides, for the post-transcriptional 
silencing or inhibition of a target gene. In certain embodi 
ments, isolated and purified nucleic acid molecules comprise 
all or part of either of SEQID NOS:1 and 2. 
0043. Other embodiments involve a recombinant host cell 
(e.g., a plant cell) having in its genome at least one recombi 
nant DNA encoding at least one iRNA (e.g., dsRNA) mol 
ecule(s). In particular embodiments, the dsRNA molecule(s) 
may be produced when ingested by a hemipteran pest to 
post-transcriptionally silence or inhibit the expression of a 
target gene in the pest or progeny of the pest. The recombinant 
DNA may comprise, for example, either of SEQID NOs: 1 
and 2, fragments of either of SEQ ID NOs: 1 and 2, and a 
polynucleotide consisting of a partial sequence of a gene 
comprising either of SEQID NOs: 1 and 2, and/or comple 
ments thereof. 
0044 Some embodiments involve a recombinant host cell 
having in its genome a recombinant DNA encoding at least 
one iRNA (e.g., dsRNA) molecule(s) comprising all or part of 
SEQID NO:12 (e.g., SEQID NO:12 and/or SEQID NO:13). 
When ingested by a hemipteran pest, the iRNA molecule(s) 
may silence or inhibit the expression of a target hunchback 
gene (e.g., a DNA comprising all or part of a polynucleotide 
selected from the group consisting of SEQID NOS:1 and 2) in 
the pest or progeny of the pest, and thereby result in cessation 
of reproduction in the pest, and/or growth, development, and/ 
or feeding in progeny of the pest. 
0045. In other embodiments, a recombinant host cell hav 
ing in its genome at least one recombinant DNA encoding at 
least one RNA molecule capable of forming a dsRNA mol 
ecule may be a transformed plant cell. Some embodiments 
involve transgenic plants comprising such a transformed 
plant cell. In addition to Such transgenic plants, progeny 
plants of any transgenic plant generation, transgenic seeds, 
and transgenic plant products, are all provided, each of which 
comprises recombinant DNA(s). In particular embodiments, 
an RNA molecule capable of forming a dsRNA molecule may 
be expressed in a transgenic plant cell. Therefore, in these and 
other embodiments, a dsRNA molecule may be isolated from 
a transgenic plant cell. In particular embodiments, the trans 
genic plant is a plant selected from the group comprising corn 
(Zea mays), soybean (Glycine max), cotton, and plants of the 
family Poaceae. 
0046 Certain embodiments involve a method for modu 
lating the expression of a target gene in a hemipteran pest cell. 
In these and other embodiments, a nucleic acid molecule may 
be provided, wherein the nucleic acid molecule comprises a 
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polynucleotide encoding an RNA molecule capable of form 
ing a dsRNA molecule. In particular embodiments, a poly 
nucleotide encoding an RNA molecule capable of forming a 
dsRNA molecule may be operatively linked to a promoter, 
and may also be operatively linked to a transcription termi 
nation sequence. In particular embodiments, a method for 
modulating the expression of a target gene in a hemipteran 
pest cell may comprise: (a) transforming a plant cell with a 
vector comprising a polynucleotide encoding an RNA mol 
ecule capable of forming a dsRNA molecule; (b) culturing the 
transformed plant cell under conditions sufficient to allow for 
development of a plant cell culture comprising a plurality of 
transformed plant cells; (c) selecting for a transformed plant 
cell that has integrated the vector into its genome; and (d) 
determining that the selected transformed plant cell com 
prises the RNA molecule capable of forming a dsRNA mol 
ecule encoded by the polynucleotide of the vector. A plant 
may be regenerated from a plant cell that has the vector 
integrated in its genome and comprises the dsRNA molecule 
encoded by the polynucleotide of the vector. 
0047 Also disclosed is a transgenic plant comprising a 
vector having a polynucleotide encoding an RNA molecule 
capable of forming a dsRNA molecule integrated in its 
genome, wherein the transgenic plant comprises the dsRNA 
molecule encoded by the polynucleotide of the vector. In 
particular embodiments, expression of an RNA molecule 
capable of forming a dsRNA molecule in the plant is suffi 
cient to modulate the expression of a target gene in a cell of a 
hemipteran pest that contacts the transformed plant or plant 
cell (for example, by feeding on the transformed plant, a part 
of the plant (e.g., leaves) or plant cell) or in a cell of a progeny 
of the hemipteran pest that contacts the transformed plant or 
plant cell (for example, by parental transmission). Such that 
reproduction of the pest is inhibited. Transgenic plants dis 
closed herein may display tolerance and/or protection from 
hemipteran pest infestations. Particular transgenic plants may 
display protection and/or enhanced protection from one or 
more pest(s) selected from the group consisting of 
Piezodorus guildini; Halyomorpha haly's, Nezara viridula, 
Acrosternum hilare, Euschistus heros, Euschistus serous, 
Chinavia hilare, C. marginiatum, Dichelops melacanthus, D. 
fircatus, Edessa meditabunda, Thyanta perditor, Horcias 
nobilellus, Taedia Stigmosa, Dysdercus peruvianus, Neome 
galotomus parvus, Leptoglossus Zonatus, Niesthreasidae, 
Lygus hesperus; and L. lineolaris. 
0048. Further disclosed herein are methods for delivery of 
control agents, such as an iRNA molecule, to a hemipteran 
pest. Such control agents may cause, directly or indirectly, an 
impairment in the ability of a hemipteran pest population to 
feed, grow or otherwise cause damage in a host. In some 
embodiments, a method is provided comprising delivery of a 
stabilized dsRNA molecule to a hemipteran pest to suppress 
at least one target gene in the pest or its progeny, thereby 
causing parental RNAi and reducing or eliminating plant 
damage in a pest host. In some embodiments, a method of 
inhibiting expression of a target gene in a hemipteran pest 
may result in cessation of reproduction in the pest, and/or 
growth, development, and/or feeding in progeny of the pest. 
In some embodiments, the method may significantly reduce 
the size of a Subsequent pest generation in an infestation, 
without directly resulting in mortality in the pest(s) that con 
tact the iRNA molecule. In some embodiments, the method 
may significantly reduce the size of a Subsequent pest gen 
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eration in an infestation, while also resulting in mortality in 
the pest(s) that contact the iRNA molecule. 
0049. In some embodiments, compositions (e.g., a topical 
composition) are provided that comprise an iRNA (e.g., 
dsRNA) molecule for use with plants, animals, and/or the 
environment of a plant or animal to achieve the elimination or 
reduction of a hemipteran pest infestation. In particular 
embodiments, the composition may be a nutritional compo 
sition or resource, or food source to be fed to the hemipteran 
pest. Some embodiments comprise making the nutritional 
composition or food source available to the pest. Ingestion of 
a composition comprising iRNA molecules may result in the 
uptake of the molecules by one or more cells of the hemi 
pteran pest, which may in turn result in the inhibition of 
expression of at least one target gene in cell(s) of the pest or 
its progeny. Ingestion of or damage to a plant or plant cell by 
a hemipteran pest infestation may be limited or eliminated in 
or on any host tissue or environment in which the pest is 
present by providing one or more compositions comprising 
an iRNA molecule in the host of the pest. 
0050. The compositions and methods disclosed herein 
may be used together in combinations with other methods and 
compositions for controlling damage by hemipteran pests. 
For example, an iRNA molecule as described herein for pro 
tecting plants from hemipteran pests may be used in a method 
comprising the additional use of one or more chemical agents 
effective against a hemipteran pest, biopesticides effective 
against a hemipteran pest, crop rotation, recombinant genetic 
techniques that exhibit features different from the features of 
RNAi-mediated methods and RNAi compositions (e.g., 
recombinant production of proteins in plants that are harmful 
to a hemipteran pest (e.g., Bt toxins)), and/or recombinant 
expression of non-parental iRNA molecules (e.g., lethal 
iRNA molecules that result in the cessation of growth, devel 
opment, and/or feeding in the hemipteran pest that ingests the 
iRNA molecule). 
II. Abbreviations 
0051 BSB Neotropical brown stink bug (Euschistus 
heros) 
0052 dsRNA double-stranded ribonucleic acid 
0053 GI growth inhibition 
0054 NCBI National Center for Biotechnology Informa 
t1On 
0055 g|DNA genomic deoxyribonucleic acid 
0056) iRNA inhibitory ribonucleic acid 
0057 ORF open reading frame 
0.058 RNAi ribonucleic acid interference 
0059 miRNA micro ribonucleic acid 
0060 siRNA small inhibitory ribonucleic acid 
0061 hpRNA hairpin ribonucleic acid 
0062 shRNA short hairpin ribonucleic acid 
0063 pRNAi parental RNA interference 
0064 UTR untranslated region 
0065 PCR Polymerase chain reaction 
0066 qPCR quantative polymerase chain reaction 
0067 RISC RNA-induced Silencing Complex 
0068 RH relative humidity 
0069 SEM standard error of the mean 
0070 YFP yellow fluorescent protein 
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III. Terms 
(0071. In the description and tables which follow, a number 
of terms are used. In order to provide a clear and consistent 
understanding of the specification and claims, including the 
Scope to be given such terms, the following definitions are 
provided: 
0072 Contact (with an organism): As used herein, the 
term “contact with' or "uptake by an organism (e.g., a hemi 
pteran pest), with regard to a nucleic acid molecule, includes 
internalization of the nucleic acid molecule into the organism, 
for example and without limitation: ingestion of the molecule 
by the organism (e.g., by feeding); contacting the organism 
with a composition comprising the nucleic acid molecule: 
and soaking of organisms with a solution comprising the 
nucleic acid molecule. 
0073 Contig: As used herein the term "contig” refers to a 
DNA sequence that is reconstructed from a set of overlapping 
DNA segments derived from a single genetic source. 
I0074 Corn plant: As used herein, the term “corn plant” 
refers to a plant of the species. Zea mays (maize). 
0075) Expression: As used herein, "expression” of a cod 
ing polynucleotide (for example, a gene or a transgene) refers 
to the process by which the coded information of a nucleic 
acid transcriptional unit (including, e.g., gDNA or cDNA) is 
converted into an operational, non-operational, or structural 
part of a cell, often including the synthesis of a protein. Gene 
expression can be influenced by external signals; for 
example, exposure of a cell, tissue, or organism to an agent 
that increases or decreases gene expression. Expression of a 
gene can also be regulated anywhere in the pathway from 
DNA to RNA to protein. Regulation of gene expression 
occurs, for example, through controls acting on transcription, 
translation, RNA transport and processing, degradation of 
intermediary molecules such as mRNA, or through activa 
tion, inactivation, compartmentalization, or degradation of 
specific protein molecules after they have been made, or by 
combinations thereof. Gene expression can be measured at 
the RNA level or the protein level by any method known in the 
art, including, without limitation, northern blot, RT-PCR, 
western blot, or in vitro, in situ, or in vivo protein activity 
assay(s). 
I0076 Genetic material: As used herein, the term “genetic 
material' includes all genes, and nucleic acid molecules, such 
as DNA and RNA. 
0077. Hemipteran pest: As used herein, the term “hemi 
pteran pest” refers to pest insects of the order Hemiptera, 
including, for example and without limitation, insects in the 
families Pentatomidae, Miridae, Pyrrhocoridae, Coreidae, 
Alydidae, and Rhopalidae, which feedon a wide range of host 
plants and have piercing and sucking mouth parts. In particu 
lar examples, a hemipteran pest is selected from the list com 
prising Euschistus heros (Fabr) (Neotropical Brown Stink 
Bug), Nezara viridula (L.) (Southern Green Stink Bug), 
Piezodorus guildinii (Westwood) (Red-banded Stink Bug), 
Halyomorpha haly's (Stat) (Brown Marmorated Stink Bug), 
Chinavia hilare (Say) (Green Stink Bug). Euschistus servus (Say) (Brown Stink Bug). Dichelops melacanthus (Dallas), 
Dichelops furcatus (F.), Edessa meditabunda (F.), Thyanta 
perditor (F) (Neotropical Red Shouldered Stink Bug), Chi 
navia marginatum (Palisot de Beauvois), Horcias nobilellus (Berg) (Cotton Bug), Taedia Stigmosa (Berg), Dysdercus 
peruvianus (Guérin-Méneville), Neomegalotomus parvus 
(Westwood), Leptoglossus zonatus (Dallas), Niesthreasidae 
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(F.), Lygus hesperus (Knight) (Western Tarnished Plant Bug). 
and Lygus lineolaris (Palisot de Beauvois). 
0078. Inhibition: As used herein, the term “inhibition. 
when used to describe an effect on a coding polynucleotide 
(for example, a gene), refers to a measurable decrease in the 
cellular level of mRNA transcribed from the coding poly 
nucleotide and/or peptide, polypeptide, or protein product of 
the coding polynucleotide. In some examples, expression of a 
coding polynucleotide may be inhibited Such that expression 
is approximately eliminated. “Specific inhibition” refers to 
the inhibition of a target coding polynucleotide without con 
sequently affecting expression of other coding polynucle 
otides (e.g., genes) in the cell wherein the specific inhibition 
is being accomplished. 
0079 Isolated: An "isolated' biological component (such 
as a nucleic acid or protein) has been Substantially separated, 
produced apart from, or purified away from other biological 
components in the cell of the organism in which the compo 
nent naturally occurs (i.e., other chromosomal and extra 
chromosomal DNA and RNA, and proteins), while effecting 
a chemical or functional change in the component (e.g., a 
nucleic acid may be isolated from a chromosome by breaking 
chemical bonds connecting the nucleic acid to the remaining 
DNA in the chromosome). Nucleic acid molecules and pro 
teins that have been "isolated include nucleic acid molecules 
and proteins purified by standard purification methods. The 
term also embraces nucleic acids and proteins prepared by 
recombinant expression in a host cell, as well as chemically 
synthesized nucleic acid molecules, proteins, and peptides. 
0080 Nucleic acid molecule: As used herein, the term 
“nucleic acid molecule' may refer to a polymeric form of 
nucleotides, which may include both sense and anti-sense 
strands of RNA, cDNA, gDNA, and synthetic forms and 
mixed polymers of the above. A nucleotide or nucleobase 
may refer to a ribonucleotide, deoxyribonucleotide, or a 
modified form of either type of nucleotide. A “nucleic acid 
molecule' as used herein is synonymous with “nucleic acid 
and “polynucleotide. A nucleic acid molecule is usually at 
least 10 bases in length, unless otherwise specified. By con 
vention, the nucleotide sequence of a nucleic acid molecule is 
read from the 5' to the 3' end of the molecule. The “comple 
ment of a nucleic acid molecule refers to a polynucleotide 
having nucleobases that may form base pairs with the nucleo 
bases of the nucleic acid molecule (i.e., A-T/U, and G-C). 
0081. Some embodiments include nucleic acids compris 
ing a template DNA that is transcribed into an RNA molecule 
that is the complement of an mRNA molecule. In these 
embodiments, the complement of the nucleic acid transcribed 
into the mRNA molecule is present in the 5' to 3' orientation, 
such that RNA polymerase (which transcribes DNA in the 5' 
to 3’ direction) will transcribe a nucleic acid from the comple 
ment that can hybridize to the mRNA molecule. Unless 
explicitly stated otherwise, or it is clear to be otherwise from 
the context, the term “complement” therefore refers to a poly 
nucleotide having nucleobases, from 5' to 3', that may form 
base pairs with the nucleobases of a reference nucleic acid. 
Similarly, unless it is explicitly stated to be otherwise (or it is 
clear to be otherwise from the context), the “reverse comple 
ment of a nucleic acid refers to the complement in reverse 
orientation. The foregoing is demonstrated in the following 
illustration: 
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ATGATGATG polynucleotide 
TACTACTAC complement" of the polynucleotide 
CATCATCAT reverse complement" of the 
polynucleotide 
Some embodiments of the invention may include hairpin 
RNA-forming RNAi molecules. In these RNAi molecules, 
both the complement of a nucleic acid to be targeted by RNA 
interference and the reverse complement may be found in the 
same molecule, such that the single-stranded RNA molecule 
may “fold over and hybridize to itself over region compris 
ing the complementary and reverse complementary poly 
nucleotides. 
I0082 “Nucleic acid molecules' include all polynucle 
otides, for example: single- and double-stranded forms of 
DNA; single-stranded forms of RNA; and double-stranded 
forms of RNA (dsRNA). The term “nucleotide sequence' or 
“nucleic acid sequence” refers to both the sense and antisense 
Strands of a nucleic acid as either individual single strands or 
in the duplex. The term “ribonucleic acid (RNA) is inclusive 
of iRNA (inhibitory RNA), dsRNA (double stranded RNA), 
siRNA (small interfering RNA), shRNA (small hairpin 
RNA), mRNA (messenger RNA), miRNA (micro-RNA), 
hpRNA (hairpin RNA), tRNA (transfer RNAs, whether 
charged or discharged with a corresponding acylated amino 
acid), and cFNA (complementary RNA). The term “deoxyri 
bonucleic acid” (DNA) is inclusive of cDNA, gDNA, and 
DNA-RNA hybrids. The terms “polynucleotide' and 
“nucleic acid.” and “fragments’ thereofwill be understood by 
those in the art as a term that includes both gldNAs, ribosomal 
RNAs, transfer RNAs, messenger RNAs, operons, and 
Smaller engineered polynucleotides that encode or may be 
adapted to encode, peptides, polypeptides, or proteins. 
I0083 Oligonucleotide: An oligonucleotide is a short 
nucleic acid polymer. Oligonucleotides may be formed by 
cleavage of longer nucleic acid segments, or by polymerizing 
individual nucleotide precursors. Automated synthesizers 
allow the synthesis of oligonucleotides up to several hundred 
bases in length. Because oligonucleotides may bind to a 
complementary nucleic acid, they may be used as probes for 
detecting DNA or RNA. Oligonucleotides composed of DNA 
(oligodeoxyribonucleotides) may be used in PCR, a tech 
nique for the amplification of DNAs. In PCR, the oligonucle 
otide is typically referred to as a “primer,” which allows a 
DNA polymerase to extend the oligonucleotide and replicate 
the complementary strand. 
I0084. A nucleic acid molecule may include either or both 
naturally occurring and modified nucleotides linked together 
by naturally occurring and/or non-naturally occurring nucle 
otide linkages. Nucleic acid molecules may be modified 
chemically or biochemically, or may contain non-natural or 
derivatized nucleotide bases, as will be readily appreciated by 
those of skill in the art. Such modifications include, for 
example, labels, methylation, Substitution of one or more of 
the naturally occurring nucleotides with an analog, inter 
nucleotide modifications (e.g., uncharged linkages: for 
example, methyl phosphonates, phosphotriesters, phospho 
ramidates, carbamates, etc., charged linkages: for example, 
phosphorothioates, phosphorodithioates, etc.; pendent moi 
eties: for example, peptides; intercalators: for example, acri 
dine, psoralen, etc.; chelators; alkylators; and modified link 
ages: for example, alpha anomeric nucleic acids, etc.). The 
term “nucleic acid molecule' also includes any topological 
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conformation, including single-stranded, double-stranded, 
partially duplexed, triplexed, hairpinned, circular, and pad 
locked conformations. 
I0085. As used herein with respect to DNA, the term "cod 
ing polynucleotide.” “structural polynucleotide,” or “struc 
tural nucleic acid molecule' refers to a polynucleotide that is 
ultimately translated into a polypeptide, via transcription and 
mRNA, when placed under the control of appropriate regu 
latory elements. With respect to RNA, the term “coding poly 
nucleotide' refers to a polynucleotide that is translated into a 
peptide, polypeptide, or protein. The boundaries of a coding 
polynucleotide are determined by a translation start codon at 
the 5'-terminus and a translation stop codon at the 3'-termi 
nus. Coding polynucleotides include, but are not limited to: 
gDNA, cDNA; EST; and recombinant polynucleotides. 
I0086. As used herein, “transcribed non-coding polynucle 
otide' refers to segments of mRNA molecules such as 5' UTR, 
3'UTR and intron segments that are not translated into a 
peptide, polypeptide, or protein. Further, “transcribed non 
coding polynucleotide' refers to a nucleic acid that is tran 
scribed into an RNA that functions in the cell, for example, 
structural RNAs (e.g., ribosomal RNA (rRNA) as exemplified 
by 5S rRNA, 5.8S rRNA, 16S rRNA 18S rRNA, 23S rRNA, 
and 28S rRNA, and the like); transfer RNA (tRNA); and 
snRNAs such as U4, U5, U6, and the like. Transcribed non 
coding polynucleotides also include, for example and without 
limitation, small RNAs (sRNA), which term is often used to 
describe small bacterial non-coding RNAs; small nucleolar 
RNAs (snoRNA); microRNAs; small interfering RNAs 
(siRNA); Piwi-interacting RNAs (piRNA); and long non 
coding RNAs. Further still, “transcribed non-coding poly 
nucleotide' refers to a polynucleotide that may natively exist 
as an intragenic 'spacer” in a nucleic acid and which is 
transcribed into an RNA molecule. 
0087 Lethal RNA interference: As used herein, the term 
“lethal RNA interference refers to RNA interference that 
results in death or a reduction in viability of the subject 
individual to which, for example, a dsRNA, miRNA, siRNA, 
shRNA, and/or hpRNA is delivered. 
0088 Parental RNA interference: As used herein, the term 
“parental RNA interference” (pRNAi) refers to a RNA inter 
ference phenotype that is observable in progeny of the subject 
(e.g., a hemipteran pest) to which, for example, a dsRNA, 
miRNA, siRNA, shRNA, and/or hpRNA is delivered. In some 
embodiments, pRNAi comprises the delivery of a dsRNA to 
a hemipteran pest, wherein the pest is thereby rendered less 
able to produce viable offspring. A nucleic acid that initiates 
pRNAi may or may not increase the incidence of mortality in 
a population into which the nucleic acid is delivered. In cer 
tain examples, the nucleic acid that initiates pRNAi does not 
increase the incidence of mortality in the population into 
which the nucleic acid is delivered. For example, a population 
of hemipteran pests may be fed one or more nucleic acids that 
initiate pRNAi, wherein the pests survive and mate but pro 
duce eggs that are less able to hatch viable progeny than eggs 
produced by pests of the same species that are not fed the 
nucleic acid(s). In one mechanism of pRNAi, parental RNAi 
delivered to a female is able to knockdown Zygotic gene 
expression in offspring embryos of the female. Bucher et al. 
(2002) Curr. Biol. 12(3):R85-6. 
0089 Genome: As used herein, the term “genome' refers 
to chromosomal DNA found within the nucleus of a cell, and 
also refers to organelle DNA found within subcellular com 
ponents of the cell. In some embodiments of the invention, a 
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DNA molecule may be introduced into a plant cell, such that 
the DNA molecule is integrated into the genome of the plant 
cell. In these and further embodiments, the DNA molecule 
may be either integrated into the nuclear DNA of the plant 
cell, or integrated into the DNA of the chloroplast or mito 
chondrion of the plant cell. The term “genome,” as it applies 
to bacteria, refers to both the chromosome and plasmids 
within the bacterial cell. In some embodiments of the inven 
tion, a DNA molecule may be introduced into a bacterium 
such that the DNA molecule is integrated into the genome of 
the bacterium. In these and further embodiments, the DNA 
molecule may be either chromosomally-integrated or located 
as or in a stable plasmid. 
0090 Sequence identity: The term “sequence identity” or 
“identity,” as used herein in the context of two polynucle 
otides or polypeptides, refers to the residues in the sequences 
of the two molecules that are the same when aligned for 
maximum correspondence over a specified comparison win 
dow. 
0091. As used herein, the term “percentage of sequence 
identity” may refer to the value determined by comparing two 
optimally aligned sequences (e.g., nucleic acid sequences or 
polypeptide sequences) of a molecule over a comparison 
window, wherein the portion of the sequence in the compari 
son window may comprise additions or deletions (i.e., gaps) 
as compared to the reference sequence (which does not com 
prise additions or deletions) for optimal alignment of the two 
sequences. The percentage is calculated by determining the 
number of positions at which the identical nucleotide or 
amino acid residue occurs in both sequences to yield the 
number of matched positions, dividing the number of 
matched positions by the total number of positions in the 
comparison window, and multiplying the result by 100 to 
yield the percentage of sequence identity. A sequence that is 
identical at every position in comparison to a reference 
sequence is said to be 100% identical to the reference 
sequence, and Vice-versa. 
0092 Methods for aligning sequences for comparison are 
well-known in the art. Various programs and alignment algo 
rithms are described in, for example: Smith and Waterman 
(1981) Adv. Appl. Math. 2:482; Needleman and Wunsch 
(1970) J. Mol. Biol. 48:443; Pearson and Lipman (1988) 
Proc. Natl. Acad. Sci. U.S.A. 85:2444; Higgins and Sharp 
(1988) Gene 73:237-44; Higgins and Sharp (1989) CABIOS 
5:151-3: Corpet et al. (1988) Nucleic Acids Res. 16:10881 
90; Huang et al. (1992) Comp. Appl. Biosci. 8:155-65; Pear 
son et al. (1994) Methods Mol. Biol. 24:307-31; Tatiana et al. 
(1999) FEMS Microbiol. Lett. 174:247-50. A detailed con 
sideration of sequence alignment methods and homology 
calculations can be found in, e.g., Altschul et al. (1990) J. 
Mo1. Biol. 215:403-10. 
(0093. The National Center for Biotechnology Information 
(NCBI) Basic Local Alignment Search Tool (BLASTTM: 
Altschul et al. (1990)) is available from several sources, 
including the National Center for Biotechnology Information 
(Bethesda, Md.), and on the internet, for use in connection 
with several sequence analysis programs. A description of 
how to determine sequence identity using this program is 
available on the internet under the “help' section for 
BLASTTM. For comparisons of nucleic acid sequences, the 
“Blast 2 sequences' function of the BLASTTM (Blastn) pro 
gram may be employed using the default BLOSUM62 matrix 
set to default parameters. Nucleic acids with even greater 
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sequence similarity to the sequences of the reference poly 
nucleotides will show increasing percentage identity when 
assessed by this method. 
0094 Specifically hybridizable/Specifically complemen 
tary: As used herein, the terms “Specifically hybridizable' 
and “Specifically complementary are terms that indicate a 
Sufficient degree of complementarity Such that stable and 
specific binding occurs between the nucleic acid molecule 
and a target nucleic acid molecule. Hybridization between 
two nucleic acid molecules involves the formation of an anti 
parallel alignment between the nucleobases of the two 
nucleic acid molecules. The two molecules are then able to 
form hydrogen bonds with corresponding bases on the oppo 
site strand to form a duplex molecule that, if it is sufficiently 
stable, is detectable using methods well known in the art. A 
polynucleotide need not be 100% complementary to its target 
nucleic acid to be specifically hybridizable. However, the 
amount of complementarity that must exist for hybridization 
to be specific is a function of the hybridization conditions 
used. 
0095 Hybridization conditions resulting in particular 
degrees of stringency will vary depending upon the nature of 
the hybridization method of choice and the composition and 
length of the hybridizing nucleic acids. Generally, the tem 
perature of hybridization and the ionic strength (especially 
the Na" and/or Mg" concentration) of the hybridization 
buffer will determine the stringency of hybridization, though 
wash times also influence stringency. Calculations regarding 
hybridization conditions required for attaining particular 
degrees of stringency are known to those of ordinary skill in 
the art, and are discussed, for example, in Sambrook et al. (ed.) Molecular Cloning: A Laboratory Manual, 2" ed., vol. 
1-3, Cold Spring Harbor Laboratory Press, Cold Spring Har 
bor, N.Y., 1989, chapters 9 and 11; and Hames and Higgins 
(eds.) Nucleic Acid Hybridization, IRL Press, Oxford, 1985. 
Further detailed instruction and guidance with regard to the 
hybridization of nucleic acids may be found, for example, in 
Tijssen, “Overview of principles of hybridization and the 
strategy of nucleic acid probe assays, in Laboratory Tech 
niques in Biochemistry and Molecular Biology-Hybridiza 
tion with Nucleic Acid Probes, Part I, Chapter 2, Elsevier, NY. 
1993; and Ausubel et al., Eds., Current Protocols in Molecu 
lar Biology, Chapter 2, Greene Publishing and Wiley-Inter 
science, NY, 1995. 
0096. As used herein, “stringent conditions' encompass 
conditions under which hybridization will only occur if there 
is less than 20% mismatch between the sequence of the 
hybridization molecule and a homologous polynucleotide 
within the target nucleic acid molecule. “Stringent condi 
tions’ include further particular levels of stringency. Thus, as 
used herein, "moderate stringency' conditions are those 
under which molecules with more than 20% sequence mis 
match will not hybridize; conditions of “high stringency” are 
those under which sequences with more than 10% mismatch 
will not hybridize; and conditions of “very high stringency’ 
are those under which sequences with more than 5% mis 
match will not hybridize. 
0097. The following are representative, non-limiting 
hybridization conditions. 
0098 High Stringency condition (detects polynucleotides 
that share at least 90% sequence identity): Hybridization in 
5xSSC buffer at 65° C. for 16 hours; wash twice in 2XSSC 
buffer at room temperature for 15 minutes each; and wash 
twice in 0.5xSSC buffer at 65° C. for 20 minutes each. 
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0099 Moderate Stringency condition (detects polynucle 
otides that share at least 80% sequence identity): Hybridiza 
tion in 5x-6xSSC buffer at 65-70° C. for 16-20 hours; wash 
twice in 2xSSC buffer at room temperature for 5-20 minutes 
each; and wash twice in 1xSSC buffer at 55-70° C. for 30 
minutes each. 
0100. Non-stringent control condition (polynucleotides 
that share at least 50% sequence identity will hybridize): 
Hybridization in 6xSSC buffer at room temperature to 55° C. 
for 16-20 hours; wash at least twice in 2x-3XSSC buffer at 
room temperature to 55° C. for 20-30 minutes each. 
0101. As used herein, the term “substantially homolo 
gous' or 'substantial homology, with regard to a nucleic 
acid, refers to a polynucleotide having contiguous nucleo 
bases that hybridize under stringent conditions to the refer 
ence nucleic acid. For example, nucleic acids that are Sub 
stantially homologous to a reference nucleic acid of either of 
SEQ ID NOS:1 and 2 are those nucleic acids that hybridize 
under Stringent conditions (e.g., the Moderate Stringency 
conditions set forth, Supra) to the reference nucleic acid of 
either of SEQ ID NOS:1 and 2. Substantially homologous 
polynucleotides may have at least 80% sequence identity. For 
example, Substantially homologous polynucleotides may 
have from about 80% to 100% sequence identity, such as 
79%; 80%; about 81%; about 82%; about 83%; about 84%: 
about 85%; about 86%; about 87%; about 88%; about 89%; 
about 90%; about 91%; about 92%; about 93%; about 94% 
about 95%; about 96%; about 97%; about 98%; about 98.5%: 
about 99%; about 99.5%; and about 100%. The property of 
Substantial homology is closely related to specific hybridiza 
tion. For example, a nucleic acid molecule is specifically 
hybridizable when there is a sufficient degree of complemen 
tarity to avoid non-specific binding of the nucleic acid to 
non-target polynucleotides under conditions where specific 
binding is desired, for example, under Stringent hybridization 
conditions. 
0102. As used herein, the term “ortholog” refers to a gene 
in two or more species that has evolved from a common 
ancestral nucleic acid, and may retain the same function in the 
two or more species. 
(0103 As used herein, two nucleic acid molecules are said 
to exhibit “complete complementarity” when every nucle 
otide of a polynucleotide read in the 5' to 3’ direction is 
complementary to every nucleotide of the other polynucle 
otide when read in the 3' to 5' direction. A polynucleotide that 
is complementary to a reference polynucleotide will exhibit a 
sequence identical to the reverse complement of the reference 
polynucleotide. These terms and descriptions are well defined 
in the art and are easily understood by those of ordinary skill 
in the art. 
0104 Operably linked: A first polynucleotide is operably 
linked with a second polynucleotide when the first polynucle 
otide is in a functional relationship with the second poly 
nucleotide. When recombinantly produced, operably linked 
polynucleotides are generally contiguous, and, where neces 
sary to join two protein-coding regions, in the same reading 
frame (e.g., in a translationally fused ORF). However, nucleic 
acids need not be contiguous to be operably linked. 
0105. The term, “operably linked,” when used in reference 
to a regulatory genetic element and a coding polynucleotide, 
means that the regulatory element affects the expression of 
the linked coding polynucleotide. “Regulatory elements.” or 
“control elements.” refer to polynucleotides that influence the 
timing and level/amount of transcription, RNA processing or 
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stability, or translation of the associated coding polynucle 
otide. Regulatory elements may include promoters; transla 
tion leaders; introns; enhancers; stem-loop structures; repres 
Sor binding polynucleotides; polynucleotides with a 
termination sequence; polynucleotides with a polyadenyla 
tion recognition sequence; etc. Particular regulatory elements 
may be located upstream and/or downstream of a coding 
polynucleotide operably linked thereto. Also, particular regu 
latory elements operably linked to a coding polynucleotide 
may be located on the associated complementary strand of a 
double-stranded nucleic acid molecule. 
0106 Promoter: As used herein, the term “promoter' 
refers to a region of DNA that may be upstream from the start 
of transcription, and that may be involved in recognition and 
binding of RNA polymerase and other proteins to initiate 
transcription. A promoter may be operably linked to a coding 
polynucleotide for expression in a cell, or a promoter may be 
operably linked to a polynucleotide encoding a signal peptide 
which may be operably linked to a coding polynucleotide for 
expression in a cell. A "plant promoter” may be a promoter 
capable of initiating transcription in plant cells. Examples of 
promoters under developmental control include promoters 
that preferentially initiate transcription in certain tissues, 
Such as leaves, roots, seeds, fibers, xylem vessels, tracheids, 
or sclerenchyma. Such promoters are referred to as “tissue 
preferred. Promoters which initiate transcription only in cer 
tain tissues are referred to as “tissue-specific''. A "cell type 
specific' promoter primarily drives expression in certain cell 
types in one or more organs, for example, vascular cells in 
roots or leaves. An “inducible' promoter may be a promoter 
which may be under environmental control. Examples of 
environmental conditions that may initiate transcription by 
inducible promoters include anaerobic conditions and the 
presence of light. Tissue-specific, tissue-preferred, cell type 
specific, and inducible promoters constitute the class of “non 
constitutive' promoters. A “constitutive' promoter is a pro 
moter which may be active under most environmental condi 
tions or in most tissue or cell types. 
0107 Any inducible promoter can be used in some 
embodiments of the invention. See Ward et al. (1993) Plant 
Mol. Biol. 22:361-366. With an inducible promoter, the rate 
of transcription increases in response to an inducing agent. 
Exemplary inducible promoters include, but are not limited 
to: Promoters from the ACEI system that respond to copper; 
In2 gene from maize that responds to benzenesulfonamide 
herbicide safeners; Tet repressor from Tn 10; and the induc 
ible promoter from a steroid hormone gene, the transcrip 
tional activity of which may be induced by a glucocorticos 
teroid hormone (Schena et al. (1991) Proc. Natl. Acad. Sci. 
USA 88:0421). 
0108 Exemplary constitutive promoters include, but are 
not limited to: Promoters from plant viruses, such as the 35S 
promoter from Cauliflower Mosaic Virus (CaMV); promoters 
from rice actin genes: ubiquitin promoters; pl.MU; MAS: 
maize H3 histone promoter; and the ALS promoter, Xbal/ 
Ncol fragment 5' to the Brassica napus ALS3 structural gene 
(or a polynucleotide similar to said Xbal/Ncol fragment) (In 
ternational PCT Publication No. WO96/30530). 
0109 Additionally, any tissue-specific or tissue-preferred 
promoter may be utilized in some embodiments of the inven 
tion. Plants transformed with a nucleic acid molecule com 
prising a coding polynucleotide operably linked to a tissue 
specific promoter may produce the product of the coding 
polynucleotide exclusively, or preferentially, in a specific 
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tissue. Exemplary tissue-specific or tissue-preferred promot 
ers include, but are not limited to: A seed-preferred promoter, 
Such as that from the phaseolin gene; a leaf-specific and 
light-induced promoter Such as that from cab or rubisco; an 
anther-specific promoter such as that from LAT52; a pollen 
specific promoter Such as that from Zm13; and a microspore 
preferred promoter Such as that from apg. 
0110 Soybean plant: As used herein, the term “soybean 
plant” refers to a plant of the species Glycine sp.: for example, 
G. max. 
0111 Transformation: As used herein, the term “transfor 
mation' or “transduction” refers to the transfer of one or more 
nucleic acid molecule(s) into a cell. A cell is “transformed by 
a nucleic acid molecule transduced into the cell when the 
nucleic acid molecule becomes stably replicated by the cell, 
either by incorporation of the nucleic acid molecule into the 
cellular genome, or by episomal replication. As used herein, 
the term “transformation' encompasses all techniques by 
which a nucleic acid molecule can be introduced into Such a 
cell. Examples include, but are not limited to: transfection 
with viral vectors; transformation with plasmid vectors; elec 
troporation (Fromm et al. (1986) Nature 319:791-3); lipofec 
tion (Feigner et al. (1987) Proc. Natl. Acad. Sci. USA 
84:7413-7); microinjection (Mueller et al. (1978) Cell 
15:579-85); Agrobacterium-mediated transfer (Fraley et al. 
(1983) Proc. Natl. Acad. Sci. USA 80:4803-7); direct DNA 
uptake; and microprojectile bombardment (Klein et al. 
(1987) Nature 327:70). 
0112 Transgene: An exogenous nucleic acid. In some 
examples, a transgene may be a DNA that encodes one or both 
strand(s) of an RNA capable of forming a dsRNA molecule 
that comprises a polynucleotide that is complementary to a 
nucleic acid molecule found in a hemipteran pest. In further 
examples, a transgene may be an antisense polynucleotide, 
wherein expression of the antisense polynucleotide inhibits 
expression of a target nucleic acid, thereby producing a paren 
tal RNAi phenotype. In still further examples, a transgene 
may be a gene (e.g., a herbicide-tolerance gene, a gene encod 
ing an industrially orpharmaceutically useful compound, or a 
gene encoding a desirable agricultural trait). In these and 
other examples, a transgene may contain regulatory elements 
operably linked to a coding polynucleotide of the transgene 
(e.g., a promoter). 
0113 Vector: A nucleic acid molecule as introduced into a 
cell, for example, to produce a transformed cell. A vector may 
include genetic elements that permit it to replicate in the host 
cell. Such as an origin of replication. Examples of vectors 
include, but are not limited to: a plasmid, cosmid; bacterioph 
age; or virus that carries exogenous DNA into a cell. A vector 
may also include one or more genes, including ones that 
produce antisense molecules, and/or selectable marker genes 
and other genetic elements known in the art. A vector may 
transduce, transform, or infect a cell, thereby causing the cell 
to express the nucleic acid molecules and/or proteins encoded 
by the vector. A vector optionally includes materials to aid in 
achieving entry of the nucleic acid molecule into the cell (e.g., 
a liposome, protein coating, etc.). 
0114 Yield: A stabilized yield of about 100% or greater 
relative to the yield of check varieties in the same growing 
location growing at the same time and under the same condi 
tions. In particular embodiments, “improved yield' or 
“improving yield’ means a cultivar having a stabilized yield 
of 105% or greater relative to the yield of check varieties in 
the same growing location containing significant densities of 
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the hemipteran pests that are injurious to that crop growing at 
the same time and under the same conditions, which are 
targeted by the compositions and methods herein. 
0115 Unless specifically indicated or implied, the terms 
“a,” “an and “the signify "at least one as used herein. 
0116. Unless otherwise specifically explained, all techni 
cal and Scientific terms used herein have the same meaning as 
commonly understood by those of ordinary skill in the art to 
which this disclosure belongs. Definitions of common terms 
in molecular biology can be found in, for example, Lewin's 
Genes X. Jones & Bartlett Publishers, 2009 (ISBN 10 
0763766321); Krebs et al. (eds.), The Encyclopedia of 
Molecular Biology, Blackwell Science Ltd., 1994 (ISBN 
0-632-02182-9); and Meyers R. A. (ed.), Molecular Biology 
and Biotechnology: A Comprehensive Desk Reference, VCH 
Publishers, Inc., 1995 (ISBN 1-56081-569-8). All percent 
ages are by weight and all solvent mixture proportions are by 
Volume unless otherwise noted. All temperatures are in 
degrees Celsius. 
IV. Nucleic Acid Molecules Comprising a 
Hemipteran Pest Polynucleotide 
0117. A. Overview 
0118. Described herein are nucleic acid molecules useful 
for the control of hemipteran pests. Described nucleic acid 
molecules include target polynucleotides (e.g., native genes, 
and non-coding polynucleotides), dsRNAs, siRNAs, shR 
NAs, hpRNAs, and miRNAs. For example, dsRNA, siRNA, 
miRNA, shRNA, and/or hpRNA molecules are described in 
Some embodiments that may be specifically complementary 
to all or part of one or more native nucleic acids in a hemi 
pteran pest. In these and further embodiments, the native 
nucleic acid(s) may be one or more target gene(s), the product 
of which may be, for example and without limitation: 
involved in a reproductive process or involved in nymph 
development. Nucleic acid molecules described herein, when 
introduced into a cell (e.g., through parental transmission) 
comprising at least one native nucleic acid(s) to which the 
nucleic acid molecules are specifically complementary, may 
initiate RNAi in the cell, and consequently reduce or elimi 
nate expression of the native nucleic acid(s). In some 
examples, reduction or elimination of the expression of a 
target gene by a nucleic acid molecule specifically comple 
mentary thereto may result in reduction or cessation of repro 
duction in the hemipteran pest, and/or growth, development, 
and/or feeding in progeny of the pest. These methods may 
significantly reduce the size of a Subsequent pest generation 
in an infestation, for example, without directly resulting in 
mortality in the pest(s) that contact the iRNA molecule. 
0119. In some embodiments, at least one target gene in a 
hemipteran pest may be selected, wherein the target gene 
comprises a hunchback polynucleotide. In particular 
examples, a target gene in a hemipteran pest is selected, 
wherein the target gene comprises a polynucleotide selected 
from among either of SEQID NOS:1 and 2. 
0120 In other embodiments, a target gene may be a 
nucleic acid molecule comprising a polynucleotide that can 
be reverse translated in silico to a polypeptide comprising a 
contiguous amino acid sequence that is at least about 85% 
identical (e.g., at least 84%, 85%, about 90%, about 95%, 
about 96%, about 97%, about 98%, about 99%, about 100%, 
or 100% identical) to the amino acid sequence of a protein 
product of a hunchback polynucleotide (i.e., a HUNCH 
BACK polypeptide, for example, SEQ ID NO:3). A target 
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gene may be any nucleic acid in a hemipteran pest, the post 
transcriptional inhibition of which has a deleterious effect on 
the capacity of the pest to produce viable offspring, for 
example, to provide a protective benefit against the pest to a 
plant. In particular examples, a target gene is a nucleic acid 
molecule comprising a polynucleotide that can be reverse 
translated in silico to a polypeptide comprising a contiguous 
amino acid sequence that is at least about 85% identical, 
about 90% identical, about 95% identical, about 96% identi 
cal, about 97% identical, about 98% identical, about 99% 
identical, about 100% identical, or 100% identical to the 
amino acid sequence that is the in silico translation product of 
SEQID NO:1. 
0121 Provided in some embodiments are DNAs, the 
expression of which results in an RNA molecule comprising 
a polynucleotide that is specifically complementary to all or 
part of a native RNA molecule that is encoded by a coding 
polynucleotide in a hemipteran pest. In some embodiments, 
after ingestion of the expressed RNA molecule by a hemi 
pteran pest, down-regulation of the coding polynucleotide in 
cells of the pest, or in cells of progeny of the pest, may be 
obtained. In particular embodiments, down-regulation of the 
coding polynucleotide in cells of the hemipteran pest may 
result in reduction or cessation of reproduction and/or prolif 
eration in the pest, and/or growth, development, and/or feed 
ing in progeny of the pest. 
I0122. In some embodiments, target polynucleotides 
include transcribed non-coding RNAs, such as 5'UTRs: 
3'UTRs; spliced leaders; introns; outrons (e.g., 5'UTR RNA 
Subsequently modified in trans splicing); donatrons (e.g., 
non-coding RNA required to provide donor sequences for 
trans splicing); and other non-coding transcribed RNA of 
target hemipteran pest genes. Such polynucleotides may be 
derived from both mono-cistronic and poly-cistronic genes. 
Thus, also described herein in connection with some embodi 
ments are iRNA molecules (e.g., dsRNAs, siRNAs, miRNAs, 
shRNAs, and hpRNAs) that comprise at least one polynucle 
otide that is specifically complementary to all or part of a 
target nucleic acid in a hemipteran pest. In some embodi 
ments an iRNA molecule may comprise polynucleotide(s) 
that are complementary to all or part of a plurality of target 
nucleic acids; for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more 
target nucleic acids. In particular embodiments, an iRNA 
molecule may be produced in vitro, or in vivo by a geneti 
cally-modified organism, Such as a plant or bacterium. Also 
disclosed are cDNAs that may be used for the production of 
dsRNA molecules, siRNA molecules, miRNA molecules, 
shRNA molecules, and/or hpRNA molecules that are specifi 
cally complementary to all or part of a target nucleic acid in a 
hemipteran pest. Further described are recombinant DNA 
constructs for use in achieving stable transformation of par 
ticular host targets. Transformed host targets may express 
effective levels of dsRNA, siRNA, miRNA, shRNA, and/or 
hpRNA molecules from the recombinant DNA constructs. 
Therefore, also described is a plant transformation vector 
comprising at least one polynucleotide operably linked to a 
heterologous promoter functional in a plant cell, wherein 
expression of the polynucleotide(s) results in an RNA mol 
ecule comprising a string of contiguous nucleobases that is 
specifically complementary to all or part of a target nucleic 
acid in a hemipteran pest. 
I0123. In particular embodiments, nucleic acid molecules 
useful for the control of hemipteran pests may include: all or 
part of a native nucleic acid isolated from Euschistus com 
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prising a hunchback polynucleotide (e.g., SEQID NO:1 or 
SEQID NO:2); DNAs that when expressed result in an RNA 
molecule comprising a polynucleotide that is specifically 
complementary to all or part of a native RNA molecule that is 
encoded by hunchback: iRNA molecules (e.g., dsRNAs, siR 
NAS, miRNAs, shRNAs, and hpRNAs) that comprise at least 
one polynucleotide that is specifically complementary to all 
or part of an RNA molecule encoded by hunchback; cDNAs 
that may be used for the production of dsRNA molecules, 
siRNA molecules, miRNA molecules, shRNA molecules, 
and/or hpRNA molecules that are specifically complemen 
tary to all or part of an RNA molecule encoded by hunchback; 
and recombinant DNA constructs for use in achieving stable 
transformation of particular host targets, wherein a trans 
formed host target comprises one or more of the foregoing 
nucleic acid molecules. 
0.124 B. Nucleic Acid Molecules 
0.125. The present invention provides, inter alia, iRNA 
(e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA) mol 
ecules that inhibit target gene expression in a cell, tissue, or 
organ of a hemipteran pest; and DNA molecules capable of 
being expressed as an iRNA molecule in a cell or microor 
ganism to inhibit target gene expression in a cell, tissue, or 
organ of a hemipteran pest. 
0126 Some embodiments of the invention provide an iso 
lated nucleic acid molecule comprising at least one (e.g., one, 
two, three, or more) polynucleotide(s) selected from the 
group consisting of: SEQID NO:1; the complement of SEQ 
ID NO:1; a fragment of at least 15 contiguous nucleotides 
(e.g., at least 19 contiguous nucleotides) of SEQ ID NO:1 
(e.g., SEQID NO:2); the complement of a fragment of at least 
15 contiguous nucleotides of SEQID NO:1; a native coding 
polynucleotide of a hemipteran organism (e.g., BSB) com 
prising SEQ ID NO:1; the complement of a native coding 
polynucleotide of a hemipteran organism comprising SEQID 
NO:1; a fragment of at least 15 contiguous nucleotides of a 
native coding polynucleotide of a hemipteran organism com 
prising SEQID NO:1; and the complement of a fragment of 
at least 15 contiguous nucleotides of a native coding poly 
nucleotide of a hemipteran organism comprising SEQ ID 
NO:1. In particular embodiments, contact with or uptake by a 
hemipteran pest of the isolated polynucleotide inhibits the 
growth, development, reproduction and/or feeding of the 
pest. 
0127. In some embodiments, an isolated nucleic acid mol 
ecule of the invention may comprise at least one (e.g., one, 
two, three, or more) polynucleotide(s) selected from the 
group consisting of: SEQID NO:12; the complement of SEQ 
ID NO:12; SEQ ID NO:13; the complement of SEQ ID 
NO:13; a fragment of at least 15 contiguous nucleotides of 
SEQ ID NO:12 or SEQ ID NO:13; the complement of a 
fragment of at least 15 contiguous nucleotides of SEQ ID 
NO:12 or SEQ ID NO:13; a native polyribonucleotide tran 
scribed in a hemipteran organism from a gene comprising 
SEQ ID NO:1; the complement of a native polyribonucle 
otide transcribed in a hemipteran organism from a gene com 
prising SEQID NO:1; a fragment of at least 15 contiguous 
nucleotides of a native polyribonucleotide transcribed in a 
hemipteran organism from a gene comprising SEQID NO:1; 
and the complement of a fragment of at least 15 contiguous 
nucleotides of a native polyribonucleotide transcribed in a 
hemipteran organism from a gene comprising SEQID NO:1. 
In particular embodiments, contact with or uptake by a hemi 
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pteran pest of the isolated polynucleotide inhibits the growth, 
development, reproduction and/or feeding of the pest. 
0128. In certain embodiments, a nucleic acid molecule of 
the invention may comprise at least one (e.g., one, two, three, 
or more) DNA(s) capable of being expressed as an iRNA 
molecule in a cell or microorganism to inhibit target gene 
expression in a cell, tissue, or organ of a hemipteran pest. 
Such DNA(s) may be operably linked to a promoter that 
functions in a cell comprising the DNA molecule to initiate or 
enhance the transcription of the encoded RNA capable of 
forming a dsRNA molecule(s). In one embodiment, the at 
least one (e.g., one, two, three, or more) DNA(s) may be 
derived from the polynucleotide of SEQ ID NO:1. Deriva 
tives of SEQID NO:1 include fragments of SEQID NO:1. In 
Some embodiments, such a fragment may comprise, for 
example, at least about 15 contiguous nucleotides of SEQID 
NO:1 or a complement thereof. Thus, such a fragment may 
comprise, for example, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 
25, 26, 27, 28, 29, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 
130, 140, 150, 160, 170, 180, 190, 200 or more contiguous 
nucleotides of SEQ ID NO:1, or a complement thereof. In 
Some examples, such a fragment may comprise, for example, 
at least 19 contiguous nucleotides (e.g., 19, 20, 21, 22, 23, 24. 
25, 26, 27, 28, 29, or 30 contiguous nucleotides) of SEQID 
NO:1, or a complement thereof 
I0129. Some embodiments comprise introducing partially 
or fully-stabilized dsRNA molecules into a hemipteran pest to 
inhibit expression of a target gene in a cell, tissue, or organ of 
the hemipteran pest. When expressed as an iRNA molecule 
(e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA) and 
taken up by a hemipteran pest, polynucleotides comprising 
one or more fragments of SEQIDNO:1 and/or SEQIDNO:2, 
and the complements thereof, may cause one or more of 
death, developmental arrest, growth inhibition, change in sex 
ratio, reduction in brood size, cessation of infection, and/or 
cessation of feeding by a hemipteran pest. In particular 
examples, polynucleotides comprising one or more frag 
ments (e.g., polynucleotides including about 15 to about 300 
nucleotides) of SEQID NO:1 and/or SEQID NO:2, and the 
complements thereof cause a reduction in the capacity of an 
existing generation of the pest to produce a Subsequent gen 
eration of the pest. 
0.130. In particular embodiments, dsRNA molecules pro 
vided by the invention comprise polynucleotides comple 
mentary to a transcript from a target gene comprising SEQID 
NO:1 and/or SEQID NO:2, and/or polynucleotides comple 
mentary to a fragment of SEQID NO:1 and/or SEQID NO:2, 
the inhibition of which target gene inahemipteran pest results 
in the reduction or removal of a polypeptide or polynucleotide 
agent that is essential for the pests or the pest’s progeny's 
growth, development, or other biological function. A selected 
polynucleotide may exhibit from about 80% to about 100% 
sequence identity to of SEQID NO:1 and/or SEQID NO:2, a 
contiguous fragment of SEQID NO:1 and/or SEQID NO:2, 
or the complement of either of the foregoing. For example, a 
selected polynucleotide may exhibit 79%; 80%; about 81%; 
about 82%; about 83%; about 84%; about 85%; about 86%: 
about 87%; about 88%; about 89%; about 90%; about 91%: 
about 92%; about 93%; about 94% about 95%; about 96%: 
about 97%; about 98%; about 98.5%; about 99%; about 
99.5%; or about 100% sequence identity to of SEQID NO:1 
and/or SEQID NO:2, a contiguous fragment of SEQID NO:1 
and/or SEQ ID NO:2, or the complement of either of the 
foregoing. 
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0131. In some embodiments, a DNA molecule capable of 
being expressed as an iRNA molecule in a cell or microor 
ganism to inhibit target gene expression may comprise a 
single polynucleotide that is specifically complementary to 
all or part of a native polynucleotide found in one or more 
target hemipteran pest species, or the DNA molecule can be 
constructed as a chimera from a plurality of such specifically 
complementary polynucleotides. 
0.132. In other embodiments, a nucleic acid molecule may 
comprise a first and a second polynucleotide separated by a 
“linker. A linker may be a region comprising any sequence of 
nucleotides that facilitates secondary structure formation 
between the first and second polynucleotides, where this is 
desired. In one embodiment, the linker is part of a sense or 
antisense coding polynucleotide for mRNA. The linker may 
alternatively comprise any combination of nucleotides or 
homologues thereof that are capable of being linked 
covalently to a nucleic acid molecule. In some examples, the 
linker may comprise an intron (e.g., as ST-LS1 intron). 
0.133 For example, in some embodiments, the DNA mol 
ecule may comprise a polynucleotide coding for one or more 
different RNA molecules, wherein each of the different RNA 
molecules comprises a first polynucleotide and a second 
polynucleotide, wherein the first and second polynucleotides 
are complementary to each other. The first and second poly 
nucleotides may be connected within an RNA molecule by a 
spacer. The spacer may constitute part of the first polynucle 
otide or the second polynucleotide. Expression of an RNA 
molecule comprising the first and second nucleotide poly 
nucleotides may lead to the formation of a dsRNA molecule 
of the present invention, by specific intramolecular base 
pairing of the first and second nucleotide polynucleotides. 
The first polynucleotide or the second polynucleotide may be 
Substantially identical to a polynucleotide native to a hemi 
pteran pest (e.g., a target gene, or transcribed non-coding 
polynucleotide), a derivative thereof, or a complementary 
polynucleotide thereto. 
0134 dsRNA nucleic acid molecules comprise double 
Strands of polymerized ribonucleotides, and may include 
modifications to either the phosphate-Sugar backbone or the 
nucleoside. Modifications in RNA structure may be tailored 
to allow specific inhibition. In one embodiment, dsRNA mol 
ecules may be modified through a ubiquitous enzymatic pro 
cess so that siRNA molecules may be generated. This enzy 
matic process may utilize an RNase III enzyme, such as 
DICER in eukaryotes, either in vitro or in vivo. See Elbashir 
etal. (2001) Nature 411:494-8; and Hamilton and Baulcombe 
(1999) Science 286(5441):950-2. DICER or functionally 
equivalent RNase III enzymes cleave larger dsRNA strands 
and/or hpRNA molecules into Smaller oligonucleotides (e.g., 
siRNAs), each of which is about 19-25 nucleotides in length. 
The siRNA molecules produced by these enzymes have 2 to 
3 nucleotide 3' overhangs, and 5' phosphate and 3' hydroxyl 
termini. The siRNA molecules generated by RNase III 
enzymes are unwound and separated into single-stranded 
RNA in the cell. The siRNA molecules then specifically 
hybridize with RNAs transcribed from a target gene, and both 
RNA molecules are subsequently degraded by an inherent 
cellular RNA-degrading mechanism. This process may result 
in the effective degradation or removal of the RNA encoded 
by the target gene in the target organism. The outcome is the 
post-transcriptional silencing of the targeted gene. In some 
embodiments, siRNA molecules produced by endogenous 
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RNase III enzymes from heterologous nucleic acid molecules 
may efficiently mediate the down-regulation of target genes 
in hemipteran pests. 
0.135. In some embodiments, a nucleic acid molecule of 
the invention may include at least one non-naturally occur 
ring polynucleotide that can be transcribed into a single 
stranded RNA molecule capable of forming a dsRNA mol 
ecule in vivo through intermolecular hybridization. Such 
dsRNAs typically self-assemble, and can be provided in the 
nutrition Source of a hemipteran pest to achieve the post 
transcriptional inhibition of a target gene. In these and further 
embodiments, a nucleic acid molecule of the invention may 
comprise two different non-naturally occurring polynucle 
otides, each of which is specifically complementary to a 
different target gene in a hemipteran pest. When such a 
nucleic acid molecule is provided as a dsRNA molecule to a 
hemipteran pest, the dsRNA molecule inhibits the expression 
of at least two different target genes in the pest. 
(0.136 C. Obtaining Nucleic Acid Molecules 
0.137. A variety of polynucleotides in hemipteran pests 
may be used as targets for the design of nucleic acid mol 
ecules of the invention, such as iRNAs and DNA molecules 
encoding iRNAs. Selection of native polynucleotides is not, 
however, a straight-forward process. Only a small number of 
native polynucleotides in the hemipteran pest will be effective 
targets. For example, it cannot be predicted with certainty 
whether a particular native polynucleotide can be effectively 
down-regulated by nucleic acid molecules of the invention, or 
whether down-regulation of a particular native polynucle 
otide will have a detrimental effect on the growth, viability, 
proliferation, and/or reproduction of the hemipteran pest. The 
vast majority of native hemipteran pest polynucleotides, such 
as ESTs isolated therefrom do not have a detrimental effection 
the growth, viability, proliferation, and/or reproduction of the 
pest. Neither is it predictable which of the native polynucle 
otides that may have a detrimental effect on a hemipteran pest 
are able to be used in recombinant techniques for expressing 
nucleic acid molecules complementary to Such native poly 
nucleotides in a host plant and providing the detrimental 
effect on the pest upon feeding without causing harm to the 
host plant. 
0.138. In particular embodiments, nucleic acid molecules 
of the invention (e.g., dsRNA molecules to be provided in the 
host plant of a hemipteran pest) are selected to target cloNAS 
that encode proteins or parts of proteins essential for hemi 
pteran pest reproduction and/or development, such as 
polypeptides involved in metabolic or catabolic biochemical 
pathways, cell division, reproduction, energy metabolism, 
embryonic development, nymph development, transcrip 
tional regulation, and the like. As described herein, contact of 
compositions by a target organism containing one or more 
dsRNAs (e.g., by injection or topical contact), at least one 
segment of which is specifically complementary to at least a 
substantially identical segment of RNA produced in the cells 
of the target pest organism, can result in failure or reduction of 
the capacity to mate, oviposit, or produce viable progeny. A 
polynucleotide, either DNA or RNA, derived from a hemi 
pteran pest can be used to construct plant cells resistant to 
infestation by the pests. The host plant of the hemipteran pest 
(e.g., Z. mays, G. max, and cotton), for example, can be 
transformed to contain one or more of the polynucleotides 
derived from the hemipteran pest as provided herein. The 
polynucleotide transformed into the host may encode one or 
more RNAs that form into a dsRNA structure in the cells or 
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biological fluids within the transformed host, thus making the 
dsRNA available if/when the pest forms a nutritional relation 
ship with the transgenic host. This may result in the Suppres 
sion of expression of one or more genes in the cells of the pest, 
and ultimately inhibition of reproduction and/or develop 
ment. 
0.139. In some embodiments, a gene is targeted that is 
essentially involved in the growth, development and repro 
duction of a hemipteran pest. Other target genes for use in the 
present invention may include, for example, those that play 
important roles in hemipteran pest viability, movement, 
migration, growth, development, infectivity, and establish 
ment offeeding sites. A target gene may therefore be a house 
keeping gene or a transcription factor. Additionally, a native 
hemipteran pest polynucleotide for use in the present inven 
tion may also be derived from a homolog (e.g., an ortholog), 
of a plant, viral, bacterial or insect gene, the function of which 
is known to those of skill in the art, and the polynucleotide of 
which is specifically hybridizable with a target gene in the 
genome of the target hemipteran pest. Methods of identifying 
a homolog of a gene with a known nucleotide sequence by 
hybridization are known to those of skill in the art. 
0140. In other embodiments, the invention provides meth 
ods for obtaining a nucleic acid molecule comprising a poly 
nucleotide for producing an iRNA (e.g., dsRNA, siRNA, 
miRNA, shRNA, and hpRNA) molecule. One such embodi 
ment comprises: (a) analyzing one or more target gene(s) for 
their expression, function, and phenotype upon dsRNA-me 
diated gene Suppression in a hemipteran pest; (b) probing a 
cDNA or gldNA library with a probe comprising all or a 
portion of a polynucleotide or a homolog thereof from a 
targeted hemipteran pest that displays an altered (e.g., 
reduced) reproduction or development phenotype in a 
dsRNA-mediated Suppression analysis; (c) identifying a 
DNA clone that specifically hybridizes with the probe; (d) 
isolating the DNA clone identified in step (b); (e) sequencing 
the cDNA or g|NA fragment that comprises the clone iso 
lated in step (d), wherein the sequenced nucleic acid molecule 
comprises all or a substantial portion of the RNA or a 
homolog thereof, and (f) chemically synthesizing all or a 
substantial portion of a gene, oran siRNA, miRNA, hpRNA, 
mRNA, shRNA, or dsRNA. 
0141. In further embodiments, a method for obtaining a 
nucleic acid fragment comprising a polynucleotide for pro 
ducing a substantial portion of an iRNA (e.g., dsRNA, 
siRNA, miRNA, shRNA, and hpRNA) molecule includes: (a) 
synthesizing first and second oligonucleotide primers specifi 
cally complementary to a portion of a native polynucleotide 
from a targeted hemipteran pest, and (b) amplifying a cDNA 
org)NA insert present in a cloning vector using the first and 
second oligonucleotide primers of step (a), wherein the 
amplified nucleic acid molecule comprises a Substantial por 
tion of a siRNA, miRNA, hpRNA, mRNA, shRNA, ordsERNA 
molecule. 
0142 Nucleic acids of the invention can be isolated, 
amplified, or produced by a number of approaches. For 
example, an iRNA (e.g., dsRNA, siRNA, miRNA, shRNA, 
and hpRNA) molecule may be obtained by PCR amplification 
of a target polynucleotide (e.g., a target gene or a target 
transcribed non-coding polynucleotide) derived from a 
gDNA or cDNA library, or portions thereof. DNA or RNA 
may be extracted from a target organism, and nucleic acid 
libraries may be prepared therefrom using methods known to 
those ordinarily skilled in the art. gldNA or cDNA libraries 
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generated from a target organism may be used for PCR ampli 
fication and sequencing of target genes. A confirmed PCR 
product may be used as a template for in vitro transcription to 
generate sense and antisense RNA with minimal promoters. 
Alternatively, nucleic acid molecules may be synthesized by 
any of a number of techniques (See, e.g., Ozaki et al. (1992) 
Nucleic Acids Research, 20: 5205-5214; and Agrawal et al. 
(1990) Nucleic Acids Research, 18: 5419-5423), including 
use of an automated DNA synthesizer (for example, a P.E. 
Biosystems, Inc. (Foster City, Calif.) model 392 or 394 DNA/ 
RNA Synthesizer), using standard chemistries, such as phos 
phoramidite chemistry. See, e.g., Beaucage et al. (1992) Tet 
rahedron, 48: 2223-2311; U.S. Pat. Nos. 4,980,460, 4,725, 
677, 4,415,732, 4,458,066, and 4,973,679. Alternative 
chemistries resulting in non-natural backbone groups, such as 
phosphorothioate, phosphoramidate, and the like, can also be 
employed. 
0.143 An RNA, dsRNA, siRNA, miRNA, shRNA, or 
hpRNA molecule of the present invention may be produced 
chemically or enzymatically by one skilled in the art through 
manual or automated reactions, or in vivo in a cell comprising 
a nucleic acid molecule comprising a polynucleotide encod 
ing the RNA, dsRNA, siRNA, miRNA, shRNA, or hpRNA 
molecule. RNA may also be produced by partial or total 
organic synthesis—any modified ribonucleotide can be intro 
duced by in vitro enzymatic or organic synthesis. An RNA 
molecule may be synthesized by a cellular RNA polymerase 
or a bacteriophage RNA polymerase (e.g., T3 RNA poly 
merase, T7 RNA polymerase, and SP6 RNA polymerase). 
Expression constructs useful for the cloning and expression 
of polynucleotides are known in the art. See, e.g., Interna 
tional PCT Publication No. WO97/32016; and U.S. Pat. Nos. 
5,593,874, 5,698,425, 5,712,135, 5,789,214, and 5,804,693. 
RNA molecules that are synthesized chemically or by in vitro 
enzymatic synthesis may be purified prior to introduction into 
a cell. For example, RNA molecules can be purified from a 
mixture by extraction with a solvent or resin, precipitation, 
electrophoresis, chromatography, or a combination thereof. 
Alternatively, RNA molecules that are synthesized chemi 
cally or by in vitro enzymatic synthesis may be used with no 
or a minimum of purification, for example, to avoid losses due 
to sample processing. The RNA molecules may be dried for 
storage or dissolved in an aqueous solution. The Solution may 
contain buffers or salts to promote annealing, and/or stabili 
zation of dsRNA molecule duplex strands. 
0144. In embodiments, a dsRNA molecule may beformed 
by a single self-complementary RNA strand or from two 
complementary RNA strands. dsRNA molecules may be syn 
thesized either in vivo or in vitro. An endogenous RNA poly 
merase of the cell may mediate transcription of the one or two 
RNA strands in vivo, or cloned RNA polymerase may be used 
to mediate transcription in vivo or in vitro. Post-transcrip 
tional inhibition of a target gene in a hemipteran pest may be 
host-targeted by specific transcription in an organ, tissue, or 
cell type of the host (e.g., by using a tissue-specific promoter); 
stimulation of an environmental condition in the host (e.g., by 
using an inducible promoter that is responsive to infection, 
stress, temperature, and/or chemical inducers); and/or engi 
neering transcription at a developmental stage or age of the 
host (e.g., by using a developmental stage-specific promoter). 
RNA strands that form a dsRNA molecule, whether tran 
scribed in vitro or in Vivo, may or may not be polyadenylated, 
and may or may not be capable of being translated into a 
polypeptide by a cells translational apparatus. 
US 2016/0208252 A1 
0145 D. Recombinant Vectors and Host Cell Transforma 
tion 
0146 In some embodiments, the invention also provides a 
DNA molecule for introduction into a cell (e.g., a bacterial 
cell, a yeast cell, or a plant cell), wherein the DNA molecule 
comprises a polynucleotide that, upon expression to RNA and 
ingestion by a hemipteran pest, achieves Suppression of a 
target gene in a cell, tissue, or organ of the pest. Thus, some 
embodiments provide a recombinant nucleic acid molecule 
comprising a polynucleotide capable of being expressed as an 
iRNA (e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA) 
molecule in a plant cell to inhibit target gene expression in a 
hemipteran pest. In order to initiate or enhance expression, 
Such recombinant nucleic acid molecules may comprise one 
or more regulatory elements, which regulatory elements may 
be operably linked to the polynucleotide capable of being 
expressed as an iRNA. Methods to express agene Suppression 
molecule in plants are known, and may be used to express a 
polynucleotide of the present invention. See, e.g., Interna 
tional PCT Publication No. WO06/073727; and U.S. Patent 
Publication No. 2006/0200878 A1) 
0147 In specific embodiments, a recombinant DNA mol 
ecule of the invention may comprise a polynucleotide encod 
ing an RNA that may form a dsRNA molecule. Such recom 
binant DNA molecules may encode RNAs that may form 
dsRNA molecules capable of inhibiting the expression of 
endogenous target gene(s) in a hemipteran pest cell upon 
ingestion. In many embodiments, a transcribed RNA may 
form a dsRNA molecule that may be provided in a stabilized 
form; e.g., as a hairpin and stem and loop structure. 
0148. In other embodiments, one strand of a dsRNA mol 
ecule may be formed by transcription from a polynucleotide 
that is Substantially homologous to a polynucleotide selected 
from the group consisting of SEQID NO:1; of SEQID NO:2: 
the complement of SEQID NO:1; the complement of SEQID 
NO:2; a fragment of at least 15 contiguous nucleotides of 
SEQID NO:1 and/or 2; the complement of a fragment of at 
least 15 contiguous nucleotides of SEQID NO:1 and/or 2; a 
native coding polynucleotide of a hemipteran organism (e.g., 
BSB) comprising SEQID NO:1 and/or 2; the complement of 
a native coding polynucleotide of a hemipteran organism 
comprising SEQID NO:1 and/or 2; a fragment of at least 15 
contiguous nucleotides of a native coding polynucleotide of a 
hemipteran organism comprising SEQID NO:1 and/or 2; and 
the complement of a fragment of at least 15 contiguous nucle 
otides of a native coding polynucleotide of a hemipteran 
organism comprising SEQID NO:1 and/or 2. 
0149. In particular embodiments, a recombinant DNA 
molecule encoding an RNA that may form a dsRNA molecule 
may comprise a coding region wherein at least two polynucle 
otides are arranged Such that one polynucleotide is in a sense 
orientation, and the other polynucleotide is in an antisense 
orientation, relative to at least one promoter, wherein the 
sense polynucleotide and the antisense polynucleotide are 
linked or connected by a spacer of for example, from about 
five (-5) to about one thousand (~1000) nucleotides. The 
spacer may form a loop between the sense and antisense 
polynucleotides. The sense polynucleotide or the antisense 
polynucleotide may be substantially homologous to an RNA 
encoded by a target gene (e.g., a hunchback gene comprising 
SEQ ID NO: 1) or fragment thereof. In some embodiments, 
however, a recombinant DNA molecule may encode an RNA 
that may form a dsRNA molecule without a spacer. In 
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embodiments, a sense coding polynucleotide and an anti 
sense coding polynucleotide may be different lengths. 
0150 Polynucleotides identified as having a deleterious 
effect on hemipteran pests or a plant-protective effect with 
regard to hemipteran pests may be readily incorporated into 
expressed dsRNA molecules through the creation of appro 
priate expression cassettes in a recombinant nucleic acid mol 
ecule of the invention. For example, such polynucleotides 
may be expressed as a hairpin with stem and loop structure by 
taking a first segment corresponding to an RNA encoded by a 
target gene polynucleotide (e.g., a hunchback gene compris 
ing SEQID NO:1, and fragments of either of the foregoing); 
linking this polynucleotide to a second segment spacer region 
that is not homologous or complementary to the first segment; 
and linking this to a third segment, wherein at least a portion 
of the third segment is substantially complementary to the 
first segment. Such a construct forms a stem and loop struc 
ture by intramolecular base-pairing of the first segment with 
the third segment, wherein the loop structure forms compris 
ing the second segment. See, e.g., U.S. Patent Publication 
Nos. 2002/0048814 and 2003/0018993; and International 
PCT Publication NOS. WO94/O1550 and WO98/O5770. A 
dsRNA molecule may be generated, for example, in the form 
of a double-stranded structure Such as a stem-loop structure (e.g., hairpin), whereby production of siRNA targeted for a 
native hemipteran pest polynucleotide is enhanced by co 
expression of a fragment of the targeted gene, for instance on 
an additional plant expressible cassette, that leads to 
enhanced siRNA production, or reduces methylation to pre 
vent transcriptional gene silencing of the dsRNA hairpin pro 
moter. 
0151. Embodiments of the invention include introduction 
of a recombinant nucleic acid molecule of the present inven 
tion into a plant (i.e., transformation) to achieve hemipteran 
pest-inhibitory levels of expression of one or more iRNA 
molecules. A recombinant DNA molecule may, for example, 
be a vector, Such as a linear or a closed circular plasmid. The 
vector System may be a single vector or plasmid, or two or 
more vectors or plasmids that together contain the total DNA 
to be introduced into the genome of a host. In addition, a 
vector may be an expression vector. Nucleic acids of the 
invention can, for example, be suitably inserted into a vector 
under the control of a suitable promoter that functions in one 
or more hosts to drive expression of a linked coding poly 
nucleotide or other DNA element. Many vectors are available 
for this purpose, and selection of the appropriate vector will 
depend mainly on the size of the nucleic acid to be inserted 
into the vector and the particular host cell to be transformed 
with the vector. Each vector contains various components 
depending on its function (e.g., amplification of DNA or 
expression of DNA) and the particular host cell with which it 
is compatible. 
0152 To impart protection from hemipteran pests to a 
transgenic plant, a recombinant DNA may, for example, be 
transcribed into an iRNA molecule (e.g., an RNA molecule 
that forms a dsRNA molecule) within the tissues or fluids of 
the recombinant plant. An iRNA molecule may comprise a 
polynucleotide that is Substantially homologous and specifi 
cally hybridizable to a corresponding transcribed polynucle 
otide within a hemipteran pest that may cause damage to the 
host plant species. The hemipteran pest may contact the iRNA 
molecule that is transcribed in cells of the transgenic host 
plant, for example, by ingesting cells or fluids of the trans 
genic host plant that comprise the iRNA molecule. Thus, 
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expression of a target gene is Suppressed by the iRNA mol 
ecule within hemipteran pests that infest the transgenic host 
plant. In some embodiments, Suppression of expression of the 
target gene in the target hemipteran pest may result in the 
plant being tolerant to attack by the pest. 
0153. In order to enable delivery of iRNA molecules to a 
hemipteran pest in a nutritional relationship with a plant cell 
that has been transformed with a recombinant nucleic acid 
molecule of the invention, expression (i.e., transcription) of 
iRNA molecules in the plant cell is required. Thus, a recom 
binant nucleic acid molecule may comprise a polynucleotide 
of the invention operably linked to one or more regulatory 
elements, such as a heterologous promoter element that func 
tions in a host cell. Such as a bacterial cell wherein the nucleic 
acid molecule is to be amplified, and a plant cell wherein the 
nucleic acid molecule is to be expressed. 
0154 Promoters suitable for use in nucleic acid molecules 
of the invention include those that are inducible, viral, syn 
thetic, or constitutive, all of which are well known in the art. 
Non-limiting examples describing Such promoters include 
U.S. Pat. No. 6,437.217 (maize RS81 promoter); U.S. Pat. 
No. 5,641,876 (rice actin promoter); U.S. Pat. No. 6,426,446 
(maize RS324 promoter); U.S. Pat. No. 6,429,362 (maize 
PR-1 promoter); U.S. Pat. No. 6,232,526 (maize A3 pro 
moter); U.S. Pat. No. 6,177,611 (constitutive maize promot 
ers); U.S. Pat. Nos. 5,322.938, 5,352,605, 5,359,142, and 
5,530,196 (CaMV 35S promoter); U.S. Pat. No. 6,433,252 
(maize L3 oleosin promoter); U.S. Pat. No. 6,429.357 (rice 
actin2 promoter, and rice actin2 intron); U.S. Pat. No. 6.294, 
714 (light-inducible promoters); U.S. Pat. No. 6,140,078 
(salt-inducible promoters); U.S. Pat. No. 6,252,138 (patho 
gen-inducible promoters); U.S. Pat. No. 6,175,060 (phospho 
rous deficiency-inducible promoters); U.S. Pat. No. 6,388, 
170 (bidirectional promoters); U.S. Pat. No. 6,635,806 
(gamma-coixin promoter); and U.S. Patent Publication No. 
2009/757,089 (maize chloroplast aldolase promoter). Addi 
tional promoters include the nopaline synthase (NOS) pro 
moter (Ebert et al. (1987) Proc. Natl. Acad. Sci. USA 84(16): 
5745-9) and the octopine synthase (OCS) promoters (which 
are carried on tumor-inducing plasmids of Agrobacterium 
tumefaciens); the caulimovirus promoters such as the cauli 
flower mosaic virus (CaMV) 19S promoter (Lawton et al. 
(1987) Plant Mol. Biol. 9:315-24); the CaMV 35S promoter 
(Odell et al. (1985) Nature 313:810-2; the figwort mosaic 
virus 35S-promoter (Walker et al. (1987) Proc. Natl. Acad. 
Sci. USA 84(19):6624-8); the sucrose synthase promoter 
(Yang and Russell (1990) Proc. Natl. Acad. Sci. USA 
87:4144-8); the R gene complex promoter (Chandler et al. 
(1989) Plant Cell 1:1175-83); the chlorophyll a?b binding 
protein gene promoter: CaMV35S (U.S. Pat. Nos. 5,322,938, 
5,352,605, 5,359,142, and 5,530,196); FMV 35S (U.S. Pat. 
Nos. 6,051,753, and 5,378,619); a PC1SV promoter (U.S. 
Pat. No. 5,850,019); the SCP1 promoter (U.S. Pat. No. 6,677, 
503); and AGRtu.nos promoters (GenBankTM Accession No. 
V00087: Depicker et al. (1982) J. Mol. Appl. Genet. 1:561 
73; Bevanet al. (1983) Nature 304:184-7). 
0155. In particular embodiments, nucleic acid molecules 
of the invention comprise a tissue-specific promoter. Such as 
a leaf-specific promoter or pollen-specific promoter. In some 
embodiments, a polynucleotide or fragment for hemipteran 
pest control according to the invention may be cloned 
between two tissue-specific promoters oriented in opposite 
transcriptional directions relative to the polynucleotide or 
fragment, and which are operable in a transgenic plant cell 
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and expressed thereinto produce RNA molecules in the trans 
genic plant cell that Subsequently may form dsRNA mol 
ecules, as described, supra. The iRNA molecules expressed in 
plant tissues may be ingested by a hemipteran pest so that 
Suppression of target gene expression is achieved. 
0156 Additional regulatory elements that may optionally 
be operably linked to a nucleic acid molecule of interest 
include 5' UTRs located between a promoter element and a 
coding polynucleotide that function as a translation leader 
element. The translation leader element is present in the fully 
processed mRNA, and it may affect processing of the primary 
transcript, and/or RNA stability. Examples of translation 
leader elements include maize and petunia heat shock protein 
leaders (U.S. Pat. No. 5,362,865), plant virus coat protein 
leaders, plant rubisco leaders, and others. See, e.g., Turner 
and Foster (1995) Molecular Biotech.3(3):225-36. Non-lim 
iting examples of 5' UTRs include GmHsp (U.S. Pat. No. 
5,659,122); PhDnaK (U.S. Pat. No. 5,362,865); AtAntl:TEV 
(Carrington and Freed (1990).J. Virol. 64:1590-7); and AGR 
tunos (GenBankTM Accession No. V00087; and Bevan et al. 
(1983) Nature 304:184-7). 
0157 Additional regulatory elements that may optionally 
be operably linked to a nucleic acid molecule of interest also 
include 3' non-translated elements, 3' transcription termina 
tion regions, or polyadenylation regions. These are genetic 
elements located downstream of a polynucleotide, and 
include polynucleotides that provide polyadenylation signal, 
and/or other regulatory signals capable of affecting transcrip 
tion or mRNA processing. The polyadenylation signal func 
tions in plants to cause the addition of polyadenylate nucle 
otides to the 3' end of the mRNA precursor. The 
polyadenylation element can be derived from a variety of 
plant genes, or from T-DNA genes. A non-limiting example 
of a 3' transcription termination region is the nopaline Syn 
thase 3' region (nos 3; Fraley et al. (1983) Proc. Natl. Acad. 
Sci. USA 80:4803-7). An example of the use of different 3' 
nontranslated regions is provided in Ingelbrecht et al., (1989) 
Plant Cell 1:671-80. Non-limiting examples of polyadenyla 
tion signals include one from a Pisum sativum RbcS2 gene 
(Ps.RbcS2-E9; Coruzzi et al. (1984) EMBO.J. 3:1671-9) and 
AGRtu.nos (GenBankTM Accession No. E01312). 
0158. Some embodiments may include a plant transfor 
mation vector that comprises an isolated and purified DNA 
molecule comprising at least one of the above-described 
regulatory elements operatively linked to one or more poly 
nucleotides of the present invention. When expressed, the one 
or more polynucleotides result in one or more RNA molecule (s) comprising a polynucleotide that is specifically comple 
mentary to all or part of a native RNA molecule in a hemi 
pteran pest. Thus, the polynucleotide(s) may comprise a 
segment encoding all or part of a polyribonucleotide present 
within a targeted hemipteran pest RNA transcript, and may 
comprise inverted repeats of all or a part of a targeted pest 
transcript. A plant transformation vector may contain poly 
nucleotides specifically complementary to more than one 
target polynucleotide, thus allowing production of more than 
one dsRNA for inhibiting expression of two or more genes in 
cells of one or more populations or species of target hemi 
pteran pests. Segments of polynucleotides specifically 
complementary to polynucleotides present in different genes 
can be combined into a single composite nucleic acid mol 
ecule for expression in a transgenic plant. Such segments may 
be contiguous or separated by a spacer. 
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0159. In other embodiments, a plasmid of the present 
invention already containing at least one polynucleotide(s) of 
the invention can be modified by the sequential insertion of 
additional polynucleotide(s) in the same plasmid, wherein the 
additional polynucleotide(s) are operably linked to the same 
regulatory elements as the original at least one polynucleotide 
(s). In some embodiments, a nucleic acid molecule may be 
designed for the inhibition of multiple target genes. In some 
embodiments, the multiple genes to be inhibited can be 
obtained from the same hemipteran pest species, which may 
enhance the effectiveness of the nucleic acid molecule. In 
other embodiments, the genes can be derived from different 
hemipteran pests, which may broaden the range of pests 
against which the agent(s) is/are effective. When multiple 
genes are targeted for Suppression or a combination of expres 
sion and Suppression, a polycistronic DNA element can be 
engineered. 
0160 A recombinant nucleic acid molecule or vector of 
the present invention may comprise a selectable marker that 
confers a selectable phenotype on a transformed cell. Such as 
a plant cell. Selectable markers may also be used to select for 
plants or plant cells that comprise a recombinant nucleic acid 
molecule of the invention. The marker may encode biocide 
resistance, antibiotic resistance (e.g., kanamycin, Geneticin 
(G418), bleomycin, hygromycin, etc.), or herbicide tolerance 
(e.g., glyphosate, etc.). Examples of selectable markers 
include, but are not limited to: a neogene which codes for 
kanamycin resistance and can be selected for using kanamy 
cin, G418, etc.; a bar gene which codes for bialaphos resis 
tance; a mutant EPSP synthase gene which encodes glypho 
sate tolerance; a nitrilase gene which confers resistance to 
bromoxynil; a mutant acetolactate synthase (ALS) gene 
which confers imidazolinone or Sulfonylurea resistance; and 
a methotrexate resistant DHFR gene. Multiple selectable 
markers are available that confer resistance to ampicillin, 
bleomycin, chloramphenicol, gentamycin, hygromycin, 
kanamycin, lincomycin, methotrexate, phosphinothricin, 
puromycin, spectinomycin, rifampicin, Streptomycin and tet 
racycline, and the like. Examples of Such selectable markers 
are illustrated in, e.g., U.S. Pat. Nos. 5,550,318; 5.633,435: 
5,780,708 and 6,118,047. 
0161. A recombinant nucleic acid molecule or vector of 
the present invention may also include a screenable marker. 
Screenable markers may be used to monitor expression. 
Exemplary screenable markers include a B-glucuronidase or 
uidA gene (GUS) which encodes an enzyme for which vari 
ous chromogenic Substrates are known (Jefferson et al. 
(1987) Plant Mol. Biol. Rep. 5:387-405); an R-locus gene, 
which encodes a product that regulates the production of 
anthocyanin pigments (red color) in plant tissues (Dellaporta 
et al. (1988) “Molecular cloning of the maize R-njallele by 
transposon tagging with Ac.” In 18' Stadler Genetics Sym 
posium, P. Gustafson and R. Appels, eds. (New York: Ple 
num), pp. 263-82); a B-lactamase gene (Sutcliffe et al. (1978) 
Proc. Natl. Acad. Sci. USA 75:3737-41); a gene which 
encodes an enzyme for which various chromogenic Sub 
strates are known (e.g., PADAC, a chromogenic cepha 
losporin); a luciferase gene (Ow et al. (1986) Science 234: 
856-9); an Xy/E gene that encodes a catechol dioxygenase 
that can convert chromogenic catechols (Zukowski et al. 
(1983) Gene 46(2-3):247-55); an amylase gene (Ikatu et al. 
(1990) Bio/Technol. 8:241-2); a tyrosinase gene which 
encodes an enzyme capable of oxidizing tyrosine to DOPA 
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and dopaquinone which in turn condenses to melanin (Katz, et 
al. (1983) J. Gen. Microbiol. 129:2703-14); and an O-galac 
tosidase. 
(0162. In some embodiments, recombinant nucleic acid 
molecules, as described, Supra, may be used in methods for 
the creation of transgenic plants and expression of heterolo 
gous nucleic acids in plants to prepare transgenic plants that 
exhibit reduced susceptibility to hemipteran pests. Plant 
transformation vectors can be prepared, for example, by 
inserting nucleic acid molecules encoding iRNA molecules 
into plant transformation vectors and introducing these into 
plants. 
(0163 Suitable methods for transformation of host cells 
include any method by which DNA can be introduced into a 
cell. Such as by transformation of protoplasts (See, e.g., U.S. 
Pat. No. 5,508,184), by desiccation/inhibition-mediated 
DNA uptake (See, e.g., Potrykus et al. (1985) Mol. Gen. 
Genet. 199:183-8), by electroporation (See, e.g., U.S. Pat. 
No. 5,384.253), by agitation with silicon carbide fibers (See, 
e.g., U.S. Pat. Nos. 5,302,523 and 5,464,765), by Agrobacte 
rium-mediated transformation (See, e.g., U.S. Pat. Nos. 
5,563,055; 5,591,616; 5,693,512; 5,824,877; 5,981,840; and 
6,384.301) and by acceleration of DNA-coated particles (See, 
e.g., U.S. Pat. Nos. 5,015,580: 5,550,318; 5,538,880; 6,160, 
208; 6.399,861; and 6,403,865), etc. Techniques that are par 
ticularly useful for transforming corn are described, for 
example, in U.S. Pat. Nos. 7,060,876 and 5,591,616; and 
International PCT Publication WO95/06722. Through the 
application of techniques such as these, the cells of virtually 
any species may be stably transformed. In some embodi 
ments, transforming DNA is integrated into the genome of the 
host cell. In the case of multicellular species, transgenic cells 
may be regenerated into a transgenic organism. Any of these 
techniques may be used to produce a transgenic plant, for 
example, comprising one or more nucleic acids encoding one 
or more iRNA molecules in the genome of the transgenic 
plant. 
0164. The most widely utilized method for introducing an 
expression vector into plants is based on the natural transfor 
mation system of Agrobacterium. A. tumefaciens and A. 
rhizogenes are plant pathogenic soil bacteria which geneti 
cally transform plant cells. The Ti and Ri plasmids of A. 
tumefaciens and A. rhizogenes, respectively, carry genes 
responsible for genetic transformation of the plant. The Ti 
(tumor-inducing)-plasmids contain a large segment, known 
as T-DNA, which is transferred to transformed plants. 
Another segment of the Tiplasmid, the Vir region, is respon 
sible for T-DNA transfer. The T-DNA region is bordered by 
terminal repeats. In modified binary vectors, the tumor-in 
ducing genes have been deleted, and the functions of the Vir 
region are utilized to transfer foreign DNA bordered by the 
T-DNA border elements. The T-region may also contain a 
selectable marker for efficient recovery of transgenic cells 
and plants, and a multiple cloning site for inserting polynucle 
otides for transfer Such as a dsRNA encoding nucleic acid. 
0.165. In some embodiments, a plant transformation vector 
is derived from a Tiplasmid of A. tumefaciens (See, e.g., U.S. 
Pat. Nos. 4,536,475, 4,693,977, 4,886,937, and 5,501,967: 
and European Patent No. EP 0122791) or a Riplasmid of A. 
rhizogenes. Additional plant transformation vectors include, 
for example and without limitation, those described by Her 
rera-Estrella et al. (1983) Nature 303:209-13: Bevan et al. 
(1983) Nature 304:184-7; Klee et al. (1985) Bio/Technol. 
3:637-42; and in European Patent No. EP 0120516, and 
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those derived from any of the foregoing. Other bacteria such 
as Sinorhizobium, Rhizobium, and Mesorhizobium that inter 
act with plants naturally can be modified to mediate gene 
transfer to a number of diverse plants. These plant-associated 
symbiotic bacteria can be made competent for gene transfer 
by acquisition of both a disarmed Tiplasmid and a Suitable 
binary vector. 
0166. After providing exogenous DNA to recipient cells, 
transformed cells are generally identified for further culturing 
and plant regeneration. In order to improve the ability to 
identify transformed cells, one may desire to employ a select 
able or screenable marker gene, as previously set forth, with 
the transformation vector used to generate the transformant. 
In the case where a selectable marker is used, transformed 
cells are identified within the potentially transformed cell 
population by exposing the cells to a selective agentoragents. 
In the case where a screenable marker is used, cells may be 
screened for the desired marker gene trait. 
0167 Cells that survive the exposure to the selective 
agent, or cells that have been scored positive in a screening 
assay, may be cultured in media that Supports regeneration of 
plants. In some embodiments, any Suitable plant tissue cul 
ture media (e.g., MS and N6 media) may be modified by 
including further Substances, such as growth regulators. Tis 
Sue may be maintained on a basic medium with growth regu 
lators until Sufficient tissue is available to begin plant regen 
eration efforts, or following repeated rounds of manual 
selection, until the morphology of the tissue is suitable for 
regeneration (e.g., at least 2 weeks), then transferred to media 
conducive to shoot formation. Cultures are transferred peri 
odically until sufficient shoot formation has occurred. Once 
shoots are formed, they are transferred to media conducive to 
root formation. Once Sufficient roots are formed, plants can 
be transferred to soil for further growth and maturation. 
0168 To confirm the presence of a nucleic acid molecule 
of interest (for example, a DNA encoding one or more iRNA 
molecules that inhibit target gene expression in a hemipteran 
pest) in the regenerating plants, a variety of assays may be 
performed. Such assays include, for example: molecular bio 
logical assays, such as Southern and northern blotting, PCR, 
and nucleic acid sequencing; biochemical assays, such as 
detecting the presence of a protein product, e.g., by immuno 
logical means (ELISA and/or western blots) or by enzymatic 
function; plant part assays, such as leaf or root assays; and 
analysis of the phenotype of the whole regenerated plant. 
0169 Integration events may be analyzed, for example, by 
PCR amplification using, e.g., oligonucleotide primers spe 
cific for a nucleic acid molecule of interest. PCR genotyping 
is understood to include, but not be limited to, polymerase 
chain reaction (PCR) amplification of gldNA derived from 
isolated host plant callus tissue predicted to contain a nucleic 
acid molecule of interest integrated into the genome, fol 
lowed by Standard cloning and sequence analysis of PCR 
amplification products. Methods of PCR genotyping have 
been well described (for example, Rios, G. et al. (2002) Plant 
J. 32:243-53) and may be applied to gldNA derived from any 
plant species (e.g., Z. mays, G. max, and cotton) or tissue type, 
including cell cultures. 
0170 A transgenic plant formed using Agrobacterium 
dependent transformation methods typically contains a single 
recombinant DNA inserted into one chromosome. The poly 
nucleotide of the single recombinant DNA is referred to as a 
“transgenic event' or “integration event. Such transgenic 
plants are heterozygous for the inserted exogenous poly 
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nucleotide. In some embodiments, a transgenic plant 
homozygous with respect to a transgene may be obtained by 
sexually mating (selfing) an independent segregant trans 
genic plant that contains a single exogenous gene to itself, for 
example a To plant, to produce Ti seed. One fourth of the Ti 
seed produced will be homozygous with respect to the trans 
gene. Germinating Ti seed results in plants that can be tested 
for heterozygosity, typically using an SNP assay or a thermal 
amplification assay that allows for the distinction between 
heterozygotes and homozygotes (i.e., a Zygosity assay). 
0171 In particular embodiments, at least 2, 3, 4, 5, 6, 7, 8, 
9 or 10 or more different iRNA molecules are produced in a 
plant cell that have a hemipteran pest-inhibitory effect. The 
iRNA molecules (e.g., dsRNA molecules) may be expressed 
from multiple nucleic acids introduced in different transfor 
mation events, or from a single nucleic acid introduced in a 
single transformation event. In some embodiments, a plural 
ity of iRNA molecules are expressed under the control of a 
single promoter. In other embodiments, a plurality of iRNA 
molecules are expressed under the control of multiple pro 
moters. Single iRNA molecules may be expressed that com 
prise multiple polynucleotides that are each homologous to 
different loci within one or more hemipteran pests (for 
example, the loci defined by SEQID NOs: 1 and 2), both in 
different populations of the same species of hemipteran pest, 
or in different species of hemipteran pests. 
0172. In addition to direct transformation of a plant with a 
recombinant nucleic acid molecule, transgenic plants can be 
prepared by crossing a first plant having at least one trans 
genic event with a second plant lacking such an event. For 
example, a recombinant nucleic acid molecule comprising a 
polynucleotide that encodes an iRNA molecule may be intro 
duced into a first plant line that is amenable to transformation 
to produce a transgenic plant, which transgenic plant may be 
crossed with a second plant line to introgress the polynucle 
otide that encodes the iRNA molecule into the second plant 
line. 
0173 The invention also includes commodity products 
containing one or more of the polynucleotides of the present 
invention. Particular embodiments include commodity prod 
ucts produced from a recombinant plant or seed containing 
one or more of the polynucleotides of the present invention. A 
commodity product containing one or more of the polynucle 
otides of the present invention is intended to include, but not 
be limited to, meals, oils, crushed or whole grains or seeds of 
a plant, or any food product comprising any meal, oil, or 
crushed or whole grain of a recombinant plant or seed con 
taining one or more of the polynucleotides of the present 
invention. The detection of one or more of the polynucle 
otides of the present invention in one or more commodity or 
commodity products contemplated herein is de facto evi 
dence that the commodity or commodity product is produced 
from a transgenic plant designed to express one or more of the 
polynucleotides of the present invention for the purpose of 
controlling plant pests using dsRNA-mediated gene Suppres 
sion methods. 
0.174. In some aspects, seeds and commodity products 
produced by transgenic plants derived from transformed plant 
cells are included, wherein the seeds or commodity products 
comprise a detectable amount of a nucleic acid of the inven 
tion. In some embodiments, such commodity products may 
be produced, for example, by obtaining transgenic plants and 
preparing food or feed from them. Commodity products com 
prising one or more of the polynucleotides of the invention 
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includes, for example and without limitation: meals, oils, 
crushed or whole grains or seeds of a plant, and any food 
product comprising any meal, oil, or crushed or whole grain 
of a recombinant plant or seed comprising one or more of the 
nucleic acids of the invention. The detection of one or more of 
the polynucleotides of the invention in one or more commod 
ity or commodity products is de facto evidence that the com 
modity or commodity product is produced from a transgenic 
plant designed to express one or more of the iRNA molecules 
of the invention for the purpose of controlling hemipteran 
pests. 
0.175. In some embodiments, a transgenic plant or seed 
comprising a nucleic acid molecule of the invention also may 
comprise at least one other transgenic event in its genome, 
including without limitation: a transgenic event from which is 
transcribed an iRNA molecule targeting a locus in a hemi 
pteran pest other than the ones defined by SEQID NOs: 1 and 
2; a transgenic event from which is transcribed an iRNA 
molecule targeting a gene in an organism other than a hemi 
pteran pest (e.g., a plant-parasitic nematode); a gene encoding 
an insecticidal protein (e.g., a Bacillus thuringiensis, Alcali 
genes spp., or Pseudomonas spp. insecticidal protein); a her 
bicide tolerance gene (e.g., a gene providing tolerance to 
glyphosate); and a gene contributing to a desirable phenotype 
in the transgenic plant, such as increased yield, altered fatty 
acid metabolism, or restoration of cytoplasmic male Sterility. 
In particular embodiments, polynucleotides encoding iRNA 
molecules of the invention may be combined with other insect 
control and disease traits in a plant to achieve desired traits for 
enhanced control of plant disease and insect damage. Com 
bining insect control traits that employ distinct modes-of 
action may provide protected transgenic plants with Superior 
durability over plants harboring a single control trait, for 
example, because of the reduced probability that resistance to 
the trait(s) will develop in the field. 
V. Target Gene Suppression in a Hemipteran Pest 
(0176 A. Overview 
0177. In some embodiments of the invention, at least one 
nucleic acid molecule useful for the control of hemipteran 
pests may be provided to a hemipteran pest, wherein the 
nucleic acid molecule leads to RNAi-mediated gene silencing 
in the pest(s). In particular embodiments, an iRNA molecule 
(e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA) may be 
provided to the hemipteran host. In some embodiments, a 
nucleic acid molecule useful for the control of hemipteran 
pests may be provided to a pest by contacting the nucleic acid 
molecule with the pest. In these and further embodiments, a 
nucleic acid molecule useful for the control of hemipteran 
pests may be provided in a feeding Substrate of the pest, for 
example, a nutritional composition. In these and further 
embodiments, a nucleic acid molecule useful for the control 
of a hemipteran pest may be provided through ingestion of 
plant material comprising the nucleic acid molecule that is 
ingested by the pest(s). In certain embodiments, the nucleic 
acid molecule is present in plant material through expression 
of a recombinant nucleic acid introduced into the plant mate 
rial, for example, by transformation of a plant cell with a 
vector comprising the recombinant nucleic acid and regen 
eration of a plant material or whole plant from the trans 
formed plant cell. 
0.178 B. RNAi-mediated Target Gene Suppression 
0179. In certain embodiments, the invention provides 
iRNA molecules (e.g., dsRNA, siRNA, miRNA, shRNA, and 
20 
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hpRNA) that may be designed to target essential native poly 
nucleotides (e.g., essential genes) in the transcriptome of a 
hemipteran (e.g., BSB) pest, for example by designing an 
iRNA molecule that comprises at least one strand comprising 
a polynucleotide that is specifically complementary to the 
target polynucleotide. The sequence of an iRNA molecule so 
designed may be identical to that of the target polynucleotide, 
or may incorporate mismatches that do not prevent specific 
hybridization between the iRNA molecule and its target poly 
nucleotide. 
0180 iRNA molecules of the invention may be used in 
methods for gene Suppression in a hemipteran pest, thereby 
reducing the level or incidence of damage caused by the pest 
on a plant (for example, a protected transformed plant com 
prising an iRNA molecule). As used herein the term “gene 
suppression” refers to any of the well-known methods for 
reducing the levels of protein produced as a result of gene 
transcription to mRNA and subsequent translation of the 
mRNA, including the reduction of protein expression from a 
gene or a coding polynucleotide including post-transcrip 
tional inhibition of expression and transcriptional Suppres 
sion. Post-transcriptional inhibition is mediated by specific 
homology between all or a part of an mRNA transcribed from 
a gene targeted for Suppression and the corresponding iRNA 
molecule used for Suppression. Additionally, post-transcrip 
tional inhibition refers to the substantial and measurable 
reduction of the amount of mRNA available in the cell for 
binding by ribosomes. 
0181. In specific embodiments wherein an iRNA mol 
ecule is a dsRNA molecule, the dsRNA molecule may be 
cleaved by the enzyme, DICER, into short siRNA molecules 
(approximately 20 nucleotides in length). The double 
stranded siRNA molecule generated by DICER activity upon 
the dsRNA molecule may be separated into two single 
stranded siRNAs; the “passenger strand' and the “guide 
Strand. The passenger strand may be degraded, and the guide 
strand may be incorporated into RISC. Post-transcriptional 
inhibition occurs by specific hybridization of the guide strand 
with a specifically complementary polynucleotide of an 
mRNA molecule, and Subsequent cleavage by the enzyme, 
Argonaute (catalytic component of the RISC complex). 
0182. In particular embodiments of the invention, any 
form of iRNA molecule may be used. Those of skill in the art 
will understand that dsRNA molecules typically are more 
stable during preparation and during the step of providing the 
iRNA molecule to a cell than are single-stranded RNA mol 
ecules, and are typically also more stable in a cell. Thus, while 
siRNA and miRNA molecules, for example, may be equally 
effective in some embodiments, a dsRNA molecule may be 
chosen due to its stability. 
0183. In certain embodiments, a nucleic acid molecule is 
provided that comprises a polynucleotide, which polynucle 
otide may be expressed in vitro to produce an iRNA molecule 
that is substantially homologous to a nucleic acid molecule 
encoded by a polynucleotide within the genome of a hemi 
pteran pest. In certain embodiments, the in vitro transcribed 
iRNA molecule may be a stabilized dsRNA molecule that 
comprises a stem-loop structure. After a hemipteran pest con 
tacts the in vitro transcribed iRNA molecule, post-transcrip 
tional inhibition of a target gene in the pest (for example, an 
essential gene) may occur. 
0184. In some embodiments of the invention, expression 
of an iRNA from a nucleic acid molecule comprising at least 
15 contiguous nucleotides (e.g., at least 19 contiguous nucle 
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otides) of a polynucleotide are used in a method for post 
transcriptional inhibition of a target gene in a hemipteran 
pest, wherein the polynucleotide is selected from the group 
consisting of: SEQ ID NO:1; the complement of SEQ ID 
NO:1; SEQ ID NO:2; the complement of SEQ ID NO:2; a 
fragment of at least 15 contiguous nucleotides of SEQ ID 
NO:1; the complement of a fragment of at least 15 contiguous 
nucleotides of SEQID NO:1; a fragment of at least 15 con 
tiguous nucleotides of SEQ ID NO:2; the complement of a 
fragment of at least 15 contiguous nucleotides of SEQ ID 
NO:2; a native coding polynucleotide of a hemipteran organ 
ism comprising SEQ ID NO:1; the complement of a native 
coding polynucleotide of a hemipteran organism comprising 
SEQ ID NO:1; a native coding polynucleotide of a hemi 
pteran organism comprising SEQID NO:2; the complement 
of a native coding polynucleotide of a hemipteran organism 
comprising SEQID NO:2; a fragment of at least 15 contigu 
ous nucleotides of a native coding polynucleotide of a hemi 
pteran organism comprising SEQID NO:1; the complement 
of a fragment of at least 15 contiguous nucleotides of a native 
coding polynucleotide of a hemipteran organism comprising 
SEQ ID NO:1; a fragment of at least 15 contiguous nucle 
otides of a native coding polynucleotide of a hemipteran 
organism comprising SEQID NO:2; and the complement of 
a fragment of at least 15 contiguous nucleotides of a native 
coding polynucleotide of a hemipteran organism comprising 
SEQ ID NO:2. In certain embodiments, expression of a 
nucleic acid molecule that is at least about 80% identical (e.g., 
79%, about 80%, about 81%, about 82%, about 83%, about 
84%, about 85%, about 86%, about 87%, about 88%, about 
89%, about 90%, about 91%, about 92%, about 93%, about 
94%, about 95%, about 96%, about 97%, about 98%, about 
99%, about 100%, and 100%) with any of the foregoing may 
be used. In these and further embodiments, a nucleic acid 
molecule may be expressed that specifically hybridizes to an 
RNA molecule present in at least one cell of a hemipteran 
pest. 
0185. It is an important feature of some embodiments 
herein that the RNAi post-transcriptional inhibition system is 
able to tolerate sequence variations among target genes that 
might be expected due to genetic mutation, strain polymor 
phism, or evolutionary divergence. The introduced nucleic 
acid molecule may not need to be absolutely homologous to 
either a primary transcription product or a fully-processed 
mRNA of a target gene, so long as the introduced nucleic acid 
molecule is specifically hybridizable to either a primary tran 
scription product or a fully-processed mRNA of the target 
gene. Moreover, the introduced nucleic acid molecule may 
not need to be full-length, relative to either a primary tran 
scription product or a fully processed mRNA of the target 
gene. 
0186 Inhibition of a target gene using the iRNA technol 
ogy of the present invention is sequence-specific; i.e., poly 
nucleotides substantially homologous to the iRNA molecule 
(s) are targeted for genetic inhibition. In some embodiments, 
an RNA molecule comprising a polynucleotide with a nucle 
otide sequence that is identical to that of a portion of a target 
gene may be used for inhibition. In these and further embodi 
ments, an RNA molecule comprising a polynucleotide with 
one or more insertion, deletion, and/or point mutations rela 
tive to a target polynucleotide may be used. In particular 
embodiments, an iRNA molecule and a portion of a target 
gene may share, for example, at least from about 80%, at least 
from about 81%, at least from about 82%, at least from about 
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83%, at least from about 84%, at least from about 85%, at 
least from about 86%, at least from about 87%, at least from 
about 88%, at least from about 89%, at least from about 90%, 
at least from about 91%, at least from about 92%, at least from 
about 93%, at least from about 94%, at least from about 95%, 
at least from about 96%, at least from about 97%, at least from 
about 98%, at least from about 99%, at least from about 
100%, and 100% sequence identity. Alternatively, the duplex 
region of a dsRNA molecule may be specifically hybridizable 
with a portion of a target gene transcript. In specifically 
hybridizable molecules, a less than full length polynucleotide 
exhibiting a greater homology compensates for a longer, less 
homologous polynucleotide. The length of the polynucle 
otide of a duplex region of a dsRNA molecule that is identical 
to a portion of a target genetranscript may beat least about 25, 
50, 100, 200, 300, 400, 500, or at least about 1000 bases. In 
some embodiments, a polynucleotide of greater than 20-100 
nucleotides may be used; for example, a polynucleotide of 
100-200 or 300-500 nucleotides may be used. In particular 
embodiments, a polynucleotide of greater than about 200-300 
nucleotides may be used. In particular embodiments, a poly 
nucleotide of greater than about 500-1000 nucleotides may be 
used, depending on the size of the target gene. 
0187. In certain embodiments, expression of a target gene 
in a hemipteran pest may be inhibited by at least 10%; at least 
33%;at least 50%; or at least 80% within a cell of the pest, 
Such that a significant inhibition takes place. Significant inhi 
bition refers to inhibition over a threshold that results in a 
detectable phenotype (e.g., cessation of reproduction, feed 
ing, development, etc.), or a detectable decrease in RNA 
and/or gene product corresponding to the target gene being 
inhibited. Although in certain embodiments of the invention 
inhibition occurs in substantially all cells of the pest, in other 
embodiments inhibition occurs only in a subset of cells 
expressing the target gene. 
0188 In some embodiments, transcriptional suppression 
is mediated by the presence in a cell of a dsRNA molecule 
exhibiting substantial sequence identity to a promoter DNA 
or the complement thereof to effect what is referred to as 
“promoter trans Suppression. Gene Suppression may be 
effective against target genes in a hemipteran pest that may 
ingest or contact Such dsRNA molecules, for example, by 
ingesting or contacting plant material containing the dsRNA 
molecules. dsRNA molecules for use in promoter trans Sup 
pression may be specifically designed to inhibit or Suppress 
the expression of one or more homologous or complementary 
polynucleotides in the cells of the hemipteran pest. Post 
transcriptional gene Suppression by antisense or sense ori 
ented RNA to regulate gene expression in plant cells is dis 
closed in U.S. Pat. Nos. 5,107,065; 5,759,829:5,283, 184; and 
5,231,020. 
(0189 C. Expression of IRNA Molecules Provided to a 
Hemipteran Pest 
(0190. Expression of iRNA molecules for RNAi-mediated 
gene inhibition in a hemipteran pest may be carried out in any 
one of many in vitro or in vivo formats. The iRNA molecules 
may then be provided to a hemipteran pest, for example, by 
contacting the iRNA molecules with the pest, or by causing 
the pest to ingest or otherwise internalize the iRNA mol 
ecules. Some embodiments of the invention include trans 
formed host plants of a hemipteran pest, transformed plant 
cells, and progeny of transformed plants. The transformed 
plant cells and transformed plants may be engineered to 
express one or more of the iRNA molecules, for example, 
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under the control of a heterologous promoter, to provide a 
pest-protective effect. Thus, when a transgenic plant or plant 
cell is consumed by a hemipteran pest during feeding, the pest 
may ingest iRNA molecules expressed in the transgenic 
plants or cells. The polynucleotides of the present invention 
may also be introduced into a wide variety of prokaryotic and 
eukaryotic microorganism hosts to produce iRNA molecules. 
The term “microorganism’ includes prokaryotic and eukary 
otic species, such as bacteria and fungi. 
0191 Modulation of gene expression may include partial 
or complete Suppression of Such expression. In another 
embodiment, a method for Suppression of gene expression in 
ahemipteran pest comprises providing in the tissue of the host 
of the pest a gene-suppressive amount of at least one dsRNA 
molecule formed following transcription of a polynucleotide 
as described herein, at least one segment of which is comple 
mentary to an mRNA within the cells of the hemipteran pest. 
A dsRNA molecule, including its modified form such as an 
siRNA, miRNA, shRNA, or hpRNA molecule, ingested by a 
hemipteran pest in accordance with the invention may be at 
least from about 80%, 81%, 82%, 83%, 84%, 85%, 86%, 
87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 
97%, 98%, 99%, or about 100% identical to an RNA mol 
ecule transcribed from a hunchback DNA molecule, for 
example, comprising a polynucleotide selected from the 
group consisting of SEQID NOS:1 and 2. Isolated and sub 
stantially purified nucleic acid molecules including, but not 
limited to, non-naturally occurring polynucleotides and 
recombinant DNA constructs for providing dsRNA mol 
ecules of the present invention are therefore provided, which 
Suppress or inhibit the expression of an endogenous coding 
polynucleotide or a target coding polynucleotide in the hemi 
pteran pest when introduced thereto. 
0.192 Particular embodiments provide a delivery system 
for the delivery of iRNA molecules for the post-transcrip 
tional inhibition of one or more target gene(s) in a hemipteran 
plant pest and control of a population of the plant pest. In 
Some embodiments, the delivery system comprises ingestion 
of a host transgenic plant cell or contents of the host cell 
comprising RNA molecules transcribed in the host cell. In 
these and further embodiments, a transgenic plant cell or a 
transgenic plant is created that contains a recombinant DNA 
construct providing a stabilized dsRNA molecule of the 
invention. Transgenic plant cells and transgenic plants com 
prising nucleic acids encoding a particular iRNA molecule 
may be produced by employing recombinant DNA technolo 
gies (which basic technologies are well-known in the art) to 
construct a plant transformation vector comprising a poly 
nucleotide encoding an iRNA molecule of the invention (e.g., 
a stabilized dsRNA molecule); to transform a plant cell or 
plant; and to generate the transgenic plant cell or the trans 
genic plant that contains the transcribed iRNA molecule. 
0193 To impart protection from hemipteran pests to a 
transgenic plant, a recombinant DNA molecule may, for 
example, be transcribed into an iRNA molecule, such as a 
dsRNA molecule, an siRNA molecule, an miRNA molecule, 
an shRNA molecule, or an hpRNA molecule. In some 
embodiments, an RNA molecule transcribed from a recom 
binant DNA molecule may form a dsRNA molecule within 
the tissues or fluids of the recombinant plant. Such a dsRNA 
molecule may be comprised in part of a polynucleotide that is 
identical to a corresponding polynucleotide transcribed from 
a DNA within a hemipteran pest of a type that may infest the 
host plant. Expression of a target gene within the hemipteran 
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pest is suppressed by the dsRNA molecule, and the Suppres 
sion of expression of the target gene in the hemipteran pest 
results in the transgenic plant being resistant to the pest. The 
modulatory effects of dsRNA molecules have been shown to 
be applicable to a variety of genes expressed in pests, includ 
ing, for example, endogenous genes responsible for cell divi 
Sion, chromosomal remodeling, and cellular metabolism or 
cellular transformation, including house-keeping genes; tran 
Scription factors; molting-related genes; and other genes 
which encode polypeptides involved in cellular metabolism 
or normal growth and development. 
0194 For transcription from a transgene in vivo or an 
expression construct, a regulatory region (e.g., promoter, 
enhancer, silencer, and polyadenylation signal) may be used 
in some embodiments to transcribe the RNA strand (or 
Strands). Therefore, in Some embodiments, as set forth, Supra, 
a polynucleotide for use in producing iRNA molecules may 
be operably linked to one or more promoter elements func 
tional in a plant host cell. The promoter may be an endog 
enous promoter, normally resident in the host genome. The 
polynucleotide of the present invention, under the control of 
an operably linked promoter element, may further be flanked 
by additional elements that advantageously affect its tran 
Scription and/or the stability of a resulting transcript. Such 
elements may be located upstream of the operably linked 
promoter, downstream of the 3' end of the expression con 
struct, and may occur both upstream of the promoter and 
downstream of the 3' end of the expression construct. 
0.195. In embodiments, suppression of a target gene (e.g., 
a hunchback gene) results in a parental RNAi phenotype; a 
phenotype that is observable in progeny of the Subject (e.g., a 
hemipteran pest) contacted with the iRNA molecule. In some 
embodiments, the pRNAi phenotype comprises the pest 
being rendered less able to produce viable offspring. In par 
ticular examples of pRNAi, a nucleic acid that initiates 
pRNAi does not increase the incidence of mortality in a 
population into which the nucleic acid is delivered. In other 
examples of pRNAi, a nucleic acid that initiates pRNAi also 
increases the incidence of mortality in a population into 
which the nucleic acid is delivered. 
0196. In some embodiments, a population of hemipteran 
pests is contacted with an iRNA molecule, thereby resulting 
in pRNAi, wherein the pests survive and mate but produce 
eggs that are less able to hatch viable progeny than eggs 
produced by pests of the same species that are not provided 
the nucleic acid(s). In some examples, such pests do not 
oviposit or produce fewer eggs than what is observable in 
pests of the same species that are not contacted with the iRNA 
molecule. In some examples, the eggs oviposited by Such 
pests do not hatch or hatch at a rate that is significantly less 
than what is observable in pests of the same species that are 
not contacted with the iRNA molecule. In some examples, the 
nymphs that hatch from eggs oviposited by Such pests are not 
viable or are less viable than what is observable in pests of the 
same species that are not contacted with the iRNA molecule. 
0.197 Transgenic crops that produce substances that pro 
vide protection from insect feeding are vulnerable to adapta 
tion by the target insect pest population reducing the durabil 
ity of the benefits of the insect protection substance(s). 
Traditionally, delays in insect pest adaptation to transgenic 
crops are achieved by (1) the planting of “refuges” (crops that 
do not contain the pesticidal Substances, and therefore allow 
survival of insects that are susceptible to the pesticidal sub 
stance(s)); and/or (2) combining insecticidal Substances with 
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multiple modes of action against the target pests, so that 
individuals that are resistant to one mode of action are killed 
by a second mode of action. 
0198 In particular examples, iRNA molecules (e.g., 
expressed from a transgene in a host plant) represent new 
modes of action for combining with Bacillus thuringiensis, 
Alcaligenes spp., or Pseudomonas spp. insecticidal protein 
technology and/or lethal RNAi technology in Insect Resis 
tance Management gene pyramids to mitigate against the 
development of insect populations resistant to either of these 
control technologies. 
0199 Parental RNAi may result in some embodiments in 
a type of pest control that is different from the control 
obtained by lethal RNAi, and which may be combined with 
lethal RNAi to result in synergistic pest control. Thus, in 
particular embodiments, iRNA molecules for the post-tran 
Scriptional inhibition of one or more target gene(s) in a hemi 
pteran plant pest can be combined with otheriRNA molecules 
to provide redundant RNAi targeting and synergistic RNAi 
effects. 
0200 Parental RNAi (pRNAi) that causes egg mortality or 
loss of egg viability has the potential to bring further durabil 
ity benefits to transgenic crops that use RNAi and other 
mechanisms for insect protection. pRNAi prevents exposed 
insects from producing progeny, and therefore from passing 
on to the next generation any alleles they carry that confer 
resistance to the pesticidal Substance(s). pRNAi is particu 
larly useful in extending the durability of insect-protected 
transgenic crops when it is combined with one or more addi 
tional pesticidal Substances that provide protection from the 
same pest populations. Such additional pesticidal Substances 
may in some embodiments include, for example, dsRNA; 
nymph-active dsRNA; insecticidal proteins (such as those 
derived from Bacillus thuringiensis, Alcaligenes spp., 
Pseudomonas spp. or other organisms); and other insecticidal 
Substances. This benefit arises because insects that are resis 
tant to the pesticidal Substances occur as a higher proportion 
of the population in the transgenic crop than in the refuge 
crop. If a ratio of resistance alleles to susceptible alleles that 
are passed on to the next generation is lower in the presence of 
pRNAi than in the absence of pRNAi, the evolution of resis 
tance will be delayed. 
0201 For example, pRNAi may not reduce the number of 
individuals in a first pest generation that are inflicting damage 
on a plant expressing an iRNA molecule. However, the ability 
of Such pests to Sustain an infestation through Subsequent 
generations may be reduced. Conversely, lethal RNAi may 
kill pests that already are infesting the plant. When pRNAi is 
combined with lethal RNAi, pests that are contacted with a 
parental iRNA molecule may breed with pests from outside 
the system that have not been contacted with the iRNA, how 
ever, the progeny of such a mating may be non-viable or less 
viable, and thus may be unable to infest the plant. At the same 
time, pests that are contacted with a lethal iRNA molecule 
may be directly affected. The combination of these two 
effects may be synergistic; i.e., the combined pRNAi and 
lethal RNAi effect may be greater than the sum of the pRNAi 
and lethal RNAi effects independently. pRNAi may be com 
bined with lethal RNAi, for example, by providing a plant that 
expresses both lethal and parental iRNA molecules; by pro 
viding in the same location a first plant that expresses lethal 
iRNA molecules and a second plant that expresses parental 
iRNA molecules; and/or by contacting female pests with the 
pRNAi molecule, and Subsequently releasing the contacted 
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pests into the plant environment, such that they can mate 
unproductively with the plant pests. 
0202 Some embodiments provide methods for reducing 
the damage to a host plant (e.g., a Soybean plant) caused by a 
hemipteran pest that feeds on the plant, wherein the method 
comprises providing in the host planta transformed plant cell 
expressing at least one nucleic acid molecule of the invention, 
wherein the nucleic acid molecule(s) functions upon being 
taken up by the pest(s) to inhibit the expression of a target 
polynucleotide within the pest(s), which inhibition of expres 
sion results in reduced reproduction, for example, in addition 
to mortality and/or reduced growth of the pest(s), thereby 
reducing the damage to the host plant caused by the pest(s). In 
Some embodiments, the nucleic acid molecule(s) comprise 
dsRNA molecules. In these and further embodiments, the 
nucleic acid molecule(s) comprise dsRNA molecules that 
each comprise more than one polynucleotide that is specifi 
cally hybridizable to a nucleic acid molecule expressed in a 
hemipteran pest cell. In some embodiments, the nucleic acid 
molecule(s) consist of one polynucleotide that is specifically 
hybridizable to a nucleic acid molecule expressed in a hemi 
pteran pest cell. 
0203. In alternative embodiments, a method for increasing 
the yield of a corn crop is provided, wherein the method 
comprises introducing into a corn plant at least one nucleic 
acid molecule of the invention; and cultivating the corn plant 
to allow the expression of an iRNA molecule comprising the 
nucleic acid, wherein expression of an iRNA molecule com 
prising the nucleic acid inhibits hemipteran pest damage and/ 
or growth, thereby reducing or eliminating a loss of yield due 
to hemipteran pest infestation. In some embodiments, the 
iRNA molecule is a dsRNA molecule. In these and further 
embodiments, the nucleic acid molecule(s) comprise dsRNA 
molecules that each comprise more than one polynucleotide 
that is specifically hybridizable to a nucleic acid molecule 
expressed in a hemipteran pest cell. In some embodiments, 
the nucleic acid molecule(s) consists of one polynucleotide 
that is specifically hybridizable to a nucleic acid molecule 
expressed in a hemipteran pest cell. 
0204. In other embodiments, a method for increasing the 
yield of a plant crop is provided, wherein the method com 
prises introducing into a female hemipteran pest (e.g., by 
injection, by ingestion, by spraying, and by expression from 
a DNA) at least one nucleic acid molecule of the invention; 
and releasing the female pest into the crop, wherein mating 
pairs including the female pest are unable or less able to 
produce viable offspring, thereby reducing or eliminating a 
loss of yield due to hemipteran pest infestation. In particular 
embodiments, such a method provides control of Subsequent 
generations of the pest. In similar embodiments, the method 
comprises introducing the nucleic acid molecule of the inven 
tion into a male hemipteran pest, and releasing the male pest 
into the crop (e.g., wherein pRNAi male pests produce less 
sperm than untreated controls). In some embodiments, the 
nucleic acid molecule is a DNA molecule that is expressed to 
produce an iRNA molecule. In some embodiments, the 
nucleic acid molecule is a dsRNA molecule. In these and 
further embodiments, the nucleic acid molecule(s) comprise 
dsRNA molecules that each comprise more than one poly 
nucleotide that is specifically hybridizable to a nucleic acid 
molecule expressed in a hemipteran pest cell. In some 
embodiments, the nucleic acid molecule(s) consists of one 
polynucleotide that is specifically hybridizable to a nucleic 
acid molecule expressed in a hemipteran pest cell. 
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0205. In some embodiments, a method for modulating the 
expression of a target gene in a hemipteran pest is provided, 
the method comprising: transforming a plant cell with a vec 
tor comprising a polynucleotide encoding at least one iRNA 
molecule of the invention, wherein the polynucleotide is 
operatively-linked to a promoter and a transcription termina 
tion element; culturing the transformed plant cell under con 
ditions sufficient to allow for development of a plant cell 
culture including a plurality of transformed plant cells; select 
ing for transformed plant cells that have integrated the poly 
nucleotide into their genomes; Screening the transformed 
plant cells for expression of an iRNA molecule encoded by 
the integrated polynucleotide; selecting a transgenic plant 
cell that expresses the iRNA molecule; and feeding the 
selected transgenic plant cell to the hemipteran pest. Plants 
may also be regenerated from transformed plant cells that 
express an iRNA molecule encoded by the integrated nucleic 
acid molecule. In some embodiments, the iRNA molecule is 
a dsRNA molecule. In these and further embodiments, the 
nucleic acid molecule(s) comprise dsRNA molecules that 
each comprise more than one polynucleotide that is specifi 
cally hybridizable to a nucleic acid molecule expressed in a 
hemipteran pest cell. In some embodiments, the nucleic acid 
molecule(s) consists of one polynucleotide that is specifically 
hybridizable to a nucleic acid molecule expressed in a hemi 
pteran pest cell. 
0206 iRNA molecules of the invention can be incorpo 
rated within the seeds of a plant species (e.g., soybean), either 
as a product of expression from a recombinant gene incorpo 
rated into a genome of the plant cells, or as incorporated into 
a coating or seed treatment that is applied to the seed before 
planting. A plant cell comprising a recombinant gene is con 
sidered to be a transgenic event. Also included in embodi 
ments of the invention are delivery systems for the delivery of 
iRNA molecules to hemipteran pests. For example, the iRNA 
molecules of the invention may be directly introduced into the 
cells of a pest(s). Methods for introduction may include direct 
mixing of iRNA into the diet of the hemipteran pest (e.g., by 
mixing with plant tissue from a host for the pest), as well as 
application of compositions comprising iRNA molecules of 
the invention to host plant tissue. For example, iRNA mol 
ecules may be sprayed onto a plant Surface. Alternatively, an 
iRNA molecule may be expressed by a microorganism, and 
the microorganism may be applied onto the plant Surface, or 
introduced into a root or stem by a physical means Such as an 
injection. As discussed, Supra, a transgenic plant may also be 
genetically engineered to express at least one iRNA molecule 
in an amount Sufficient to kill the hemipteran pests known to 
infest the plant. iRNA molecules produced by chemical or 
enzymatic synthesis may also be formulated in a manner 
consistent with common agricultural practices, and used as 
spray-on products for controlling plant damage by a hemi 
pteran pest. The formulations may include the appropriate 
adjuvants (e.g., Stickers and wetters) required for efficient 
foliar coverage, as well as UV protectants to protect iRNA 
molecules (e.g., dsRNA molecules) from UV damage. Such 
additives are commonly used in the bioinsecticide industry, 
and are well known to those skilled in the art. Such applica 
tions may be combined with other spray-on insecticide appli 
cations (biologically based or otherwise) to enhance plant 
protection from hemipteran pests. 
0207 All references, including publications, patents, and 
patent applications, cited herein are hereby incorporated by 
reference to the extent they are not inconsistent with the 
explicit details of this disclosure, and are so incorporated to 
the same extent as if each reference were individually and 
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specifically indicated to be incorporated by reference and 
were set forth in its entirety herein. The references discussed 
herein are provided solely for their disclosure prior to the 
filing date of the present application. Nothing herein is to be 
construed as an admission that the inventors are not entitled to 
antedate such disclosure by virtue of prior invention. 
0208. The following Examples are provided to illustrate 
certain particular features and/or aspects. These Examples 
should not be construed to limit the disclosure to the particu 
lar features or aspects described. 
EXAMPLES 
Example 1 
RNAi Constructs 
Template Preparation by PCR and dsRNA Synthesis 
0209. The strategies used to provide specific templates for 
hunchback dsRNA production are shown in FIG. 1A and FIG. 
1B. Template DNAs intended for use in hunchback dsRNA 
synthesis are prepared by PCR using specific primers and 
first-strand cDNA prepared from total RNA. For hunchback 
selected target gene regions, two separate PCR amplifications 
are performed. FIG. 1. A The first PCR amplification intro 
duces a T7 promoter sequence at the 5' end of the amplified 
sense Strands. The second reaction incorporates the T7 pro 
motersequence at the 5' ends of the antisense strands. The two 
PCR amplified fragments for each region of the target genes 
are then mixed in approximately equal amounts, and the 
mixture is used as transcription template for dsRNA produc 
tion. FIG. 1A. 
0210 For the YFP negative control, a single PCR ampli 
fication is performed. FIG. 1B. The PCR amplification intro 
duced a T7 promoter sequence at the 5' ends of the amplified 
sense and antisense strands. The two PCR amplified frag 
ments for each region of the target genes were then mixed in 
approximately equal amounts, and the mixture was used as 
transcription template for dsRNA production. FIG. 1B. 
dsRNA for the negative control YFP coding region was pro 
duced using specific primers and a DNA clone of the YFP 
coding region as template. The PCR product amplified for 
hunchback and YFP were used as a template for in vitro 
synthesis of dsRNAs using the MEGAScript high-yield tran 
scription kit (Applied Biosystems Inc., Foster City, Calif.). 
The synthesized dsRNAs were purified using the RNeasy 
Mini kit (Qiagen, Valencia, Calif.) or an AMBIONR MEGA 
script(R) RNAi kit, essentially as prescribed by the manufac 
turer's instructions. dsRNA preparations were quantified 
using a NANODROPTM 8000 spectrophotometer (THERMO 
SCIENTIFIC, Wilmington, Del.) or equivalent means, and 
analyzed by gel electrophoresis to determine purity. 
Example 2 
Real-Time PCR Analysis 
0211 Quantitative Real-Time PCR. E. heros tissues for 
qRT-PCR were collected from Zero to three day-old females 
injected with dsRNA as described in Example 6. After seven 
days, female ovaries were dissected under a stereo micro 
scope in nuclease-free 1xPBS (pH 7.4) and frozen individu 
ally on dry ice in collection microtubes. Tissue disruption was 
performed with the RL lysis buffer and the KleckoTM tissue 
pulverizer (Garcia Manufacturing, Visalia, Calif.). Following 
tissue maceration, the total RNA was isolated in high 
throughput format using the Norgen Total RNA Purification 
US 2016/0208252 A1 
96-well kit (Norgen BioteK Corp., Ontario, Canada) follow 
ing the manufacturer's protocol using TurboTM DNase (Life 
Technologies, Carlsbad, Calif.) for 1 hour at 37° C. on the 
elutant. cDNA synthesis was performed using the high capac 
ity clNARTkit (Life technologies, Carlsbad, Calif.) accord 
ing to the manufacturer's protocol with the following modi 
fications. Total RNA was adjusted to 50 ng/ul with nuclease 
free water. RNA samples were heated to 70° C. for 10 minutes 
and cooled to 4°C. Half reactions were initiated by addition 
of 5ul of 2x mix. The primer mix, which is supplied solely as 
random primers, was first spiked with custom synthesized 
T20VN oligo (Integrated DNA Technologies, Coralville, 
Iowa) to a final concentration of 2 in order to improve the 
sensitivity of 3'UTR based assays. Following first strand syn 
thesis, the samples were diluted 1:3 with nuclease free. 
0212 E. heros qRT-PCR primers and hydrolysis probes 
were designed using LightCycler Probe Design Software 2.0 
(Roche, Basel, Switzerland) for the reference gene and 
Primer Express(R) Software Version3.0 (Applied Biosystems, 
Grand Island, N.Y.) for the target genes (Supplemental Table 
2). Non-injected insects were used as controls. E. heros actin 
was used as the reference gene. Probes were labeled with 
FAM (6-Carboxy Fluorescein Amidite). The final primer con 
centrations were 0.4 uMand probe concentrations were 0.2 in 
10 ul reaction volumes. Relative transcript levels were ana 
lyzed by probe hydrolysis qRT-PCR using Roche LightCy 
cler480 (Roche, Basel, Switzerland). All assays included 
negative controls of no-template (mix only). For the standard 
curves, a blank was included in the source plate to check for 
sample cross-contamination. PCR cycling conditions 
included a 10 minute target activation incubation at 95°C., 
followed by 40 cycles of denaturation at 95°C. for 10 sec 
onds, anneal/extend at 60° C. for 40 seconds, and FAM acqui 
sition at 72°C. for 1 second. The reaction was followed by a 
10 second cool-down at 40°C. The data was analyzed using 
LightCyclerTM Software v1.5 and relative changes in expres 
sion were calculated using 2^* method (Livak and Schmit 
tgen (2001) Methods 25(4):402-08). 
0213 Non-injected insects and YFP dsRNA-injected 
insects were used as controls. The BSB Actin (SEQ ID 
NO:14) was used as a reference gene (Ponton et al. (2011) J 
Insect Physiol 57 (6):840-50). The primers and probes for the 
gene of interest (GOI) and reference genes appear in Table 1. 
TABLE 1. 
Oligonucleotides and probes for BSB probe 
hydrolysis CPCR assay. 
NAME SEQUENCE 
Reference GENE 
Actin Actin-F TCAAGGAAAAACTGTGCTATGT 
Actin Actin-R TACCGATGGTGATGACCTGA 
Actin Actin-Fam ACCGCCGCTGCC 
Target 
hio ho-FMGB CCCGACTCCGGCACAA 
hio hb-R MGB TGACCGTACTCCGCGTCAT 
hio ho-FAMMGB TCGTTAAAGAGGAGCCGCGA 
0214. The hb transcript levels in E. heros ovary drop sig 
nificantly (by over 80%) after hb dsRNA injection (FIG. 4). 
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Example 3 
Construction of Plant Transformation Vectors 
0215. An entry vector harboring a target gene construct for 
dsRNA hairpin formation comprising segments of hunch 
back (SEQ ID NO: 1) is assembled using a combination of 
chemically synthesized fragments (DNA2.0, Menlo Park, 
Calif.) and standard molecular cloning methods. Intramo 
lecular hairpin formation by RNA primary transcripts is 
facilitated by arranging (within a single transcription unit) 
two copies of a target gene segment in opposite orientation to 
one another, the two segments being separated by a linker 
sequence (e.g. ST-LS1 intron, SEQID NO:6; Vancanneyt et 
al. (1990) Mol. Gen. Genet. 220:245-250). Thus, the primary 
mRNA transcript contains the two hunchback gene segment 
sequences as large inverted repeats of one another, separated 
by the linker sequence. A copy of a promoter (e.g. maize 
ubiquitin 1, U.S. Pat. No. 5,510,474; 35S from Cauliflower 
Mosaic Virus (CaMV); promoters from rice actin genes: 
ubiquitin promoters; pEMU; MAS; maize H3 histone pro 
moter, ALS promoter, phaseolin gene promoter; cab: rubisco; 
LAT52: Zm 13; and/or apg) is used to drive production of the 
primary mRNA hairpintranscript, and a fragment comprising 
a 3' untranslated region, for example and without limitation, a 
maize peroxidase 5 gene (ZmPer53'UTR v2; U.S. Pat. No. 
6,699.984), Atubi10, AtEf1, or StPinII is used to terminate 
transcription of the hairpin-RNA-expressing gene. 
0216. The entry vector described above is used in standard 
GATEWAYR recombination reactions with a typical binary 
destination vector to produce hunchback hairpin RNA 
expression transformation vectors for Agrobacterium-medi 
ated plant embryo transformations. 
0217. A negative control binary vector which comprises a 
gene that expresses a YFP hairpin dsRNA is constructed by 
means of standard GATEWAYR recombination reactions 
with a typical binary destination vector and entry vector. The 
entry vector comprises a YFP hairpin sequence under the 
expression control of a maize ubiquitin 1 promoter and a 
fragment comprising a 3' untranslated region from a maize 
peroxidase 5 gene. 
0218. A binary destination vector comprises a herbicide 
tolerance gene (aryloxyalknoate dioxygenase; (AAD-1 V3, 
U.S. Pat. No. 7,838,733, and Wright et al. (2010) Proc. Natl. 
Acad. Sci. U.S.A. 107:20240-5)) under the regulation of a 
plant operable promoter (e.g., Sugarcane bacilliform badnavi 
rus (Sc3V) promoter (Schenk et al. (1999) Plant Mol. Biol. 
39:1221-30) or ZmUbil (U.S. Pat. No. 5,510.474)). 5' UTR 
and intron from these promoters, are positioned between the 
3' end of the promoter segment and the start codon of the 
AAD-1 coding region. A fragment comprising a 3' untrans 
lated region from a maize lipase gene (ZmLip 3'UTR; U.S. 
Pat. No. 7,179,902) is used to terminate transcription of the 
AAD-1 mRNA. 
0219. A further negative control binary vector that com 
prises a gene that expresses a YFP protein, is constructed by 
means of standard GATEWAYR recombination reactions 
with a typical binary destination vector and entry vector. The 
binary destination vector comprises a herbicide tolerance 
gene (aryloxyalknoate dioxygenase; AAD-1 V3) (as above) 
under the expression regulation of a maize ubiquitin 1 pro 
moter and a fragment comprising a 3' untranslated region 
from a maize lipase gene (ZmLip 3'UTR). The entry vector 
comprises a YFP coding region under the expression control 
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of a maize ubiquitin 1 promoter and a fragment comprising a 
3' untranslated region from a maize peroxidase 5 gene. 
Example 4 
Insect Rearing and Candidate Gene Selection in 
Neotropical Brown Stink Bug (Euschistus heros) 
0220 Insect Rearing. 
0221) Neotropical Brown Stink Bugs (BSB; Euschistus 
heros) were reared in a 27°C. incubator, at 65% relative 
humidity, with 16:8 hour light: dark cycle. One gram of eggs 
collected over 2-3 days was seeded in 5 L containers with 
filter paper discs at the bottom; the containers were covered 
with #18 mesh for ventilation. Each rearing containeryielded 
approximately 300-400 adult BSB. At all stages, the insects 
were fed fresh green beans three times per week and a sachet 
of seed mixture containing Sunflower seeds, soybeans, and 
peanuts (3:1:1 by weight ratio) was replaced once a week. 
Water was supplemented in vials with cotton plugs as wicks. 
After the initial two weeks, insects were transferred to a new 
container once a week. 
0222 RNAi Target Selection. 
0223 Six stages of BSB development were selected for 
mRNA library preparation. Total RNA was extracted from 
insects frozen at -70° C. and homogenized in 10 volumes of 
Lysis/Binding buffer in Lysing MATRIX A 2 mL tubes (MP 
BIOMEDICALS, Santa Ana, Calif.) on a FastPrep R-24 
Instrument (MP BIOMEDICALS). Total mRNA was 
extracted using a mirVana TM miRNA. Isolation Kit (AM 
BION: INVITROGEN) according to the manufacturer's pro 
tocol. RNA sequencing using an Illumina R. HiSegTM system 
(San Diego, Calif.) provided candidate target gene sequences 
for use in RNAi insect control technology. HiSegTM generated 
a total of about 378 million reads for the six samples. Reads 
were assembled individually for each sample using TRINITY 
assembler software (Grabherr et al. (2011) Nature Biotech. 
29:644-652). The assembled transcripts were combined to 
generate a pooled transcriptome. This BSB pooled transcrip 
tome contains 378,457 sequences. 
0224 BSB Hunchback Ortholog Identification. 
0225. A tBLASTn search of the BSB pooled transcrip 
tome was performed using sequences of the Drosophila 
hunchback (hb-PA, GENBANKAccession No. NP 731267) 
protein. BSB hunchback (SEQID NO:1) was identified as a 
Euschistus heros candidate target gene that may lead to hemi 
pteran pest mortality, or inhibition of growth, development, or 
reproduction. This gene encodes a HUNCHBACK protein, 
which corresponds to a C2H2-type Zinc-finger protein family 
transcription factor that is also defined as a gap gene, a gene 
loss of which produces a gap in the body plan. 
0226. The sequence of SEQID NO:1 is novel. There was 
no significant homologous nucleotide sequence found with a 
search in GENBANK. The closest homolog of the BSB 
HUNCHBACK amino acid sequence (SEQ ID NO:3) is a 
Oncopeltus fasciatus protein having GENBANK Accession 
No. AAR23151.1 (80% similar; 73% identical over the 
homology region). 
0227 Template Preparation and dsRNA Synthesis. 
0228 cDNA was prepared from total BSB RNA extracted 
from a single young adult insect (about 90 mg) using TRI 
ZolR Reagent (LIFE TECHNOLOGIES, Grand Island, 
N.Y.). The insect was homogenized at room temperature in a 
1.5 mL microcentrifuge tube with 200LL of TRIZolR using a 
pellet pestle (FISHERBRAND, Grand Island, N.Y.) and 
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Pestle Motor Mixer (COLE-PARMER, Vernon Hills, Ill.). 
Following homogenization, an additional 800 uL of TRIZolR) 
was added, the homogenate was Vortexed, and then incubated 
at room temperature for five minutes. Cell debris was 
removed by centrifugation and the Supernatant was trans 
ferred to a new tube. Following manufacturer-recommended 
TRIZolR extraction protocol for 1 mL of TRIZol(R), the RNA 
pellet was dried at room temperature and resuspended in 200 
uL Tris Buffer from a GFX PCR DNA AND GEL EXTRAC 
TION KIT (IllustraTM; GE HEALTHCARE LIFE SCI 
ENCES, Pittsburgh, Pa.) using Elution Buffer Type 4 (i.e. 10 
mM Tris-HCl pH8.0). RNA concentration was determined 
using a NANODROPTM 8000 spectrophotometer (THERMO 
SCIENTIFIC, Wilmington, Del.). 
0229 cDNA was reverse-transcribed from 5ug BSB total 
RNA template and oligo dT primer using a SUPERSCRIPT 
III FIRST-STRAND SYNTHESIS SYSTEMTM for RT-PCR 
(INVITROGEN), following the supplier's recommended 
protocol. The final volume of the transcription reaction was 
brought to 100 uL with nuclease-free water. 
0230 Primers for BSB hb-1 dsRNA BSB hb-1-F (SEQ 
ID NO:7) and BSB hb-1-R (SEQ ID NO:8) were used to 
amplify DNA templates for dsRNA transcription. The DNA 
templates were amplified using “touch-down” PCR (anneal 
ing temperature lowered from 60°C. to 50° C. in a 1° C./cycle 
decrease) with 1 uL of cDNA (above) as the template. Frag 
ments comprising a 469 bp segment of hunchback (i.e. BSB 
hb-1, SEQ ID NO:2) were generated during 35 cycles of 
PCR. The above procedure was used to amplify a 301 bp 
negative control template YFPv2 (SEQID NO:9) using prim 
ers YFPv2 F (SEQ ID NO:10) and YFPv2. R (SEQ ID 
NO:11). The BSB-specific and YFPv2 primers containeda T7 
phage promoter sequence (SEQ ID NO:4) at their 5' ends, 
enabling the use of the aforementioned BSB DNA fragments 
for dsRNA transcription. 
0231 dsRNAs were synthesized using 2 ul of PCR prod 
uct (above) as the template with a MEGAScriptTM RNAi kit 
(AMBION) or HiScribe(RT7 In Vitro Transcription Kit, used 
according to the manufacturer's instructions. See FIGS. 1A 
and 1B. dsRNA was quantified on a NANODROPTM 8000 
spectrophotometer and diluted to 1 ug/uI in nuclease-free 
0.1XTE buffer (1 mM Tris HCL, 0.1 mM EDTA, pH 7.4). 
Example 5 
dsRNA Injection into 2" Instar Neotropical Brown 
Stink Bug (Euschistus heros) Nymphs 
0232 BSB Artificial Diet. 
0233 bsb artificial diet was prepared as follows and used 
within two weeks of preparation. Lyophilized green beans 
were blended to a fine powder in a MAGIC BULLETR) 
blender while raw (organic) peanuts were blended in a sepa 
rate MAGIC BULLETR) blender. Blended dry ingredients 
were combined (weight percentages: greenbeans, 35%; pea 
nuts, 35%; sucrose, 5%; Vitamin complex (e.g. Vanderzant 
Vitamin Mixture for insects, SIGMA-ALDRICH), 0.9%); in 
a large MAGIC BULLETR) blender, which was capped and 
shaken well to mix the ingredients. The mixed dry ingredients 
were then added to a mixing bowl. In a separate container, 
water and benomyl anti-fungal agent (50 ppm; 25uL 20,000 
ppm solution/50 mL diet solution) were mixed well and then 
added to the dry ingredient mixture. All ingredients were 
mixed by hand until the solution was fully blended. The diet 
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was shaped into desired sizes, wrapped loosely in aluminum 
foil, heated for 4 hours at 60°C., then cooled and stored at 4° 
C. 
0234. Injection of dsRNA into BSB Hemocoel. 
0235 BSB were reared on a green bean and seed diet, as 
the colony described above, in a 27°C. incubator at 65% 
relative humidity and 16:8 hour light: dark photoperiod. Sec 
ond instar nymphs (each weighing 1 to 1.5 mg) were gently 
handled with a small brush to prevent injury and were placed 
in a Petridish on ice to chill and immobilize the insects. Each 
insect was injected with 55.2 mL of a 500 ng/uL dsRNA 
Solution (i.e., 27.6 ng dsRNA; dosage of 18.4 to 27.6 g/g, 
body weight). Injections were performed using a 
NANOJECTTM II injector (DRUMMOND SCIENTIFIC, 
Broomhall, Pa.) equipped with an injection needle pulled 
from a Drummond 3.5 inch #3-000-203-G/X glass capillary. 
The needle tip was broken and the capillary was backfilled 
with light mineral oil, then filled with 2 to 3 uI of dsRNA. 
dsRNA was injected into the abdomen of the nymphs (10 
insects injected per dsRNA per trial), and the trials were 
repeated on three different days. Injected insects (5 per well) 
were transferred into 32-well trays (Bio-RT-32 Rearing Tray: 
BIO-SERV, Frenchtown, N.J.) containing a pellet of artificial 
BSB diet and covered with Pull-N-PeelTM tabs (BIO-CV-4: 
BIO-SERV). Moisture was supplied by means of 1.25 mL 
water in a 1.5 mL microcentrifuge tube with a cotton wick. 
The trays were incubated at 26.5°C., 60% humidity and 16: 
8 hour light: dark photoperiod. Viability counts and weights 
were taken on day 7 after the injections. 
0236. Injection of dsRNA that Targets Hunchback mRNA 
in BSB 2" Instar Nymphs. 
0237 dsRNA homologous to a YFP coding region, 
YFPv2, was used as a negative control in BSB injection 
experiments. As summarized in Table 2, 27.6 ng BSB hb-1 
dsRNA injected into the hemocoel of 2" instar BSB did not 
lead to increased mortality within seven days. 
TABLE 2 
Results of BSB hunchback dsRNA injection into the hemocoel of 2" 
instar Brown Stink Bug nymphs seven days after injection. 
Table shows mean percent mortality, N number of trials, standard error 
of the mean (SEM) and a p-value of two-tailed student t-test. 
Treatment Mean % mortality SEM N trials t-test (p) 
BSB hb-1 1O.O 5.77 3 1.OOE--OO 
Not injected 13.3 3.33 3 6.43E-O1 
YFPv2 dsRNA 1O.O 5.77 3 
Example 6 
Egg Hatch Following dsRNA Injection in Euschistus 
heros 
0238. Injection of dsRNA into BSB Hemocoel. 
0239 BSB were reared as described above for the colony. 
In the following exemplification, young adults (up to one 
week post adult molt) were collected and chilled in a second 
ary container on ice. The females and males were separated 
based on structural dimorphism of the genitalia. Female BSB 
were handled with Featherweight entomology forceps and 
27 
Jul. 21, 2016 
injected with dsRNA using a NANOJECTTM II injector 
(DRUMMOND SCIENTIFIC, Broomhall, Pa.) equipped 
with an injection needle pulled from a Drummond 3.5 inch 
#3-000-203-G/X glass capillary. The needle tip was broken 
and the capillary was backfilled with light mineral oil then 
filled with 3 ul, dsRNA. Ten females (approximately 90 mg 
each) per treatment were injected with dsRNA. Each female 
was injected into the abdomen twice consecutively with 69 
nL 1 lug/uL dsRNA for a total of 138 n (138 ng). Each batch 
often females was moved into a 1 quart (-950 mL) bin with 
an opening in the lid and #18 mesh for ventilation. Two adult 
males were added to each bin often females. The insects were 
Supplied with a vial of water, green beans, and seeds as 
described in the rearing procedure. The insects were kept at 
26.5°C., 60% humidity and 16:8 light: dark photoperiod. 
0240 Surviving female counts, oviposited eggs and egg 
hatch numbers were collected on a daily basis starting seven 
to nine days after injection and continued for up to 24 days. 
Eggs were removed daily and kept in Petri dishes or multi 
well plates on a layer of 1% agarose in water. The adult insects 
were transferred into bins with fresh water and food every 
week. 
0241 Injections of dsRNA that targets hunchback in BSB 
females decrease egg oviposition. In one exemplification, 
females injected with dsRNA that targets a 301 nt sequence 
(SEQ ID NO:9) of the YFP coding region were used as a 
negative control and compared to un-injected and females 
injected with BSB hb-1 dsRNA (SEQID NO:2). As summa 
rized in Table 3 and Table 5 hunchback dsRNA-injected 
females oviposited lower numbers of eggs from YFPv2 
dsRNA injected and not injected controls. Table 7 shows a 
statistical difference in the number of eggs oviposited by 
females injected with hunchback dsRNA when compared to 
those injected with YFP dsRNA. The hatch rates from the 
above eggs were dramatically reduced in all trials (Table 4. 
Table 6, and Table 8). Results from the first two weeks of 
oviposition in trial 1 were also binned by week, as presented 
in FIGS. 5A-5C. While oviposition was not affected both 
development and egg hatch were reduced. Eggs that showed 
development had a phenotype with underdeveloped limbs 
and head structures (FIGS. 6A-6C.) 
TABLE 3 
Number of eggs oviposited per female per day in trial 1. Ten females 
were injected with dsRNA targeted against BSB hunchback or negative 
control YFPv2. Counts of eggs were collected starting on day 7 post 
injection and continued for 21 consecutive days post injection. 
Two-tailed T-tests were performed in Excel. 
total mean ii of 
number eggs day. Std. 
dsRNA of eggs female Deviation Std. Error t-test (p) 
BSB hb-1 971 8.53 2.39 O616 2.94E-O1 
YFPv2 1280 10.1 2.05 O.S29 
not inj. 1429 9.53 2.89 0.747 7.S2E-O1 
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TABLE 4 
Number of eggs hatched per female per day in trial 1. Ten females were injected with dsRNA 
targeted against BSB hunchback or negative control YFPv2. Counts of eggs hatched were 
collected starting on day 7 post injection and continued for 21 consecutive days post 
injection. Two-tailed t-tests were performed in Excel for mean # hatched day? female. 
% egg total number of mean # eggs Std. Std. t-test 
dsRNA hatch eggs hatched hatched day? female Deviation Error (p) 
BSB hb-1 27.29 26S 2.42 1.44 O.37 2.24E-O3* 
YFPv2 85.55 1095 8.66 1.84 O48 
not inj. 76.84 1098 7.32 2.66 O.69 112E-O1 
*indicates significant difference (p-value < 0.05) 
TABLE 5 
Number of eggs oviposited per female per day in trial 2. Ten females 
were injected with dsRNA targeted against BSB hunchback or negative 
control YFPv2. Counts of eggs were collected starting on day 9 post 
injection and continued for 24 consecutive days post injection. 
Two-tailed T-tests were performed in Excel. 
mean ii of 
total number eggs day. Std. Std. 
dsRNA of eggs female Deviation Error t-test (p) 
BSB hb-1 625 7.27 1.69 0.437 2.82E-O1 
YFPv2 740 6.53 1.97 O.S.09 
TABLE 6 
Number of eggs hatched per female per day in trial 2. Ten females were injected with dsRNA 
targeted against BSB hunchback or negative control YFPv2. Counts of eggs hatched were 
collected starting on day 9 post injection and continued for 24 consecutive days post 
injection. Two-tailed t-tests were performed in Excel for mean # hatched day? female. 
% egg total number of mean # eggs Std. Std. t-test 
dsRNA hatch eggs hatched hatched day? female Deviation Error (p) 
BSB hb-1 18.08 113 1.59 1.94 O49 3.99E-OS* 
YFPv2 77.84 576 5.14 1.79 O45 
*indicates significant difference (p-value < 0.05) 
TABLE 7 
Number of eggs oviposited per female per day in trial 3. Ten females 
were injected with dsRNA targeted against BSB hunchback or 
negative control YFPv2. Counts of eggs were collected starting 
on day 9 post injection and continued for 23 consecutive days 
post iniection. Two-tailed T-tests were performed in Excel. 
mean ii of 
total number eggs day. Std. Std. 
dsRNA of eggs female Deviation Error t-test (p) 
BSB hb-1 555 5.60 1.72 0.444 4.46E-02* 
YFPv2 921 6.8O 1.38 O.356 
*indicates significant difference (p-value <0.05) 
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Number of eggs hatched per female per day in trial 3. Ten females were injected with dsRNA 
targeted against BSB hunchback or negative control YFPv2. Counts of eggs hatched were 
collected starting on day 9 post injection and continued for 23 consecutive days post 
injection. Two-tailed t-tests were performed in Excel for mean H hatched/day/female. 
% egg total number of mean # eggs Std. t-test 
dsRNA hatch eggs hatched hatched day? female Deviation Error (p) 
BSB hb-1 14.05 78 O.83 O.83 O.213 2.48E-13* 
YFPv2 83.61 770 5.72 1.21 O311 
*indicates significant difference (p-value < 0.05) 
Example 7 
Transgenic Zea mays Comprising Hemipteran Pest 
Sequences 
0242 Ten to 20 transgenic To Zea mays plants harboring 
expression vectors for nucleic acids comprising SEQ ID 
NO:1 and/or SEQ ID NO:2 are generated as described in 
EXAMPLE3. A further 10-20 Ti Zea mays independent lines 
expressing hairpin dsRNA for an RNAi construct are 
obtained for BSB challenge. Hairpin dsRNA may be derived 
comprising a segment of SEQID NO:1. These are confirmed 
through RT-PCR or other molecular analysis methods. Total 
RNA preparations from selected independent Ti lines are 
optionally used for RT-PCR with primers designed to bind in 
the linker of the hairpin expression cassette in each of the 
RNAi constructs. In addition, specific primers for each target 
gene in an RNAi construct are optionally used to amplify and 
confirm the production of the pre-processed mRNA required 
for siRNA production in planta. The amplification of the 
desired bands for each target gene confirms the expression of 
the hairpin RNA in each transgenic Zea mays plant. Process 
ing of the dsRNA hairpin of the target genes into siRNA is 
Subsequently optionally confirmed in independent transgenic 
lines using RNA blot hybridizations. 
0243 Moreover, RNAi molecules having mismatch 
sequences with more than 80% sequence identity to target 
genes affect hemipterans in a way similar to that seen with 
RNAi molecules having 100% sequence identity to the target 
genes. The pairing of mismatch sequence with native 
sequences to form a hairpin dsRNA in the same RNAi con 
struct delivers plant-processed siRNAs capable of affecting 
the growth, development, reproduction, and viability offeed 
ing hemipteran pests. 
0244. In planta delivery of dsRNA, siRNA, shRNA, 
hpRNA, or miRNA corresponding to target genes and the 
Subsequent uptake by hemipteran pests through feeding 
results in down-regulation of the target genes in the hemi 
pteran pest through RNA-mediated gene silencing. When the 
function of a target gene is important at one or more stages of 
development, the growth, development, and/or reproduction 
of the hemipteran pest is affected, and in the case of at least 
one of Euschistus heros, Piezodorus guildinii, Halyomorpha 
haly's, Nezara viridula, Acrosternum hilare, and Euschistus 
servus leads to failure to successfully infest, feed, develop, 
and/or reproduce, or leads to death of the hemipteran pest. 
The choice of target genes and the Successful application of 
RNAi is then used to control hemipteran pests. 
0245 Phenotypic Comparison of Transgenic RNAi Lines 
and Non-Transformed Zea mays. 
0246 Target hemipteran pest genes or sequences selected 
for creating hairpin dsRNA have no similarity to any known 
plant gene sequence. Hence it is not expected that the pro 
duction or the activation of (systemic) RNAi by constructs 
targeting these hemipteran pest genes or sequences will have 
any deleterious effect on transgenic plants. However, devel 
opment and morphological characteristics of transgenic lines 
are compared with non-transformed plants, as well as those of 
transgenic lines transformed with an “empty vector having 
no hairpin-expressing gene. Plant root, shoot, foliage and 
reproduction characteristics are compared. There is no 
observable difference in root length and growth patterns of 
transgenic and non-transformed plants. Plant shoot charac 
teristics Such as height, leaf numbers and sizes, time of flow 
ering, floral size and appearance are similar. In general, there 
are no observable morphological differences between trans 
genic lines and those without expression of target iRNA mol 
ecules when cultured in vitro and in Soil in the glasshouse. 
Example 8 
Transgenic Glycine max Comprising Hemipteran 
Pest Sequences 
0247 Ten to 20 transgenic To Glycine max plants harbor 
ing expression vectors for nucleic acids comprising SEQID 
NO:2 or a segment of SEQID NO:1 are generated as is known 
in the art, including for example by Agrobacterium-mediated 
transformation, as follows. Mature Soybean (Glycine max) 
seeds are sterilized overnight with chlorine gas for sixteen 
hours. Following sterilization with chlorine gas, the seeds are 
placed in an open container in a LAMINARTM flow hood to 
dispel the chlorine gas. Next, the sterilized seeds are imbibed 
with sterile HO for sixteen hours in the dark using a black 
box at 24°C. 
0248 
0249. The split soybean seed comprising a portion of an 
embryonic axis protocol requires preparation of soybean seed 
material which is cut longitudinally, using a #10 blade affixed 
to a scalpel, along the hilum of the seed to separate and 
remove the seed coat, and to split the seed into two cotyledon 
sections. Careful attention is made to partially remove the 
embryonic axis, wherein about /2-/3 of the embryo axis 
remains attached to the nodal end of the cotyledon. 
0250 
0251. The split soybean seeds comprising a partial portion 
of the embryonic axis are then immersed for about 30 minutes 
in a solution of Agrobacterium tumefaciens (e.g., strain EHA 
101 or EHA 105) containing binary plasmid comprising SEQ 
ID NO:1 and/or SEQID NO:2. The Agrobacterium tumefa 
ciens solution is diluted to a final concentration of W-0.6 
ODso before immersing the cotyledons comprising the 
embryo axis. 
Preparation of Split-Seed Soybeans. 
Inoculation. 
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0252 Co-Cultivation. 
0253) Following inoculation, the split soybean seed is 
allowed to co-cultivate with the Agrobacterium tumefaciens 
strain for 5 days on co-cultivation medium (Agrobacterium 
Protocols, vol. 2, 2" Ed., Wang, K. (Ed.) Humana Press, New 
Jersey, 2006) in a Petri dish covered with a piece of filter 
paper. 
0254 Shoot Induction. 
0255. After 5 days of co-cultivation, the split soybean 
seeds are washed in liquid Shoot Induction (SI) media con 
sisting of B5 salts, B5 vitamins, 28 mg/L Ferrous, 38 mg/L 
Na2EDTA, 30 g/L sucrose, 0.6 g/L MES, 1.11 mg/L BAP 
100 mg/L TIMENTINTM,200 mg/L cefotaxime, and 50 mg/L 
Vancomycin (pH 5.7). The split soybean seeds are then cul 
tured on Shoot Induction I (SII) medium consisting of B5 
salts, B5 vitamins, 7 g/L Noble agar, 28 mg/L Ferrous, 38 
mg/L Na2EDTA, 30 g/L Sucrose, 0.6 g/L MES, 1.11 mg/L 
BAP.50 mg/L TIMENTINTM,200 mg/L cefotaxime, 50 mg/L 
Vancomycin (pH 5.7), with the flat side of the cotyledon 
facing up and the nodal end of the cotyledon imbedded into 
the medium. After 2 weeks of culture, the explants from the 
transformed split soybean seed are transferred to the Shoot 
Induction II (SIII) medium containing SI I medium supple 
mented with 6 mg/L glufosinate (LIBERTYR). 
0256 Shoot Elongation. 
0257. After 2 weeks of culture on SI II medium, the coty 
ledons are removed from the explants and a flush shoot pad 
containing the embryonic axis are excised by making a cut at 
the base of the cotyledon. The isolated shoot pad from the 
cotyledon is transferred to Shoot Elongation (SE) medium. 
The SE medium consists of MS salts, 28 mg/L Ferrous, 38 
mg/L NaEDTA, 30 g/L Sucrose and 0.6g/L IVIES, 50 mg/L 
asparagine, 100 mg/L L-pyroglutamic acid, 0.1 mg/L IAA, 
0.5 mg/L GA3, 1 mg/L Zeatin riboside, 50 mg/L TIMEN 
TINTM, 200 mg/L cefotaxime, 50 mg/L. Vancomycin, 6 mg/L 
glufosinate, 7 g/L Noble agar, (pH 5.7). The cultures are 
transferred to fresh SE medium every 2 weeks. The cultures 
are grown in a CONVIRONTM growth chamber at 24°C. with 
an 18hphotoperiod at a light intensity of 80-90 umol/m sec. 
0258 Rooting. 
0259 Elongated shoots which developed from the cotyle 
don shoot pad are isolated by cutting the elongated shoot at 
the base of the cotyledon shootpad, and dipping the elongated 
shoot in 1 mg/LIBA (Indole 3-butyric acid) for 1-3 minutes to 
promote rooting. Next, the elongated shoots are transferred to 
rooting medium (MS salts, B5 vitamins, 28 mg/L Ferrous, 38 
mg/L Na-EDTA, 20g/L sucrose and 0.59 g/LIVIES, 50 mg/L 
asparagine, 100 mg/L L-pyroglutamic acid 7 g/L Noble agar, 
pH 5.6) in phyta trays. 
0260 Cultivation. 
0261) Following culture in a CONVIRONTM growth 
chamber at 24°C., 18hphotoperiod, for 1-2 weeks, the shoots 
which have developed roots are transferred to a soil mix in a 
covered sundae cup and placed in a CONVIRONTM growth 
chamber (models CMP4030 and CMP3244, Controlled Envi 
ronments Limited, Winnipeg, Manitoba, Canada) under long 
day conditions (16 hours light/8 hours dark) at a light inten 
sity of 120-150 umol/m secunder constant temperature (22° 
C.) and humidity (40-50%) for acclimatization of plantlets. 
The rooted plantlets are acclimated in Sundae cups for several 
weeks before they are transferred to the greenhouse for fur 
ther acclimatization and establishment of robust transgenic 
Soybean plants. 
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0262. A further 10-20 T. Glycine max independent lines 
expressing hairpin dsRNA for an RNAi construct are 
obtained for BSB challenge. Hairpin dsRNA may be derived 
as set forth in SEQID NO:2 or otherwise further comprising 
SEQIDNO:1. These are confirmed through RT-PCR or other 
molecular analysis methods, as known in the art. Total RNA 
preparations from selected independent T lines are option 
ally used for RT-PCR with primers designed to bind in the 
linker of the hairpin expression cassette in each of the RNAi 
constructs. In addition, specific primers for each target gene 
in an RNAi construct are optionally used to amplify and 
confirm the production of the pre-processed mRNA required 
for siRNA production in planta. The amplification of the 
desired bands for each target gene confirms the expression of 
the hairpin RNA in each transgenic Glycine max plant. Pro 
cessing of the dsRNA hairpin of the target genes into siRNA 
is Subsequently optionally confirmed in independent trans 
genic lines using RNA blot hybridizations. 
0263. RNAi molecules having mismatch sequences with 
more than 80% sequence identity to target genes affect BSB 
in a way similar to that seen with RNAi molecules having 
100% sequence identity to the target genes. The pairing of 
mismatch sequence with native sequences to form a hairpin 
dsRNA in the same RNAi construct delivers plant-processed 
siRNAs capable of affecting the growth, development, repro 
duction, and viability of feeding hemipteran pests. 
0264. In planta delivery of dsRNA, siRNA, or miRNA 
corresponding to target genes and the Subsequent uptake by 
hemipteran pests through feeding results in down-regulation 
of the target genes in the hemipteran pest through RNA 
mediated gene silencing. When the function of a target gene is 
important at one or more stages of development, the growth, 
development, and/or reproduction of the hemipteran pest is 
affected, and in the case of at least one of Euschistus heros, 
Piezodorus guildinii, Halyomorpha haly's, Nezara viridula, 
Acrosternum hilare, and Euschistus servus leads to failure to 
Successfully infest, feed, develop, and/or reproduce, or leads 
to death of the hemipteran pest. The choice of target genes and 
the successful application of RNAi is then used to control 
hemipteran pests. 
0265 Phenotypic comparison of transgenic RNAi lines 
and non-transformed Glycine max. Target hemipteran pest 
genes or sequences selected for creating hairpin dsRNA have 
no similarity to any known plant gene sequence. Hence it is 
not expected that the production or the activation of (sys 
temic) RNAi by constructs targeting these hemipteran pest 
genes or sequences will have any deleterious effect on trans 
genic plants. However, development and morphological char 
acteristics of transgenic lines are compared with non-trans 
formed plants, as well as those of transgenic lines 
transformed with an "empty' Vector having no hairpin-ex 
pressing gene. Plant root, shoot, foliage and reproduction 
characteristics are compared. There is no observable differ 
ence in root length and growth patterns of transgenic and 
non-transformed plants. Plant shoot characteristics such as 
height, leaf numbers and sizes, time of flowering, floral size 
and appearance are similar. In general, there are no observ 
able morphological differences between transgenic lines and 
those without expression of target iRNA molecules when 
cultured in vitro and in soil in the glasshouse. 
Example 9 
E. heros Bioassays on Artificial Diet 
0266. In dsRNA feeding assays on artificial diet, 32-well 
trays are set up with an ~18 mg pellet of artificial diet and 
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water, as for injection experiments. dsRNA at a concentration 
of 200 ng/uL is added to the food pellet and water sample, 100 
uL to each of two wells. Five 2" instar E. heros nymphs are 
introduced into each well. Water samples and dsRNA that 
targets YFP transcript are used as negative controls. The 
experiments are repeated on three different days. Surviving 
insects are weighed and the mortality rates are determined 
after 7 days of treatment. 
0267 Feeding bioassays on adult female E. heros are per 
formed as 32-well trays as described above. Young (less than 
one week of adulthood) mated females are introduced into 
bioassay trays with artificial diet, one pertray. After 7 days of 
exposure to dsRNA up to ten adult females are moved to 
containers with green beans, water, seeds, and two males. 
Female viability as well as the numbers of eggs oviposited 
and eggs hatched are recorded for the following two weeks. 
The data shows that the numbers of eggs oviposited and/or 
hatched are significantly reduced. 
Example 10 
Transgenic Arabidopsis thaliana Comprising 
Hemipteran Pest Sequences 
0268 Arabidopsis transformation vectors containing a 
target gene construct for hairpin formation comprising seg 
ments of hunchback (SEQ ID NO: 1) are generated using 
standard molecular methods similar to EXAMPLE 4. Arabi 
dopsis transformation is performed using standard Agrobac 
terium-based procedure. Ti seeds are selected with glufosi 
nate tolerance selectable marker. Transgenic T Arabidopsis 
plants are generated and homozygous simple-copy T trans 
genic plants are generated for insect studies. Bioassays are 
performed on growing Arabidopsis plants with inflores 
cences. Five to ten insects are placed on each plant and moni 
tored for survival within 14 days. 
0269 Construction of Arabidopsis Transformation Vec 
tOrS. 
0270 Entry clones based on an entry vector harboring a 
target gene construct for hairpin formation comprising a seg 
ment of hunchback (SEQ ID NO: 1) are assembled using a 
combination of chemically synthesized fragments (DNA2.0, 
Menlo Park, Calif.) and standard molecular cloning methods. 
Intramolecular hairpin formation by RNA primary transcripts 
is facilitated by arranging (within a single transcription unit) 
two copies of a target gene segment in opposite orientations, 
the two segments being separated by an linker sequence (e.g. 
ST-LS1 intron: SEQID NO:6) (Vancanneytet al. (1990) Mol. 
Gen. Genet. 22002):245-50). Thus, the primary mRNA tran 
Script contains the two hunchback gene segment sequences as 
large inverted repeats of one another, separated by the linker 
sequence. A copy of a promoter (e.g. Arabidopsis thaliana 
ubiquitin 10 promoter (Callis et al. (1990) J. Biological 
Chem. 265:12486-12493)) is used to drive production of the 
primary mRNA hairpintranscript, and a fragment comprising 
a 3' untranslated region from Open Reading Frame 23 of 
Agrobacterium tumefaciens (AtuORF233' UTR v1; U.S. Pat. 
No. 5,428, 147) is used to terminate transcription of the hair 
pin-RNA-expressing gene. 
0271 The hairpin clone within the entry vector described 
above is used in standard GATEWAYOR) recombination reac 
tion with a typical binary destination vector to produce hair 
pin RNA expression transformation vectors for Agrobacte 
rium-mediated Arabidopsis transformation. 
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0272. The binary destination vector comprises a herbicide 
tolerance gene, DSM-2v2 (U.S. Patent App. No. 2011/ 
01.07455), under the regulation of a Cassava vein mosaic 
virus promoter (CsVMV Promoter v2, U.S. Pat. No. 7,601, 
885; Verdaguer et al. (1996) Plant Mol. Biol. 31:1129-39). A 
fragment comprising a 3' untranslated region from Open 
Reading Frame 1 of Agrobacterium tumefaciens (AtuORF1 
3' UTR v6; Huang et al. (1990).J. Bacteriol. 172:1814-22) is 
used to terminate transcription of the DSM2v2 mRNA. 
0273 A negative control binary construct which com 
prises a gene that expresses a YFP hairpin RNA, is con 
structed by means of standard GATEWAYR recombination 
reactions with a typical binary destination vector and entry 
vector. An entry construct comprises a YFP hairpin sequence 
(hpyFPv2, SEQID NO:5) under the expression control of an 
Arabidopsis Ubiquitin 10 promoter (as above) and a fragment 
comprising an ORF23 3' untranslated region from Agrobac 
terium tumefaciens (as above). 
0274 Production of Transgenic Arabidopsis Comprising 
Insecticidal Hairpin RNAs. Agrobacterium-Mediated Trans 
formation. 
0275 Binary plasmids containing hairpin sequences are 
electroporated into Agrobacterium strain GV3101 
(pMP9CRK). The recombinant Agrobacterium clones are 
confirmed by restriction analysis of plasmids preparations of 
the recombinant Agrobacterium colonies. A Qiagen Plasmid 
Max Kit (Qiagen, Catil 12162) is used to extract plasmids 
from Agrobacterium cultures following the manufacture rec 
ommended protocol. 
(0276 Arabidopsis Transformation and T. Selection. 
0277 Twelve to fifteen Arabidopsis plants (c.V. Columbia) 
are grown in 4" pots in the greenhouse with light intensity of 
250 umol/m, 25°C., and 18:6 hours of light: dark conditions. 
Primary flower stems are trimmed one week before transfor 
mation. Agrobacterium inoculums are prepared by incubat 
ing 10 LL recombinant Agrobacterium glycerol stock in 100 
mL LB broth (Sigma L3022)+100 mg/L Spectinomycin-50 
mg/L Kanamycin at 28°C. and shaking at 225 rpm for 72 
hours. Agrobacterium cells are harvested and Suspended into 
5% sucrose+0.04% Silwet-L77 (Lehle Seeds Cat #VIS-02)+ 
10 ug/L benzamino purine (BA) solution to ODoo 0.8-1.0 
before floral dipping. The above-ground parts of the plant are 
dipped into the Agrobacterium solution for 5-10 minutes, 
with gentle agitation. The plants are then transferred to the 
greenhouse for normal growth with regular watering and 
fertilizing until seed set. 
Example 11 
Growth and Bioassays of Transgenic Arabidopsis 
(0278. Selection of TArabidopsis Transformed with Hair 
pin RNAi Constructs. 
(0279. Up to 200 mg of T seeds from each transformation 
are stratified in 0.1% agarose solution. The seeds are planted 
in germination trays (10.5"x21"x1"; T.O. Plastics Inc., Clear 
water, Minn.) with #5 sunshine media. Transformants are 
selected for tolerance to Ignite R (glufosinate) at 280 g/ha at 6 
and 9 days postplanting. Selected events are transplanted into 
4" diameter pots. Insertion copy analysis is performed within 
a week of transplanting via hydrolysis quantitative Real-Time 
PCR (qPCR) using Roche LightCycler480TM. The PCR prim 
ers and hydrolysis probes are designed against DSM2V2 
selectable marker using LightCyclerTM Probe Design Soft 
ware 2.0 (Roche). Plants are maintained at 24°C., with a 16:8 
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hour light: dark photoperiod under fluorescent and incandes 
cent lights at intensity of 100-150 mE/ms. 
0280 E. heros Nymph Plant Feeding Bioassay. 
0281 At least four low copy (1-2 insertions), four medium 
copy (2-3 insertions), and four high copy (>4 insertions) 
events are selected for each construct. Plants are grown to a 
reproductive stage (plants containing flowers and siliques). 
The surface of soil is covered with ~50 mL volume of white 
sand for easy insect identification. Five to ten 2" instar E. 
heros nymphs are introduced onto each plant. The plants are 
covered with plastic tubes that are 3" in diameter, 16" tall, and 
with wall thickness of 0.03" (Item No. 484485, Visipack 
Fenton Mo.); the tubes are covered with nylon mesh to isolate 
the insects. The plants are kept under normal temperature, 
light, and watering conditions in a conviron. In 14 days, the 
insects are collected and weighed; percent mortality as well 
as growth inhibition (1-weight treatment/weight control) are 
calculated. YFP hairpin-expressing plants are used as con 
trols. 
0282. The pRNAi Arabidopsis T plants are selected and 
grown in greenhouse, as described above. One to 5 newly 
emerged BSB adults are released on each plant and the entire 
plant is covered as described above to prevent adults from 
escaping. One week after release, female adults are recovered 
from each plant and maintained in the laboratory for egg 
collection. Depending on the parental RNAi target and 
expected phenotype, parameters such as number of eggs per 
female, percent egg hatch and nymph mortality are recorded 
and compared with control plants. 
0283 T. Arabidopsis Seed Generation and T Bioassays. 
0284. T seed is produced from selected low copy (1-2 
insertions) events for each construct. Plants (homozygous 
and/or heterozygous) are subjected to E. heros nymph and 
adult feeding bioassay, as described above. T. Seed is har 
Vested from homozygotes and stored for future analysis. 
Example 12 
Transformation of Additional Crop Species 
0285 Cotton is transformed with hunchback (with or 
without a chloroplast transit peptide) to provide control of 
stink bugs by utilizing a method known to those of skill in the 
art, for example, Substantially the same techniques previously 
described in EXAMPLE 14 of U.S. Pat. No. 7,838,733, or 
Example 12 of PCT International Patent Publication No. WO 
2007/053482. 
Example 13 
pRNAi-Mediated Insect Protection 
0286 Parental RNAi that causes egg mortality or loss of 
egg viability brings further durability benefits to transgenic 
crops that use RNAi and other mechanisms for insect protec 
tion. A basic two-patch model was used to demonstrate this 
utility. 
0287. One patch contained a transgenic crop expressing 
insecticidal ingredients, and the second patch contained a 
refuge crop not expressing insecticidal ingredients. Eggs 
were oviposited in the two modeled patches according to their 
relative proportions. In this example, the transgenic patch 
represented 95% of the landscape, and the refuge patch rep 
resented 5%. The transgenic crop expressed an insecticidal 
protein active against the insect. 
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0288 Pest to the insecticidal protein was modeled as 
monogenic, with two possible alleles; one (S) conferring 
susceptibility, and the other (R) conferring resistance. The 
insecticidal protein was modeled to cause 97% mortality of 
homozygous susceptible (SS) nymphs that feed on it. There 
was assumed to be no mortality of nymphs that are homozy 
gous for the resistance allele (RR). Resistance to the insecti 
cidal protein was assumed to be incompletely recessive, 
whereby the functional dominance is 0.3 (there is 67.9% 
mortality of nymphs that are heterozygous (RS) for resistance 
to the protein that feed on the transgenic crop). 
0289. The transgenic crop also expressed parentally active 
dsRNA that, through RNA-interference (pRNAi), causes the 
eggs of adult female insects that are exposed to the transgenic 
crop to be non-viable. Insect resistance to the pRNAi was also 
considered to be monogenic with two possible alleles; one 
(X) conferring susceptibility of the adult female to RNAi, and 
the other (Y) conferring resistance of the adult female to 
RNAi. Assuming a high level of exposure to the dsRNAs, the 
pRNAi was modeled to cause 99.9% of eggs produced by a 
homozygous susceptible (XX) female to be non-viable. The 
model assumed that pRNAi has no effect on the viability of 
eggs produced by homozygous resistant (YY) females. Resis 
tance to the dsRNA was assumed to be recessive, whereby the 
functional dominance is 0.01 (98.9% of eggs produced by a 
female that is heterozygous (XY) for resistance to dsRNA are 
non-viable). 
0290. In the model, there was random mating among sur 
viving adults and random oviposition across the two patches 
in accordance with their relative proportions. The genotypic 
frequencies of viable offspring followed Mendelian genetics 
for a two-locus genetic system. 
0291. The effect of pRNAi required the adult females to 
feed on plant tissue expressing parental active dsRNA. The 
interference with egg development may be lower for adult 
females emerging from the refuge crop than from the trans 
genic crop; adults may feed more extensively in the patch in 
which they emerged following nymph development. There 
fore, the relative magnitude of the pRNAi effect on female 
adults emerging from the refuge patch was varied, with the 
proportion of the pRNAi effect ranging from 0 (no effect of 
pRNAi on adult females emerging from the refuge patch) to 1 
(same effect of pRNAi on adult females emerging from the 
refuge patch as on adult females emerging from the trans 
genic patch). 
0292. This model could be easily adjusted to demonstrate 
the situation when the effect of pRNAi is also or alternatively 
achieved by feeding of adult males on plant tissue expressing 
parental active dsRNA. 
0293 Frequencies of the two resistance alleles were cal 
culated across generations. The initial frequencies of both of 
the resistance alleles (R and Y) were assumed to be 0.005. 
Results were presented as the number of insect generations 
for the frequencies of each of the resistance alleles to reach 
0.05. To examine the resistance delay caused by the pRNAi, 
simulations that included pRNAi were compared to simula 
tions that did not include pRNAi, but were identical in every 
other way. FIG. 2. 
0294 The model was also modified to include nymph 
active interfering dsRNA in combination with the insecticidal 
protein in the transgenic crop. Therein, the nymph RNAi was 
assigned an effect of 97% nymph mortality for homozygous 
RNAi-susceptible nymph (genotype XX), and no effect on 
nymph that are homozygous RNAi-resistant (YY). There was 
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67.9% mortality of nymph that were heterozygous for RNAi 
resistance (XY). It was assumed that the same mechanism of 
resistance applied to both nymph active RNAi and pRNAi. As 
before, the pRNAi effect on adult females emerging from the 
refuge patch relative to the effect on adult females emerging 
from the transgenic patch was varied from 0 to 1. As before, 
to examine the resistance delay caused by the pRNAi, simu 
lations that included pRNAi were compared to simulations 
that did not include pRNAi, but were identical in every other 
way (including nymph RNAi). FIG. 3. 
0295) A clear resistance management benefit of pRNAi 
was observed when the magnitude of the pRNAi effect on egg 
viability for female adults emerging from the refuge patch 
was reduced compared with magnitude of the effect for adults 
emerging from the transgenic patch. The transgenic crops that 
produced parental active dsRNA in addition to an insecticidal 
protein were much more durable compared with transgenic 
crops that produced only an insecticidal protein. Similarly, 
transgenic crops that produced parental active dsRNA in 
addition to both an insecticidal protein and a nymph active 
dsRNA were much more durable compared with transgenic 
crops that produced only an insecticidal protein and a nymph 
active dsRNA. In the latter case, the durability benefit applied 
to both the insecticidal protein and the insecticidal interfering 
dsRNA. 
Example 14 
Transgenic Plants Comprising a Hemipteran Pest 
Sequence and Additional RNAi Constructs 
0296. A transgenic plant comprising a heterologous cod 
ing sequence in its genome that is transcribed into an iRNA 
molecule that targets an organism other than a hemipteran 
pest is secondarily transformed via Agrobacterium or WHIS 
KERSTM methodologies (See Petolino and Arnold (2009) 
SEQUENCE LISTING 
<16 Os NUMBER OF SEO ID NOS : 14 
<21 Os SEQ ID NO 1 
&211s LENGTH: 2237 
&212s. TYPE: DNA 
<213> ORGANISM: Euchistus heros 
<4 OOs SEQUENCE: 1 
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Methods Mol. Biol. 526:59-67) to produce one or more insec 
ticidal dsRNA molecules (for example, at least one dsRNA 
molecule including a dsRNA molecule targeting a gene com 
prising SEQID NO:1). Plant transformation plasmid vectors 
prepared essentially as described in EXAMPLE 3 are deliv 
ered via Agrobacterium or WHISKERSTM-mediated trans 
formation methods into Suspension cells or immature 
embryos obtained from a transgenic plant comprising a het 
erologous coding sequence in its genome that is transcribed 
into an iRNA molecule that targets an organism other than a 
hemipteran pest. 
Example 15 
Transgenic Plants Comprising an RNAi Construct 
and Additional Hemipteran Pest Control Sequences 
0297. A transgenic plant comprising a heterologous cod 
ing sequence in its genome that is transcribed into an iRNA 
molecule that targets a hemipteran pest organism (for 
example, at least one dsRNA molecule including a dsRNA 
molecule targeting a gene comprising SEQID NO: 1) is sec 
ondarily transformed via Agrobacterium or WHISKERSTM 
methodologies (see Petolino and Arnold (2009) Methods 
Mol. Biol. 526:59-67) to produce one or more insecticidal 
protein molecules, for example, Cry1A, Cry2A, Cry3A, 
Cry 11A, or Cry51A insecticidal proteins. Plant transforma 
tion plasmid vectors prepared essentially as described in 
EXAMPLE 3 are delivered via Agrobacterium or WHIS 
KERSTM-mediated transformation methods into suspension 
cells or immature embryos obtained from a transgenic plant 
comprising a heterologous coding sequence in its genome 
that is transcribed into an iRNA molecule that targets a hemi 
pteran pest organism. Doubly-transformed plants are 
obtained that produce iRNA molecules and insecticidal pro 
teins for control of hemipteran pests. 
gcc ctittggg tittagttctic tacgagctgc tictaccatcc act agg act a got citat citt 60 
citct cittata ttagttctgg atatatat ct ct ct ct citct at citat atct acagctggga 12O 
acaccgtagt cqtcttttgt tittatatata ttgcctgcat gttggaatga gatgattata 18O 
act cotgata tatactittaa caatc.cgagg atgaacatcg gtgtgcaata coacccaagg 24 O 
catt.ccgtct tcc.cgaattt ggagcac cat coatggatgg ct tcc.ccgac to cqgcacaa 3 OO 
gtcgittaaag aggagcc.gcg agatgacgcg gagtacggit c agaacagcca ggaga.gc.cag 360 
Ctgcc.gctga cqc.cgcc.ccc ctitcCagggc tacccc.ccgg ggaacacct a cc.gc.gaggcc 42O 
acgc.ccc.cta aggatacgcc cc cc.gc.ctcc accc cct cqc ct caggagala gCagga aggc 48O 
agctic caact Cogagggaga gtact acgag agcggagagt cc ctaaagag gCtgcagatg 54 O 
gcc ct coat a ggaccgggat gataacggag gaga agctgc aatgtc.ctgt atgcgagttc 6 OO 
tottgcagtg to aggtolaca gttcaatgaa caccitattgt cacacgagac taaatgttcc 660 
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- Continued 
gccatggttc tta accctga cqgttct c ct aatcct ctac caatcgtag 469 
<210s, SEQ ID NO 3 
&211s LENGTH: 555 
212. TYPE: PRT 
<213> ORGANISM: Euchistus heros 
<4 OOs, SEQUENCE: 3 
Met Ile Ile Thr Pro Asp Ile Tyr Phe Asn Asn Pro Arg Met Asin Ile 
1. 5 1O 15 
Gly Val Glin Tyr Asp Pro Arg His Ser Val Phe Pro Asn Lieu. Glu. His 
2O 25 3O 
His Pro Trp Met Ala Ser Pro Thr Pro Ala Glin Val Val Lys Glu Glu 
35 4 O 45 
Pro Arg Asp Asp Ala Glu Tyr Gly Glin Asn. Ser Glin Glu Ser Glin Lieu. 
SO 55 6 O 
Pro Leu. Thr Pro Pro Pro Phe Glin Gly Tyr Pro Pro Gly Asn Thr Tyr 
65 70 7s 8O 
Arg Glu Ala Thr Pro Pro Lys Asp Thr Pro Pro Ala Ser Thr Pro Ser 
85 90 95 
Pro Glin Glu Lys Glin Glu Gly Ser Ser Asn Ser Glu Gly Glu Tyr Tyr 
1OO 105 11 O 
Glu Ser Gly Glu Ser Lieu Lys Arg Lieu Gln Met Ala Lieu. His Arg Thr 
115 120 125 
Gly Met Ile Thr Glu Glu Lys Lieu Gln Cys Pro Val Cys Glu Phe Ser 
13 O 135 14 O 
Cys Ser Val Arg Ser Glin Phe Asin Glu. His Leu Lleu Ser His Glu Thr 
145 150 155 160 
Lys Cys Ser Met Cys Asp Phe Ser Gly Glu Thir Ser Glu Lys Lieu. Arg 
1.65 17O 17s 
Glu. His Met Arg Asn. Wal His Asp Cys Asp Asp Asp Ser Ser Trp Gly 
18O 185 19 O 
Glu Glu Glu Lieu. Asn Thr Pro Llys Val Asn. Ser Glin Gly Llys Wall Lys 
195 2OO 2O5 
Thr Phe Arg Cys Lys Gln Cys Glu Phe Ser Ala Val Thr Lys Lieu. Glu 
21 O 215 22O 
Phe Trp Asp His Ser Arg Thr His Ile Lys Glin Glu Arg Lieu. Lieu. Thir 
225 23 O 235 24 O 
Cys Pro Llys Cys Pro Phe Val Thr Glu Tyr Lys His His Lieu. Glu Tyr 
245 250 255 
His Lieu. Arg Asn His Phe Gly Ser Llys Pro Phe Lys Cys Asp Llys Cys 
26 O 265 27 O 
Ser Tyr Ser Cys Val Asn Llys Ser Met Lieu. Asn. Ser His Lieu Lys Ser 
27s 28O 285 
His Ser Asn Ile Tyr Glin Phe Arg Cys Ala Asp Cys Thr Tyr Ala Thr 
29 O 295 3 OO 
Llys Tyr Cys His Ser Lieu Lys Lieu. His Lieu. Arg Llys Tyr Ala His Asn 
3. OS 310 315 32O 
Pro Ala Met Val Lieu. Asn Pro Asp Gly Ser Pro Asn Pro Leu Pro Ile 
3.25 330 335 
Val Asp Val Tyr Gly. Thir Arg Arg Gly Pro Lys Glin Llys Pro Lys Asn 
34 O 345 35. O 
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- Continued 
Glu Glin Gln Pro Glin Glin Pro Pro Glin Wall Pro Thir Ile Phe Asn. Pro 
355 360 365 
Tyr Ser Lieu. Leu Pro Thr Gln Met Pro Tyr Tyr Asn Ile Lieu. Asn Gly 
37 O 375 38O 
Phe Gly Gly Phe Pro Phe Pro Glin Asp Val Asn Met Glu Glu Lys Asn 
385 390 395 4 OO 
Asn Asn Val Glu Lys Glu Glu Ile Arg Glu Asp Lys Ala Pro Lieu. Asp 
4 OS 41O 415 
Lieu. Ser Cys Pro Glu Pro Met Val Glu Asp Ser Asn Glin Glu Ala Pro 
42O 425 43 O 
Val Lys Asn Arg Arg Lys Gly Lys Ala Phe Llys Lieu. Asp Arg Ile Ala 
435 44 O 445 
Lieu. Arg Lieu. Glin Glin Glin Val Glu Val Glu Glu Gln Pro Glu Pro Pro 
450 45.5 460 
Llys Pro Ile Pro Pro Pro Val Val Ser Glu Pro Ala Lys Ser Pro Glu 
465 470 47s 48O 
Ile Llys Ser Cys Glu Ala Asp Ser Glu Glin Gln Llys Val Glu Lys Thr 
485 490 495 
Glu Glin Glu Asn Val Tyr Ser Cys Thr Phe Cys Asp Ile Leu Phe Lys 
SOO 505 51O 
Asp Ile Val Met Tyr Thr Met His Met Gly Tyr His Gly Tyr Glu Asp 
515 52O 525 
Pro Phe Lys Cys Asn Met Cys Gly Glin Glin Thr Thr Asp Llys Val Ser 
53 O 535 54 O 
Phe Phe Lieu. His Ile Ala Arg Thr Ser His Ser 
5.45 550 555 
<210s, SEQ ID NO 4 
&211s LENGTH: 2O 
&212s. TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
22 Os. FEATURE: 
<223> OTHER INFORMATION: T7 phage promoter 
<4 OOs, SEQUENCE: 4 
taatacgact cactataggg 2O 
<210s, SEQ ID NO 5 
&211s LENGTH: 471 
&212s. TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
22 Os. FEATURE: 
<223> OTHER INFORMATION: YFP v2 hpRNA encoding sequence 
<4 OOs, SEQUENCE: 5 
atgtcatctg gag cacttct Cttt catggg aagattic ctt acgttgttgga gatggaaggg 6 O 
aatgttgatg gcc acaccitt tag catacgt gggaaaggct acggagatgc ct cagtggga 12 O 
aaggac tagt accoggttggg aaagg tatgt ttctgcttct acctittgata tatatataat 18O 
aattat cact aattagtagt aatatagitat ttcaagtatt tttittcaaaa taaaagaatg 24 O 
tagtatatag c tattgcttt totgtag titt ataagtgtgt at attittaat ttata actitt 3OO 
tctaatatat gaccaaaa.ca toggtgatgtg caggttgatc cqcggittact titcc.cactga 360 
ggcatctocq tag cctitt co cacg tatgct aaaggtgtgg ccatcaa.cat tcc ctitc cat 42O 
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citccacaacg taaggaatct tcc catgaaa gagaagtgct c cagatgaca t 
<210s, SEQ ID NO 6 
&211s LENGTH: 222 
&212s. TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
22 Os. FEATURE: 
223s OTHER INFORMATION: ST-LS1 intron 
<4 OOs, SEQUENCE: 6 
gact agtacc ggttgggaaa got atgtttic togcttct acc tittgatatat atataataat 
tat cactaat tagtag taat at agtatttic aag tatttitt ttcaaaataa aagaatgtag 
tatatagota ttgcttittct gtag tittata agtgttgtata ttittaattta taacttittct 
aatatatgac Caaaac atgg tatgtgcag gttgatc.cgc gg 
<210s, SEQ ID NO 7 
&211s LENGTH: 45 
&212s. TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
22 Os. FEATURE: 
<223> OTHER INFORMATION: Primer oligonucleotide BSB bh-1-F 
<4 OO > SEQUENCE: 7 
ttaatacgac toactatagg gagagtccac gactg.cgatg atgac 
<210 SEQ ID NO 8 
&211s LENGTH: 48 
&212s. TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
22 Os. FEATURE: 
<223> OTHER INFORMATION: Primer oligonucleotide BSB hb-1-R 
<4 OOs, SEQUENCE: 8 
ttaatacgac toactatagg gagacitacga ttggtagagg attaggag 
<210s, SEQ ID NO 9 
&211s LENGTH: 301 
&212s. TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
22 Os. FEATURE: 
<223> OTHER INFORMATION: Sense strand of YFP v2-targeted dsRNA 
<4 OOs, SEQUENCE: 9 
Catctggagc acttct Cttt catgggaaga titcct tacgt ttggagatg gaagggaatg 
ttgatggc.ca cacctittagc atacgtggga aaggctacgg agatgcctica gtgggaaagg 
ttgatgcaca gttcatctgc acaactggtg atgttcc tigt gcc ttggagc acacttgtca 
c cactict cac ctatggagca cagtgctttg C caagtatgg to cagagttg aaggactitct 
acaagt cctg. tatgccagat ggctatgtgc aagagcgcac aat cacctitt gaaggagatg 
9 
<210s, SEQ ID NO 10 
&211s LENGTH: 47 
&212s. TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
22 Os. FEATURE: 
<223> OTHER INFORMATION: Primer oligonucleotide YFPv2-F 
<4 OOs, SEQUENCE: 10 
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- Continued 
tatgtc.gc.cc tigactittga gcaggaaatg gcc accgc.cg Ctgcctic cac ctic cctggag 72 O 
aagt cctatgaactt.ccc.ga C9gtcagg to atcac catcg gtaacgagag gttc.cgttgc 78O 
ccagaggctic tict tccagcc titcCttcttg gg tatggaat cittgcggitat coatgag act 84 O 
gtct acaact c catcatgaa gtgcgacgtt gaCat Cagga aggacttgta CC caac acc 9 OO 
gtcCtctic.cg gaggtaccac catgt accca gg tattgctg acaggatgca gaaggaaatc 96.O 
accocc ct cq ctic cittcaac catcaagat.c aagat cattg citcc.cccaga aaggaagitac 1 O2O 
tccg tatgga t cqgtggttc catcttggct tcc ct gtc.ca cct tccago a gatgtggat.c 108 O 
tccaag Cagg aatacgacga atc.cggcc.ca ggcatcgt.cc accgcaaatg Cttic 1134 
What may be claimed is: 
1. An isolated nucleic acid comprising at least one poly 
nucleotide selected from the group consisting of: 
SEQ ID NO:1; the complement of SEQID NO:1; a frag 
ment of at least 15 contiguous nucleotides of SEQ ID 
NO:1; the complement of a fragment of at least 15 con 
tiguous nucleotides of SEQ ID NO:1; a native coding 
sequence of a hemipteran organism comprising SEQID 
NO:1; the complement of a native coding sequence of a 
hemipteran organism comprising SEQ ID NO:1; a 
native non-coding sequence of a hemipteran organism 
that is transcribed into a native RNA molecule compris 
ing SEQ ID NO:1; the complement of a native non 
coding sequence of a hemipteran organism that is tran 
scribed into a native RNA molecule comprising SEQID 
NO:1; a fragment of at least 15 contiguous nucleotides 
of a native coding sequence of a hemipteran organism 
comprising SEQ ID NO:1; the complement of a frag 
ment of at least 15 contiguous nucleotides of a native 
coding sequence of a hemipteran organism comprising 
SEQ ID NO:1; a fragment of at least 15 contiguous 
nucleotides of a native non-coding sequence of a hemi 
pteran organism that is transcribed into a native RNA 
molecule comprising SEQ ID NO:1; and the comple 
ment of a fragment of at least 15 contiguous nucleotides 
of a native non-coding sequence of a hemipteran organ 
ism that is transcribed into a native RNA molecule com 
prising SEQID NO:1. 
2. The polynucleotide of claim 1, wherein the polynucle 
otide is selected from the group consisting of SEQID NO:1 
and SEQID NO:2. 
3. A plant transformation vector comprising the polynucle 
otide of claim 1. 
4. The polynucleotide of claim 1, wherein the organism is 
selected from the group consisting of Euschistus heros (Fabr.) 
(Neotropical Brown Stink Bug), Nezara viridula (L.) (South 
ern Green Stink Bug), Piezodorus guildinii (Westwood) 
(Red-banded Stink Bug), Halyomorpha halys (Stat) (Brown 
Marmorated Stink Bug), Chinavia hilare (Say) (Green Stink 
Bug), Euschistus serous (Stal) (Brown Stink Bug), Dichelops 
melacanthus (Dallas), Dichelops fircatus (F), Edessa med 
itabunda (F.), Thyanta perditor (F.) (Neotropical Red Shoul 
dered Stink Bug), Chinavia marginatum (Palisot de Beau 
vois), Horcias nobilellus (Berg) (Cotton Bug), Taedia 
Stigmosa (Berg), Dysdercus peruvianus (Guérin-Méneville), 
NeOmegalotomus parvus (Westwood), Leptoglossus Zonatus 
(Dallas), Niesthrea Sidae (F), Lygus hesperus (Knight) 
(Western Tarnished Plant Bug), and Lygus lineolaris (Palisot 
de Beauvois). 
5. A ribonucleic acid (RNA) molecule transcribed from the 
polynucleotide of claim 1. 
6. A double-stranded ribonucleic acid molecule produced 
from the expression of the polynucleotide of claim 1. 
7. The double-stranded ribonucleic acid molecule of claim 
6, wherein contacting the polynucleotide sequence with a 
hemipteran pest inhibits the expression of an endogenous 
nucleotide sequence specifically complementary to the poly 
nucleotide. 
8. The double-stranded ribonucleic acid molecule of claim 
7, wherein contacting said ribonucleotide molecule with a 
hemipteran pest kills or inhibits the growth, reproduction, 
and/or feeding of the pest. 
9. The double stranded RNA of claim 6, comprising a first, 
a second and a third RNA segment, wherein the first RNA 
segment comprises the polynucleotide, wherein the third 
RNA segment is linked to the first RNA segment by the 
second polynucleotide sequence, and wherein the third RNA 
segment is substantially the reverse complement of the first 
RNA segment, such that the first and the third RNA segments 
hybridize when transcribed into a ribonucleic acid to form the 
double-stranded RNA. 
10. The RNA of claim 5, selected from the group consisting 
of a double-stranded ribonucleic acid molecule and a single 
stranded ribonucleic acid molecule of between about 15 and 
about 30 nucleotides in length. 
11. A plant transformation vector comprising the poly 
nucleotide of claim 1, wherein the heterologous promoter is 
functional in a plant cell. 
12. A cell transformed with the polynucleotide of claim 1. 
13. The cell of claim 12, wherein the cell is a prokaryotic 
cell. 
14. The cell of claim 12, wherein the cell is a eukaryotic 
cell. 
15. The cell of claim 14, wherein the cell is a plant cell. 
16. A plant transformed with the polynucleotide of claim 1. 
17. A seed of the plant of claim 16, wherein the seed 
comprises the polynucleotide. 
18. A commodity product produced from the plant of claim 
16, wherein the commodity product comprises a detectable 
amount of the polynucleotide. 
19. The plant of claim 16, wherein the at least one poly 
nucleotide is expressed in the plant as a double-stranded 
ribonucleic acid molecule. 
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20. The cell of claim 15, wherein the cell is a Zea mays cell, 
a Glycine max cell, or a cell from a Gossypium sp. 
21. The plant of claim 16, wherein the plant is maize, 
Soybean, or cotton. 
22. The plant of claim 16, wherein the at least one poly 
nucleotide is expressed in the plant as a ribonucleic acid 
molecule, and the ribonucleic acid molecule inhibits the 
expression of an endogenous polynucleotide that is specifi 
cally complementary to the at least one polynucleotide when 
a hemipteran pest ingests a part of the plant. 
23. The polynucleotide of claim 1, further comprising at 
least one additional polynucleotide that encodes an RNA 
molecule that inhibits the expression of an endogenous pest 
gene. 
24. The polynucleotide of claim 23, wherein the additional 
polynucleotide encodes an iRNA molecule that results in a 
parental RNAi phenotype. 
25. The polynucleotide of claim 24, wherein the additional 
polynucleotide encodes an iRNA molecule that inhibits the 
expression of a Brahma or kruppel gene. 
26. The polynucleotide of claim 23, wherein the additional 
polynucleotide encodes an iRNA molecule that results in 
decreased growth and/or development and/or mortality in a 
hemipteran pest that contacts the iRNA molecule (lethal 
RNAi). 
27. A plant transformation vector comprising the poly 
nucleotide of claim 23, wherein the additional polynucleotide 
(s) are each operably linked to a heterologous promoter func 
tional in a plant cell. 
28. The polynucleotide of claim 1, wherein the polynucle 
otide is operably linked to a heterologous promoter. 
29. A method for controlling a hemipteran pest population, 
the method comprising providing an agent comprising a ribo 
nucleic acid (RNA) molecule that functions upon contact 
with the hemipteran pest to inhibit a biological function 
within the hemipteran pest, wherein the RNA is specifically 
hybridizable with a polynucleotide selected from the group 
consisting of SEQ ID NOs: 12 and 13; the complement of 
either of SEQ ID NOS:12 and 13; a fragment of at least 15 
contiguous nucleotides of either of SEQID NOs: 12 and 13: 
the complement of a fragment of at least 15 contiguous nucle 
otides of either of SEQ ID NOS:12 and 13: a transcript of 
either of SEQID NOS:1 and 2: the complement of a transcript 
of either of SEQ ID NOS:1 and 2; a fragment of at least 15 
contiguous nucleotides of a transcript of either of SEQ ID 
NOs: 1 and 2; and the complement of a fragment of at least 15 
contiguous nucleotides of a transcript of either of SEQ ID 
NOS:1 and 2. 
30. The method according to claim 29, wherein the agent is 
a double-stranded RNA molecule. 
31. A method for controlling a hemipteran pest population, 
the method comprising: 
introducing into a hemipteran pest, a ribonucleic acid 
(RNA) molecule that functions upon contact with the 
hemipteran pest to inhibit a biological function within 
the hemipteran pest, wherein the RNA is specifically 
hybridizable with a polynucleotide selected from the 
group consisting of any of 
SEQID NOs: 12 and 13, 
the complement of either of SEQID NOS:12 and 13, 
a fragment of at least 15 contiguous nucleotides of either 
of SEQID NOs: 12 and 13, 
the complement of a fragment of at least 15 contiguous 
nucleotides of either of SEQID NOS:12 and 13, 
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a transcript of either of SEQID NOs: 1 and 2. 
the complement of a transcript of either of SEQ ID 
NOS:1 and 2, 
a fragment of at least 15 contiguous nucleotides of a tran 
script of either of SEQID NOS:1 and 2, and 
the complement of a fragment of at least 15 contiguous 
nucleotides of a transcript of either of SEQID NOs: 1 
and 2. 
thereby producing a hemipteran pest having a pRNAi 
phenotype. 
32. The method according to claim 31, wherein the RNA is 
introduced into a male hemipteran pest. 
33. The method according to claim 31, wherein the RNA is 
introduced into a female hemipteran pest, the method further 
comprising releasing the female hemipteran pest having the 
pRNAi phenotype into the pest population, wherein mating 
between the female hemipteran pest having the pRNAi phe 
notype and male pests of the population produces fewer 
viable offspring than mating between other female pests and 
male pests of the population. 
34. A method for controlling a hemipteran pest population, 
the method comprising: 
providing an agent comprising a first and a second poly 
nucleotide sequence that functions upon contact with the 
hemipteran pest to inhibit a biological function within 
the hemipteran pest, wherein the first polynucleotide 
sequence comprises a region that exhibits from about 
90% to about 100% sequence identity to from about 19 
to about 30 contiguous nucleotides of SEQID NO:12, 
and wherein the first polynucleotide sequence is specifi 
cally hybridized to the second polynucleotide sequence. 
35. The method according to claim 34, wherein the ribo 
nucleic acid molecule is a double-stranded ribonucleic acid 
molecule. 
36. The method according to claim 34, wherein the hemi 
pteran pest population is reduced relative to a population of 
the same pest species infesting a host plant of the same host 
plant species lacking the transformed plant cell. 
37. A method for controlling a hemipteran pest population, 
the method comprising: 
providing in a host plant of a hemipteran pest a transformed 
plant cell comprising the polynucleotide of claim 1, 
wherein the polynucleotide is expressed to produce a 
ribonucleic acid molecule that functions upon contact 
with a hemipteran pest belonging to the population to 
inhibit the expression of a target sequence within the 
hemipteran pest and results in decreased reproduction of 
the hemipteran pest or pest population, relative to repro 
duction of the same pest species on a plant of the same 
host plant species that does not comprise the polynucle 
otide. 
38. The method according to claim 37, wherein the ribo 
nucleic acid molecule is a double-stranded ribonucleic acid 
molecule. 
39. The method according to claim 37, wherein the hemi 
pteran pest population is reduced relative to a hemipteran pest 
population infesting a host plant of the same species lacking 
the transformed plant cell. 
40. A method of controlling hemipteran pest infestation in 
a plant, the method comprising providing in the diet of a 
hemipteran pest a ribonucleic acid (RNA) that is specifically 
hybridizable with a polynucleotide selected from the group 
consisting of: 
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SEQID NOs: 12 and 13; 
the complement of either of SEQID NOS:12 and 13: 
afragment of at least 15 contiguous nucleotides of either of 
SEQID NOs: 12 and 13; 
the complement of a fragment of at least 15 contiguous 
nucleotides of either of SEQID NOS:12 and 13: 
a transcript of any of either of SEQID NOS:1 and 2: 
the complement of a transcript of either of SEQID NOs: 1 
and 2: 
a fragment of at least 15 contiguous nucleotides of a tran 
script of either of SEQID NOS:1 and 2; and 
the complement of a fragment of at least 15 contiguous 
nucleotides of a transcript of either of SEQ ID NOs: 1 
and 2. 
41. The method according to claim 40, wherein the diet 
comprises a plant cell transformed to express the polynucle 
otide. 
42. The method according to claim 40, wherein the specifi 
cally hybridizable RNA is comprised in a double-stranded 
RNA molecule. 
43. A method for improving the yield of a corn crop, the 
method comprising: 
introducing the nucleic acid of claim 1 into a corn plant to 
produce a transgenic corn plant; and 
cultivating the corn plant to allow the expression of the at 
least one polynucleotide; wherein expression of the at 
least one polynucleotide inhibits hemipteran pest repro 
duction or growth and loss of yield due to hemipteran 
pest infection. 
44. The method according to claim 43, wherein expression 
of the at least one polynucleotide produces an RNA molecule 
that Suppresses at least a first target gene in a hemipteran pest 
that has contacted a portion of the plant. 
45. A method for producing a transgenic plant cell, the 
method comprising: 
transforming a plant cell with a vector comprising the 
nucleic acid of claim 1: 
culturing the transformed plant cell under conditions Suf 
ficient to allow for development of a plant cell culture 
comprising a plurality of transformed plant cells; 
Selecting for transformed plant cells that have integrated 
the at least one polynucleotide into their genomes; 
Screening the transformed plant cells for expression of a 
ribonucleic acid (RNA) molecule encoded by the at least 
one polynucleotide; and 
selecting a plant cell that expresses the RNA. 
46. The method according to claim 45, wherein the RNA 
molecule is a double-stranded RNA molecule. 
47. A method for producing a hemipteran pest-resistant 
transgenic plant, the method comprising: 
providing the transgenic plant cell produced by the method 
of claim 44; and 
regenerating a transgenic plant from the transgenic plant 
cell, wherein expression of the ribonucleic acid mol 
ecule encoded by the at least one polynucleotide is suf 
42 
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ficient to modulate the expression of a target gene in a 
hemipteran pest that contacts the transformed plant. 
48. A method for producing a transgenic plant cell, the 
method comprising: 
transforming a plant cell with a vector comprising a means 
for protecting a plant from a hemipteran pest; 
culturing the transformed plant cell under conditions Suf 
ficient to allow for development of a plant cell culture 
comprising a plurality of transformed plant cells; 
selecting for transformed plant cells that have integrated 
the means for protecting a plant from a hemipteran pest 
into their genomes; 
screening the transformed plant cells for expression of a 
means for inhibiting expression of an essential gene in a 
hemipteran pest; and 
selecting a plant cell that expresses the means for inhibiting 
expression of an essential gene in a hemipteran pest. 
49. A method for producing a hemipteran pest-resistant 
transgenic plant, the method comprising: 
providing the transgenic plant cell produced by the method 
of claim 47; and 
regenerating a transgenic plant from the transgenic plant 
cell, wherein expression of the means for inhibiting 
expression of an essential gene in a hemipteran pest is 
Sufficient to modulate the expression of a target gene in 
a hemipteran pest that contacts the transformed plant. 
50. The nucleic acid of claim 1, further comprising a poly 
nucleotide encoding a polypeptide from Bacillus thuringien 
sis, Alcaligenes spp., or Pseudomonas spp. 
51. The nucleic acid of claim 50, wherein the polypeptide 
from B. thuringiensis is selected from a group comprising 
Cry1A, Cry2A, Cry3A, Cry 11A, and Crys 1A. 
52. The cell of claim 15, wherein the cell comprises a 
polynucleotide encoding a polypeptide from Bacillus thur 
ingiensis, Alcaligenes spp., or Pseudomonas spp. 
53. The cell of claim 52, wherein the polypeptide from B. 
thuringiensis is selected from a group comprising Cry1A, 
Cry2A, Cry3A, Cry11A, and Cry51A. 
54. The plant of claim 16, wherein the plant comprises a 
polynucleotide encoding a polypeptide from Bacillus thur 
ingiensis, Alcaligenes spp., or Pseudomonas spp. 
55. The plant of claim 53, wherein the polypeptide from B. 
thuringiensis is selected from a group comprising Cry1A, 
Cry2A, Cry3A, Cry11A, and Cry51A. 
56. The method according to claim 45, wherein the trans 
formed plant cell comprises a nucleotide sequence encoding 
a polypeptide from Bacillus thuringiensis, Alcaligenes spp., 
or Pseudomonas spp. 
57. The method according to claim 56, wherein the 
polypeptide from B. thuringiensis is selected from a group 
comprising Cry1A, Cry2A, Cry3A, Cry11A, and Crys 1A. 
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